ABSTRACT
Microparticles of hydrogels, also known as microgels, have garnered extensive attention due to their versatile properties and wide range of applications in different fields of science, technology, and medicine. Among the developed technologies to produce microgels, the precise control over fluid handling offered by microfluidics enables particular fine‐tuning of the shape, size, and composition of microgels. This article provides a review of recent progress in the development of microfluidic technologies for the fabrication of microgels based on different hydrogel‐based biomaterials for diverse practical applications. The fundamental principles of different microfluidic‐based techniques for microgel formation are summarized including chip‐based, capillary‐based, valve‐based, three‐dimensional printed, and digital microfluidics. Following, strategies for producing microgels from various natural and synthetic polymers using a range of potential crosslinking techniques with varying sizes, structures (water‐in‐oil, oil‐in‐water, higher order emulsion, and core‐shell), and morphologies (spherical, non‐spherical, Janus, and porous) are discussed in detail. Subsequently, the practical applications of microgels produced via microfluidic technologies are summarized across various fields including cell encapsulation, tissue engineering, particle removal, sensors, and food and nutrition, with current challenges and opportunities highlighted to motivate future research in the field.
Keywords: biomedical science, hydrogel microparticles, microfabrication, microfluidics, microgels
Recent advances in microfluidic technologies for microgel fabrication are critically reviewed, highlighting the capabilities and limitations of major microfluidic platforms and discussing how platform design, material selection, and crosslinking strategies influence microgel architecture and functionality. Current challenges and future opportunities in scalable manufacturing, downstream purification, and application‐driven design are explored to advance biomedical and industrial translation of microgels.

1. Introduction
Hydrogels represent an appealing category of biomaterials based on their ability to retain high water contents [1], enabling their capacity to suppress protein adsorption and/or encapsulate and release bioactive substances such as cells and drugs [2, 3]. The diverse applications of hydrogels are driven by the compositional diversity of hydrogels, both in terms of the choice of the water‐soluble backbone polymer (e.g. natural polymers such as alginate, agarose, dextran, chitosan, hyaluronic acid, gelatin, collagen, and peptides [4] or synthetic polymers such as poly(ethylene glycol), polyglycerol, poly(acrylic acid), poly(vinyl alcohol), and poly(acrylamide) [5]) as well as the crosslinking mechanism [6, 7] (e.g., ionic crosslinking [8], photopolymerization [9], solvent evaporation [10], covalent bonding [11], phase separation [12], and temperature/pH changes [13]), both of which directly impact the swelling, degradation, porosity, and gelation conditions of the resulting hydrogels.
Micrometer‐sized hydrogel particles (hereafter “microgels”) offer many beneficial properties for developing functional biomaterials including their facile injectability, biomimetic mechanics, and ability to regulate diffusion in and out of the gel [14, 15]. Microgels with dimensions between 1 µm and 1000 µm have diverse applications in the biomedical field including tissue engineering [16], drug delivery [17], biosensing [18], and cellular biology [19]. The suitability of microgels for these applications depends on the properties of microgels, which are closely linked to their structure, morphology, composition, and size. Thus, it is important to produce microgels on this size scale in a controlled manner to be able to adjust their properties according to the needs of targeted biological and pharmaceutical applications. However, common techniques for producing microparticles such as emulsion polymerization, dispersion polymerization, solvent extraction, and spray drying have traditionally posed challenges in fabricating microgels with highly uniform sizes [20], largely leading to the production of microgels smaller than 100 µm with high polydispersity and relatively limited control over morphology [21].
In order to address these limitations, various microfabrication technologies including microfluidics [22], photolithography [23], micro‐molding [24], bioprinting [25], and electrohydrodynamic co‐jetting [26] have been recently developed to fabricate microgels with targeted properties. Among these technologies, microfluidics is one of the most effective technologies to produce microgels due to its precise control over fluid flow, small sample sizes, and potential for high throughput [27, 28], enabling the fabrication of microgels with highly controllable structures, compositions, and sizes. Microfluidics involves the precise control of fluid flow in microenvironments [29, 30], which in microfluidic devices typically consist of a series of channels, reservoirs, and valves on the micro‐scale that are patterned on a substrate such as glass, silicon, or a polymer [31, 32, 33]. The microchannels are usually between a few to a few hundred micrometers in size, and the fluid flow can be controlled precisely using external stimuli. From a technological perspective, the behavior of fluids at the microscopic level can exhibit substantial differences compared to what is typically observed at the macroscale [34, 35], facilitating the fabrication of structures or materials that are unprecedented or even unattainable at macroscales [36, 37]. These advantages of microfluidics have led to its use in fabricating microgels and microstructures for diverse application areas such as tissue engineering [38, 39], drug delivery [31, 40], fiber technology [41, 42], diagnostics [32, 43], advanced materials [44, 45], and organ‐on‐a‐chip engineering [46, 47].
In this paper, we provide a systematic review of microfluidic‐based technologies to produce microgels, including chip‐based, capillary‐based, three‐dimensional (3D) printed, digital, valve‐based, and tubular microfluidic devices (Figure 1). We then summarize the main materials and crosslinking mechanisms used for microgel formation coupled with the various structures and morphologies of microgels that are accessible using emerging microfluidic methods. Finally, we critically analyze the use of the resulting microgels in applications including cell encapsulation, tissue engineering, drug delivery, sensors, particle removal, material fabrication, and food and nutrition, linking current application performance with needs for further developments in microfluidic platforms for microgel production.
FIGURE 1.

Microfluidic techniques for microgel fabrication. (A) Microchip schematic of (a) syringe pumps connected to PDMS chip via tubing, (b) flow‐focusing, and (c) T‐junction geometries. (B) Schematic of (a) water‐in‐oil (W/O) single emulsion, (b) core‐shell, and (c) water‐in‐oil‐in‐water (W/O/W) double emulsion fabrication using a capillary microfluidic device. (C) Schematic of a 3D‐printed microfluidic device. (D) Schematic of a digital device illustrating (a) two hydrogel precursors, (b) merging and mixing, (c) splitting, and (d) the resulting microgels formed. (E) Schematic of a valve‐based device with valves to (a) control droplet formation, (b) immobilize single droplets, and (c) sort droplets through different channels. (F) Schematic of tubular microfluidic devices with syringe pumps connected to a flow‐focusing junction piece with tubing.
2. Microfluidic‐Based Techniques to Produce Microgels
2.1. Chip‐Based Microfluidic Devices
Chip‐based microfluidic devices control the flow of fluids through microchannels of varying geometries to produce monodisperse microgels. Continuous and dispersed phase fluids are typically introduced into the inlets of the microfluidic chip using syringe pumps, and microgels are formed within the microchip and subsequently collected after eluting from the outlet tubing [48]. By varying the channel geometry and/or the flow rate of the inlet fluids, the size, shape, and composition of the microgels can be controlled [49, 50]. Table 1 summarizes different types of chip‐based microfluidic devices used for various types of microgel production.
TABLE 1.
Chip‐based microfluidic devices for the fabrication of microgels made from different materials having various sizes and morphologies for diverse applications.
| Microfluidic device material | Microgel fabrication mechanism | Microgel material | Crosslinking mechanism | Microgel size (µm) | Microgel morphology | Application | Reference |
|---|---|---|---|---|---|---|---|
| Polydimethyl‐siloxane (PDMS) | Flow focusing | Alginate | Competitive ligand exchange crosslinking | 106 | Spherical (W/O) | Nanoparticle encapsulation | [53] |
| Ionic crosslinking | 70–100 | Spherical (W/O) | Heavy metal removal (Cu2+ and Ni2+) | [72] | |||
| Ionic crosslinking | 15 | Biconcave (W/O) | Antibody encapsulation | [86] | |||
| Ionic crosslinking | 196 | Spherical, multicompartment (W/O) | Encapsulation of fluorescent nanoparticle, magnetic bead, and HUVEC and HepG2 cells | [87] | |||
| Ionic crosslinking | 45–65 | Disk‐shaped (W/O) | Cell analysis | [88] | |||
| Poly(ethylene glycol) diacrylate (PEGDA) | Photopolymerization | 60–100 | Spherical (W/O) | Detection of bioactive molecules (Neutravidin) | [89] | ||
| Michael‐type addition reaction | 55 | Spherical (W/O) | Bacteria detection (Pseudomonas aeruginosa) | [18] | |||
| Photopolymerization | 88 | Spherical (W/O) | Protein detection (streptavidin) | [64] | |||
| Photopolymerization | 48 | Janus (W/O) | DNA detection | [90] | |||
| Photopolymerization | 50 | Janus (W/O) | Viral encapsulation | [91] | |||
| Photopolymerization | 150–450 | Rod‐shaped (W/O) | Bioprinting, actuators, micro‐ and nanoelectronics, medical applications | [92] | |||
| Poly(N‐isopropylacrylamide) (PNIPAM) | Photopolymerization | 2.5 | Janus (W/O) | Controlled self‐assembly | [93] | ||
| Photopolymerization | 200 | Janus (W/O) | Magnetically responsive | [77] | |||
| Photopolymerization | 100 | Spherical, core‐shell (W/O) | Controlled release of dextran and rhodamine‐B | [94] | |||
| Gelatin methacryloyl (GelMA) | Photopolymerization | 30–115 | Spherical (W/O) | Bioactive delivery (tetracycline hydrochloride) | [62] | ||
| Temperature change | 70–120 | Spherical (W/O) | Cell scaffold fabrication | [95] | |||
| Star‐PEG | Photopolymerization | 20 | Spherical (W/O) | Cholera toxin removal | [96] | ||
| Michael‐type addition reaction | 50–350 | Rod‐shaped (W/O) | Cell encapsulation (normal human dermal fibroblasts) | [16] | |||
| Agarose | Temperature | 100 | Spherical, water‐in‐oil (W/O) | Cell encapsulation (hPSCs) | [48] | ||
| Dextran + alginate | Ionic crosslinking | ∼50 | Spherical with spikes (W/W) | Drug delivery | [54] | ||
| Carboxymethyl cellulose | Ionic crosslinking | ∼300–1800 | Spherical, rod‐shaped, star‐like, ellipsoidal (W/O) | Food, enhanced oil recovery, medical treatments, drug delivery | [71] | ||
| 4‐Arm poly(ethylene glycol)‐maleimide (PEG‐4MAL) | Michael‐type addition reaction | 200 | Spherical (W/O) | Protein encapsulation (VEGF) | [97] | ||
| Gelatin | Temperature | 40–140 | Spherical (W/O) | Cell encapsulation (C2C12 cells) | [98] | ||
| Polyvinyl alcohol (shell), drug solution (core) | Photopolymerization | 200 | Spherical, core‐shell (W/O) | Drug delivery (bevacizumab + docetaxel) | [99] | ||
| Dextran | Horseradish peroxidase catalyzed crosslinking | 65–111 | Spherical (W/W) | Cell encapsulation (HepG2) | [100] | ||
| PNIPAM + polyacrylamide (pAAm) | Photopolymerization | 60 | Spherical and Janus (W/O) | Encapsulation and controlled release of drugs | [63] | ||
| PNIPAM + poly(anhydride) | Photopolymerization | 40–70 | Janus (W/O) | Water and oil emulsion stabilization | [101] | ||
| HE800 exopolysaccharide | Ionic crosslinking | 102 | Spherical (W/O) | Protein encapsulation (BSA) | [65] | ||
| PEG norbornene (PEGNB) | Photopolymerization | 90–130 | Spherical (W/O) | Cell encapsulation (A549 cells) | [58] | ||
| 1,2,4,5‐Benzene tetracarboxylic acid (BTA) and 4‐hydroxy pyridine (PHP) | Temperature change | 15–105 | Spherical (W/O) | Drug delivery, bioseparation, biosensors | [102] | ||
| Poly(ethylene glycol) methyl ether acrylate (PEGMEA)/PEGDA | Photopolymerization | 40–200 | Spherical (W/O) | Drug or cell delivery | [68] | ||
| T‐junction | Alginate | Ionic crosslinking | 94–150 | Spherical (W/O) | Cell encapsulation (Jurkat cells) | [69] | |
| Ionic crosslinking | 350 | Spherical (W/O) | Spheroid fabrication for drug testing | [85] | |||
| PEGDA | Photopolymerization | 40–160 | Spherical (W/O) | Biomedical applications | [84] | ||
| Carboxymethyl cellulose + dextran | Hydrazone crosslinking | 25–200 | Spherical (W/O) | Cell encapsulation, drug delivery, biosensors | [11] | ||
| Modified T‐junction | Alginate | Ionic crosslinking | ∼100–400 | Spherical (W/O) | Encapsulation of bioactive or cellular material | [83] | |
| Flow focusing (2 junctions) | Acrylamide + magnetic monomer | Photopolymerization + temperature | 75 | Spherical, oil‐in‐water‐oil(O/W/O) | Magnetically responsive | [78] | |
| Flow focusing (3 junctions) | Alginate (shell), protein solution (core) | Ionic crosslinking | ∼70–100 | Spherical, core‐shell (W/O) | Protein encapsulation, drug delivery | [75] | |
| Parallel flow focusing (6 junctions) | PEG‐4MAL | Covalent crosslinking | 60–100 | Spherical (W/O) | Cell encapsulation (hMSC) | [81] | |
| Flow focusing + T‐junction | Chitosan lactate | Ionic crosslinking | 104 | Spherical (W/O) | Cell encapsulation (hMSC) | [74] | |
| Flow focusing (2 junctions) + T‐junction | Alginate | Ionic crosslinking | 12–100 | Spherical, rod‐shaped, disk shaped, threads, plugs (W/O) | Drug carriers, immobilization matrixes for bioreactor systems, tissue engineering | [73] | |
| Flow focusing + picoinjection | Alginate | Ionic crosslinking | 8–30 | Spherical and non‐spherical (W/O) | Long‐term cell culturing, immobilization of protein components | [52] | |
| Stop flow lithography | PEGDA | Photopolymerization | 250 | Rectangular | Nucleic acid detection | [103] | |
| 100 | Cuboidal | Cell adhesion | [104] | ||||
| ∼4.5–24 | Rectangular with height gradient | Magnetically responsive material | [105] | ||||
| 200 | Square‐shaped | Patterned cell adhesion | [106] | ||||
| 100–400 | Square‐shaped, triangular, spherical | Cell encapsulation (NIH 3T3 cells) | [107] | ||||
| PEGDA + acrylic acid | Photopolymerization | 20–300 | Disc, triangular, rectangular, Janus | Production of nanoparticle‐embedded magnetic particles | [108] | ||
| Hydrodynamic focusing lithography | PEGDA | Photopolymerization | 20–150 | Multicompartment triangular, pentagonal, ring‐shaped | Protein conjugation, production of new complex particles | [109] | |
| Poly(methyl methacrylate) (PMMA) | Flow focusing | Carrageenan + egg whites | Glutaraldehyde (covalent) + temperature | 200–220 | Spherical (W/O) | Food and nutrition | [56] |
| Polydimethylacrylamide | Redox polymerization and photopolymerization | 400–1000 | Spherical (W/O) | Photocatalysts for organic synthesis or water splitting for hydrogen production | [110] | ||
| Poly(2‐hydroxyethyl methacrylate) | Photopolymerization | 19–112 | Spherical (W/W) | Synthesis of biocompatible and biodegradable materials for green chemistry | [111] | ||
| Flow focusing + T‐junction + coaxial | Dextran/PEGDA/alginate | Horseradish peroxidase catalyzed crosslinking/photopolymerization/ionic crosslinking | 40–400 | Spherical, fiber, Janus core‐shell (W/O) | Controlled production of micromaterials | [112] | |
| Perfluoropolyether | Stop flow lithography | PEGDA | Photopolymerization | ∼15–200 | Triangular, rectangular, cylindrical, | Anti‐counterfeiting application | [113] |
| PDMS + glass | Flow focusing + coaxial | PEG + dextran | Phase separation | Double emulsion: ∼200–325; triple emulsion: ∼210–300 | Spherical, double and triple W/W emulsions | Encapsulation of target cells and biomolecules | [76] |
| Glass | Flow focusing | Alginate (shell), type 1 collagen (core) | Ionic crosslinking | 100–200 | Spherical, core‐shell (W/W/O) | Cell encapsulation (BMSCs) | [114] |
| Whey protein | Temperature + pH change | 40–100 | Spherical (W/O) | Food and nutrition | [60] | ||
| T‐junction | Poly(ferrocenylsilane) | Photopolymerization | 5–12 | Spherical, oil‐in‐water (O/W) | Redox‐responsive | [61] |
Chip‐based microfluidic devices can be made of various materials, with polydimethylsiloxane (PDMS) the most common choice based on its transparency, elastomeric properties, ease of fabrication (via a commercially available two‐component kit), gas permeability, relative cytocompatibility, and low cost [27, 51]. To fabricate PDMS chips with microchannels, the soft lithography technique is most commonly used [52, 53, 54, 55] in which a wafer mold is first constructed by designing a patterned photomask for microchannels, placing it on a photoresist‐coated silicon wafer, and exposing the coated wafer to UV light. The UV exposure imprints the desired microchannel pattern on the wafer by crosslinking the photoresists at the exposed area, resulting in the fabrication of a mold. A PDMS mixture is then poured onto the mold and heated to facilitate the curing of the PDMS elastomer, after which the cured PDMS slab with the desired microchannel pattern is removed from the mold. The inlet and outlet connections are created by punching holes through the PDMS slab which is then bonded to a glass slide to create the microfluidic chip [52].
As an alternative to PDMS, poly(methyl methacrylate) (PMMA) has also been used for chip fabrication based on its compatibility with physiological fluids, optical transparency, low cost, and ease of manufacturing given that PMMA fabrication does not require clean room facilities [56]. Unlike PDMS, PMMA does not typically swell in contact with organic solvents, which could potentially expand the use of microchips to applications that require the use of polar solvents [57]. However, PMMA is gas impermeable and much stiffer, both properties that may pose challenges in some cell‐related applications [58]; alternately, gas impermeability can in some cases be advantageous to prevent evaporation during one or more incubation steps [59]. Glass microfluidic devices have also been fabricated via wet‐etching, although their fabrication process is typically more costly than PDMS and PMMA [60, 61]. Glass‐based devices offer the benefits of transparency and (particularly compared to PDMS or PMMA) enhanced solvent compatibility but suffer from the same glass impermeability drawbacks as PMMA devices while also being significantly easier to break.
To produce microgels from chip‐based devices, continuous and dispersed phases flow through their respective channels until they meet at a junction. Droplets are then rapidly formed at the junction as the shear stress of one of the fluids (typically the continuous phase) overcomes the interfacial tension of the other fluid (typically the dispersed phase) [62, 63]. The balance between viscous and interfacial forces is commonly represented by the capillary number (Ca), with droplet formation typically occurring over a range of critical Ca values that depend on the interfacial tension and both the viscosity and velocity of the continuous phase [64, 65]. To demonstrate the effect of Ca on microgel formation, Celetti et al. held all other variables constant while varying Ca by changing the continuous phase flow rate [64]. As seen in Figure 2A, when Ca was within a certain range, droplet formation was stable and the microgels were monodisperse; however, unstable droplet formation occurred outside of this range. However, while Ca is the primary predictive parameter used to predict efficient droplet formation, stable droplet formation in practical microfluidic systems is also influenced by factors including channel wettability, surfactant dynamics, the viscosity ratio between the dispersed and continuous phases, and device geometry that must also be considered in device design [66, 67].
FIGURE 2.

Chip‐based microfluidic devices for microgel fabrication. (A) Diagram illustrating (a) elongation flow, (b) stable emulsions, and (c) unstable emulsions from a flow‐focusing device based on the dispersed phase flow rate (Q p) and the capillary number (Ca). Adapted from the literature [64]. Copyright 2016, with permission from Elsevier. (B) Optical image of a flow‐focusing microfluidic device used to produce calcium alginate microgels. Adapted from the literature [72]. Copyright 2021, with permission from Elsevier. (C) Schematic of multiple flow‐focusing junctions in series to produce O/W/O double emulsions. Depending on the flow rates used, the microgels can have one or two encapsulated cores. Reprinted with permission from the literature [78]. Copyright 2009 Wiley. (D) Schematic of a parallel microfluidic device with six flow‐focusing junctions to produce microgels at an increased rate. Adapted from the literature [81]. (E) Microscopy image of a T‐junction device illustrating the continuous phase (black arrow) forcing the dispersed phase (green arrow) into droplets. Adapted from the literature [82] under a Creative Commons Attribution license 4.0 (CC BY). (F) Schematic of a modified T‐junction device with an additional channel at the junction to improve the crosslinking process. Adapted from the literature [83]. Copyright 2008, with permission from Elsevier.
The size of microgels produced from microchips is dependent on the flow rates and viscosities of the fluids as well as the size of the microchannels, all of which are adjustable for producing microgels of desired diameters [63, 64]. Dang et al. investigated the effects of these factors on the size of PEG microgels using a PDMS flow‐focusing microchip [68]. Doubling the width of the microchannels reduces the velocity of fluid and thus increases microgel diameter, increasing the continuous phase flow rate increases the fluid velocity and thus decreases the microgel diameter, and increasing the dispersed phase flow rate leads to an increase in diameter due to more of the dispersed phase volume being injected into each droplet. It is important to note that the flow rates can only be varied to values within a certain range to maintain an acceptable ratio of the continuous and dispersed phase flow rate, with flow rates outside of this range resulting in unstable droplet formation [68].
Two main microchannel junction geometries are used for microgel fabrication: T‐junction and flow‐focusing. T‐junction geometries consist of a continuous phase channel and a single perpendicular dispersed phase channel (Figure 2B); in contrast, flow‐focusing geometries typically consist of a single inner dispersed fluid channel with two outer continuous fluid channels approaching it from either side (Figure 2C). In both cases, the shear force of the continuous phase flow breaks the dispersed phase flow into droplets that are then subsequently crosslinked to form microgels [18, 69]. While both geometries form monodisperse microgels, T‐junctions perform best at lower Ca numbers while flow‐focusing geometries perform better at higher Ca numbers [70]. Although the single inlet of T‐junction devices make them simpler than flow‐focusing chips that have at least two inlets, flow‐focusing chips produce droplets at a faster rate [70], leading flow‐focusing microchips to be the most commonly used microfluidic devices for microgel fabrication [22, 48, 68, 71, 72].
Several modifications have been made to the typical flow‐focusing geometry to address the specific challenges of gelling the microfluidic emulsion droplets formed into microgels [73, 74]. For example, Ahmed et al. fabricated microgels using the flow‐focusing mechanism in which alginate was pinched off by an oil phase followed by a picoinjection site in which a calcium solution was merged into the alginate droplets via electrocoalescence to crosslink the microgels [52]. Alterations have also been made to the flow‐focusing design to produce core‐shell or higher order emulsions [75, 76, 77]. For example, oil‐in‐water‐in‐oil (O/W/O) double emulsion magnetic microgels were fabricated using two flow‐focusing junctions in series [78], with a magnetic oil solution formed into droplets by the shear stress from an aqueous solution at the first flow‐focusing junction followed by a secondary oil phase pinching off the oil‐in‐water emulsion from the first step in the second flow‐focusing junction to make aqueous microgels encapsulated with a magnetic fluid (Figure 2C). In principle, any composite microgel with any number of phases could be fabricated using a similar approach. Beyond droplet generation and gelation, post‐processing represents an important consideration in the practical implementation of microgel fabrication strategies. Because droplet generation commonly relies on using a mixture of oil and surfactant as the continuous phase to generate stable droplets, subsequent washing and purification are generally required to remove residual oil and surfactant before biomedical applications. The purification of microgels from oil phases does not typically significantly modify the structural integrity of the microgel and can often be effectively implemented and reproduced in practical applications via flow‐based filtration strategies [79, 80]. However, particularly in cell encapsulation systems, the precise solvent used and the method used to remove the solvent can have significant impacts on the cell viability that can be maintained following post‐processing. Moreover, the complete removal of surface‐bound oil droplets and surfactant residues can be challenging, highlighting the need for efficient purification strategies to ensure the cytocompatibility and subsequent biological performance of the microgels. As such, customized purification strategies may be required depending on the specific material system and the targeted application of the microgel.
Although flow‐focusing devices rapidly fabricate microgels, throughput is still limited given that the geometry inherently only allows for one droplet to be produced at a time. To overcome this challenge, Headen et al. developed a two‐layer microfluidic device with six flow‐focusing junctions in parallel [81]. On the lower layer, the dispersed and continuous phase met at six parallel junctions to form the droplets which subsequently traveled to the top layer to merge with a crosslinking agent, after which all channels were merged together to exit the chip (Figure 2D). The addition of the parallel flow‐focusing junctions increased the microgel throughput by 600% without affecting the monodispersity or size of the microgels when compared to single channel devices.
While the perpendicular geometry of T‐junctions makes them easier to fabricate, it also reduces the options for effectively adding crosslinker into a microgel‐based fabrication process (Figure 2E) [69, 82, 84]. Some studies have made slight modifications to the geometry to better control on‐chip gelation. Amici et al. added an acid stream to the T‐junction that triggered the controlled release of calcium to enable alginate crosslinking at the time of droplet formation (Figure 2F) [83]. Similarly, Sabhachandani et al. added an extra channel to the T‐junction to supply calcium to the alginate microgel for crosslinking purposes [85], with the third calcium solution channel opened after the droplet fabrication was complete to add calcium to the droplet holding area and induce gelation.
2.2. Capillary‐Based Microfluidic Devices
Capillary microfluidic devices use capillaries to produce single and higher‐order emulsions. Table 2 summarizes the use of capillary‐based microfluidic devices for microgel production. Glass capillary devices are most commonly used due to their efficient microchannel alignment (allowing for all fluid flow along the same axis) as well as their compatibility with a wide range of chemicals [115]. Although the fabrication process is expensive and time‐consuming, there are designs that utilize commercially available pre‐made parts to accelerate the process [115]. Coaxial geometries in which circular capillaries are concentrically aligned inside square capillaries (also referred to as co‐flow) are most commonly used (Figure 3A) [116]. Similar to microgel formation in microchips, microgels are formed when the shear force of the outer fluid overcomes the interfacial tension of the inner fluid when the two immiscible fluids meet at the orifice of the injection capillary [76]. The resulting microgels flow through the collection capillary where they are removed from the device. Syringe pumps are commonly used to flow the dispersed phase through the injection capillary and the continuous phase in the same direction through the space between the inner and square capillary. The size of the resulting microgels is mainly dependent on the flow rates of the fluids as well as the diameter of the injection capillary tip, which can be tapered using a micropipette puller to achieve a desired orifice size [40, 116]. As an alternative to coaxial geometry, a flow‐focusing setup can also be used consisting of a single cylindrical collection capillary inside a square capillary [117, 118]. In this geometry, the dispersed fluid flows in the square capillary toward the collection capillary while the continuous phase flows in the opposite direction between the collection and square capillaries. When the two immiscible fluids meet, the flow of the continuous phase focuses the dispersed phase into the collection tube to form microgels [117, 118]. For both geometries, the surface of the capillaries is treated so that the surface of the injection capillary is hydrophilic and the surface of the collection capillary is hydrophobic for W/O emulsions; the opposite is done for O/W emulsions [119].
TABLE 2.
Capillary‐based microfluidic devices for the fabrication of microgels made from different materials having various sizes and morphologies for diverse applications.
| Microfluidic device material | Microgel fabrication mechanism | Microgel material | Crosslinking mechanism | Microgel size (µm) | Microgel morphology | Application | Reference |
|---|---|---|---|---|---|---|---|
| Glass | Coaxial | Alginate | Ionic crosslinking | 40–300 | Hemi‐spherical, mushroom‐like, disk‐like, plug like (W/O) | Drug delivery (iopamidol) | [40] |
| Alginate + PNIPAM | Ionic crosslinking | 190–380 | Tear drop, lamp‐like, mushroom‐like, double‐dimpled, bowl‐like (W/O) | Construction of lock–key particles and self‐propelled particles, modeling of macromolecules | [128] | ||
| Alginate (shell), cell media (core) | Ionic crosslinking | 200–600 | Spherical, core‐shell (W/W/O) | Cell encapsulation (HepG2 and NIH 3T3 cells) | [120] | ||
| Alginate + echium oil | Ionic crosslinking | 115–227 | Spherical (O/W/O) | Food and nutrition | [122] | ||
| Alginate (with polyethylene glycol (PEG) and dextran) + chitosan | Ionic crosslinking | 210–238 (alginate), 124–144 width × 350–433 length (chitosan) | Teardrop‐like, peach‐like, cap‐like, mushroom‐like, dimple‐like, convex‐like, red blood cell‐like, and snowman‐like | Drug delivery, tissue engineering, and optical materials | [129] | ||
| Gelatin methacryloyl (GelMA) | Photopolymerization | 165 | Spherical (W/O) | Cell encapsulation (BMSC) | [9] | ||
| Gellan | Ionic crosslinking | 185–342 | Spherical (W/O) | Food and nutrition | [119] | ||
| Polyethylene glycol diacrylate (PEGDA) | Photopolymerization | 320 | Spherical (W/O/W) | Detection of toxic molecules | [121] | ||
| PEGDA + graphene oxide | Photopolymerization | 150–350 | Spherical (W/O) | Oil decontamination | [130] | ||
| Star‐PEG‐acrylate (shell), PBS (core) | Photopolymerization | 80–155 | Spherical, core‐shell (W/O/W) | Biomolecule encapsulation | [125] | ||
| Poly(N‐isopropylacrylamide) (PNIPAM) + alginate | Ionic crosslinking | 150–300 | Mushroom‐like, Janus (W/O) | Temperature responsive | [8] | ||
| PNIPAM | Photopolymerization | 400 | Spherical (W/O/W/O) | Pharmaceutics, food, cosmetics, and separation | [123] | ||
| Poly(vinyl alcohol) (PVA) | Photopolymerization | 150–200 | Spherical (W/O/W) | Polymer‐based microcapsules for mechanically triggered release | [127] | ||
| Poly(2‐methacryloyloxyethyl phosphorylcholine) | Photopolymerization | ∼250 | Spherical (W/O) | Liposome encapsulation | [131] | ||
| Coaxial + flow focusing | Polyacrylamide | Photopolymerization | 100–150 | Spherical (W/O) | Optical applications | [117] | |
| Polyacrylamide + PNIPAM | Photopolymerization + phase separation | ∼120 | Spherical, Janus (W/O) | Magnetically actuated displays, applications requiring directional orientation or transportation of particles | [118] | ||
| PDMS + glass | Flow focusing + coaxial | PEG + dextran | N/A |
Double emulsion: ∼200–325, Triple emulsion: ∼210–300 |
Spherical, (double and triple W/W emulsions) | Encapsulation of target cells and biomolecules | [76] |
FIGURE 3.

Capillary microfluidic devices to produce microgels. (A) Schematic and optical microscopy image of an injection and collection capillary inside of a square capillary to produce single emulsion W/O microgels. Adapted from the literature [119]. Copyright 2020, with permission from Elsevier. (B) Schematic illustration of two concentrically aligned cylindrical capillaries within square capillaries for mild and rapid gelation of core‐shell microgels. Adapted with permission from the literature [120]. Copyright IOP Publishing. All rights reserved. (C and D) Schematic and optical microscopy images of (C) W/O/W and (D) O/W/O double emulsions using two coaxially aligned capillaries with opposing flows of immiscible fluids in the region between the cylindrical and square capillaries. Adapted with permission from the literature [121]. Copyright 2019 Wiley. Adapted from the literature [122]. Copyright 2017, with permission from Elsevier. (E) Schematic of single emulsion capillary devices in series to produce third order water‐in‐oil‐in‐water‐in‐oil (W/O/W/O) microgels. Adapted from the literature [116, 123] with permissions from the Royal Society of Chemistry. Copyright 2007 Wiley.
Relative to chip‐based devices, capillary microfluidic devices are more commonly used to fabricate monodisperse higher‐order emulsions. For example, core‐shell microgels can be fabricated using capillary devices in which the core and shell phases flow in their respective concentrically aligned capillaries and the continuous fluid flows in the same direction in the region between the outer round capillary and the square capillary (Figure 3B) [120, 124]. To produce double emulsions, the injection and collection capillaries are typically arranged in the same coaxial alignment as used for single emulsions with the inner fluid flowing through the injection capillary, the middle fluid flowing through the space between the injection and square capillary in the same direction, and the outer fluid flowing in the opposite direction through the space between the collection and square capillary (Figure 3C,D) [121]. When all three fluids meet at the end of the injection capillary, the balance of forces results in the formation of double emulsion‐templated microgels that subsequently exit the device through the collection capillary [121, 122]. When the inner and outer fluids are aqueous solutions and the middle fluid is an oil, W/O/W double emulsions are made; the opposite set‐up of fluids is used to fabricate O/W/O double emulsions [121, 122, 125, 126, 127]. Higher order emulsions such as W/O/W/O microgels have also been fabricated using more complex capillary devices. For example, in a study done by Chu et al., three single emulsion devices were used in series to produce triple emulsions in which the inner, inner middle, outer middle, and outer fluid are composed of aqueous, oil, aqueous, and oil solutions, respectively (Figure 3E) [123]. Single emulsions are fabricated in the first device in series, with the inner fluid inserted through the injection capillary and the inner middle fluid flowed in the same direction through the space between the injection and square capillaries. The produced microgels then enter the second device in series through the injection capillary, with the process repeated until W/O/W/O emulsions are fabricated and exit the device via the collection tube [123].
In addition to their structural versatility, capillary‐based microfluidic devices present practical advantages during downstream processing. Because glass capillaries exhibit excellent chemical resistance, they are compatible with a broader range of organic solvents than the polymeric materials commonly used in chip‐based microfluidic devices. This compatibility enables the fabrication of microgels from precursor solutions that require organic solvents and facilitates the subsequent washing and purification steps needed to remove residual oil phases, surfactants, or solvent residues. As such, capillary‐based platforms are particularly attractive for applications involving solvent‐sensitive precursor systems or complex emulsion‐templated microgels in which efficient post‐processing is essential for preserving microgel integrity and functionality.
2.3. 3D Printing
Three‐dimensional (3D) printing technology represents a rapid and cost‐effective strategy to fabricate microfluidic devices with geometric degrees of freedom in not only 2D but also 3D, facilitating the fabrication of microgels with different morphologies [132, 133]. Table 3 shows a summary of 3D‐printed microfluidic devices used for microgel production. With proper 3D resin selection, the microfluidic device materials can be designed to be optically transparent, biocompatible, and/or compatible with a wide range of chemicals similar to chip‐based and capillary‐based devices [134]. However, in contrast to chip‐or capillary‐based devices, 3D printing offers a significant advantage in terms of minimizing the dead volume and footprint of the device and thus save both material and fabrication time [135]. For example, when compared to a glass capillary device, a 3D printed version of the same device was reported to have 20 times less dead volume [19]. 3D printing also better enables the fabrication of parallelized devices that are compact and easy to produce, resulting in higher microgel throughput [134, 136]. For example, Femmer et al. developed a microfluidic device with 28 parallel junctions that can produce droplets at a rate of 3 L/h (Figure 4A) [133]. However, the microfluidic device geometry is limited by the resolution of the 3D printer, especially in hollow channels. Improved resolution can be achieved by optimizing the curing process of the device material or using more expensive 3D printers with higher resolution [134, 136], with photolithography chip‐based strategies preferred if high‐resolution features are required.
TABLE 3.
3D printed microfluidic devices for the fabrication of microgels made from different materials with various sizes and morphologies for diverse applications.
| Microfluidic device material | Microgel fabrication mechanism | Microgel material | Crosslinking mechanism | Microgel size (µm) | Microgel morphology | Application | Reference |
|---|---|---|---|---|---|---|---|
| Visjet M3 Crystal | Diffusion mixing pattern | Alginate | Ionic crosslinking | 0.3–1.7 | Spherical (W/O) | Drug delivery | [140] |
| VisiJet M2R‐CL | Flow‐focusing | 400 | Spherical (W/O) | Antifouling liposome encapsulation | [137] | ||
| PDMS | Airflow needle | 1240–1380 | Spherical, multicomponent (W/W) | Encapsulation of human umbilical vein endothelial cell (HUVEC) and mesenchymal stem cell (MSC) | [139] | ||
| VeroClear RGD810 | Parallel coaxial (4 junctions) | Six‐armed poly(ethylene‐co‐propylene glycol) (Star‐PEG) | Photopolymerization | 500 | Spherical (O/W/O) | Long‐term release, cell encapsulation | [134] |
| eShell600 | Parallel flow‐focusing (28 junctions) | 500 | Spherical (W/O) | Selective extraction and purification, oral drug delivery, biomedical applications | [133] | ||
| PlasCLEAR | Coaxial | Alginate (shell), Matrigel (core) | Photopolymerization | 136 | Spherical, core‐shell (W/W) | Cell encapsulation (hNSC) | [19] |
| Photoreactive resin (R11) | Coaxial | Alginate (shell), collagen (core) | Ionic crosslinking | 250–500 | Spherical, double emulsion (W/O, W/O/W) | Cell encapsulation (NIH 3T3) | [138] |
| Polyamide (SLS PA 2200) + polypropylene (SI‐25) | Hydrodynamic focusing micromixers | Alginate (shell), peptide solution (core) | Ionic crosslinking | 98–179 | Spherical, core‐shell (W/W) | Peptide encapsulation (polymyxin B) | [135] |
| ABS‐like resin | T‐junction | Polyethylene glycol diacrylate (PEGDA) | Photopolymerization | 39–1404 | Spherical (W/O) | Mass production for chemical and biological applications | [132] |
| PIC100 resin | Parallel flow‐focusing (3 junctions) | Dextran | Horseradish peroxidase catalyzed | 200 | Spherical (W/O) | Cell encapsulation (MSC) | [136] |
FIGURE 4.

3D printing‐based microfluidic devices for microgel production. (A) (a) Schematic and (b) corresponding micrograph of a 3D‐printed parallelized device with 28 droplet forming junctions used to increase microgel throughput. Reprinted with permission from the literature [133]. Copyright 2015 American Chemical Society. (B) Schematic and corresponding image of 3D‐printed modules connected to form coaxial devices to produce (a) W/O/W droplets and (b) double‐layered fibrous microgels. Adapted from the literature [138]. Copyright 2018, with permission from Elsevier. (C) Schematic illustration of a 3D‐printed screw‐and‐nut based device with a height adjustable T‐junction to control the microgel diameter. Reprinted from the literature [132]. Copyright 2019, with permission from Elsevier. (D) Schematic of (a) the 3D‐printing set‐up to fabricate unique microspheroid structures and (b) the PDMS microchip used as the print nozzle for a 3D‐printer. Adapted with permission from the literature [139]. Copyright 2018 Wiley.
To 3D print microfluidic devices, the 3D device is designed using a computer‐aided design program and then sliced into 2D vertical layers which are then printed layer‐by‐layer via a 3D printer [132, 137]. A variety of microfluidic device geometries including flow‐focusing, coaxial, and T‐junction has been 3D printed using these techniques [132, 137, 138], with more complex designs and designs that have void spaces typically requiring the co‐printing of support structures during the printing process that are later removed prior to use by high pressure and chemical washing [134]. A variety of 3D printing technologies including stereolithography (SLA), digital light processing (DLP), photopolymer inkjet printing (Polyjet), and fused deposition modeling (FDM) can be used depending on the target device geometry. SLA, DLP, and Polyjet printers all use photoreactive liquid resins that are extruded from the nozzle and are subsequently cured using a light source, typically UV light [19, 134, 138]. In contrast, FDM prints by extruding a melted form of the printing material that immediately cools down and hardens into solid form following deposition. Since the FDM technique results in a rougher surface that can potentially affect the fluid mechanics inside the device, it is less commonly used than the other strategies for microfluidic device fabrication [132].
Relative to other fabrication methods, 3D printing allows significantly more flexibility in that that the device can be printed in multiple separate parts to allow for different connections and the device geometry can be easily adjusted as needed without costly or time‐consuming photomasking or coaxial capillary alignment procedures. For example, Morimoto et al. fabricated multiple coaxial modules connected via screw threads, with the number and type of connected modules determined the shape and order of microgels produced (Figure 4B) [138]. A similar idea was used for the fabrication of a T‐junction device incorporating a screw piece vertically connected to the device by a screw‐and‐nut combination at the junction area, with the vertical gap height of the junction (and consequently the microgel size) controllable based on how far the screw was inserted into the device (Figure 4C) [132]. 3D printing also allows for the fabrication of novel devices that may be difficult to fabricate with other methods that cannot reproduce the z‐axis resolution or patterning capacity of 3D printing. For example, a 3D printed three‐way co‐extrusion device can be used to form a multi‐layered jet that produces microgels when the jet stream becomes spontaneously unstable [19], while 3D printed micromixer devices can force different inlet fluids to meet in a large flow region and drive microgel formation due to different mixing principles [135]. The design freedom that 3D printers offer thus allows more options for microgel fabrication than any other method.
While 3D printing is typically used to fabricate microfluidic chips that can then be used to produce microgels using a separate process, a PDMS microfluidic device has also been reported to be used as the nozzle of a 3D printer to directly produce microgels [139]. Subjecting the microgels to airflow at the outlet of the printing needle causes the microgel components to rotate with respect to each other, resulting in unique microgel structures (Figure 4D) [139]. Beyond enabling the fabrication of complex microgel architectures, 3D printed microfluidic devices also offer practical advantages for downstream processing. The ability to fabricate complex 3D geometries in a single manufacturing step facilitates the integration of multiple processing units such as droplet generation, mixing, gelation, and washing into a single microfluidic platform. Such integrated designs can reduce manual handling and sample transfer between fabrication steps, thereby minimizing processing time and the risk of sample contamination or microgel damage. However, when oil phases or surfactants are employed for droplet generation, conventional washing and purification steps remain necessary before the resulting microgels can be used in biomedical applications.
2.4. Digital Microfluidics
While the previously described continuous microfluidic techniques are most popular, digital microfluidics (DMF) can also be used to fabricate microgels. Table 4 summarizes different examples of digital microfluidic platforms used to produce microgels. DMF utilizes electric forces to manipulate small volumes of fluids and other materials (e.g., cells) across electrodes to form microgels via the splitting, merging, and mixing of different reagents [141, 142]. Unlike other methods, DMF precisely controls each individual droplet's formation and movement, which allows for individual microgels to be screened, analyzed, and addressed [141, 143]. This ability is specifically advantageous for hydrogel cell culture applications in which it is critical to control and analyze cells and their surrounding environment [143, 144]. However, this highly precise control comes with the drawback of low microgel throughput when compared to continuous microfluidic techniques [141].
TABLE 4.
Digital microfluidic platforms for the fabrication of microgels made from different materials having various sizes and morphologies for diverse applications.
| Microfluidic device material | Microgel fabrication mechanism | Microgel material | Crosslinking mechanism | Microgel size (µm) | Microgel morphology | Application | Reference |
|---|---|---|---|---|---|---|---|
| Glass, electrodes, parylene‐C, Teflon | Passive dispensing | Collagen type 1 (core), basement membrane extract (shell) | Temperature | ∼800–1000 | Cuboidal, core‐shell | Cell invasion studies | [144] |
| Glass, electrodes, Teflon | Passive dispensing | Geltrex, type 1 collagen, alginate, agarose, polyacrylamide | Temperature, photopolymerization, ionic crosslinking | 500–2000 | Star, heart, triangle, diamond | 3D cell culture (MDCK) | [141] |
| Electrowetting + dielectrophoresis | Polyethylene glycol diacrylate (PEGDA) | Photopolymerization | 1000 | Cuboidal | Cell encapsulation (NIH 3T3) | [146] | |
| Electrowetting | Alginate | Ionic crosslinking | 500 | Spherical | 3D cell culture (MCF‐7) | [143] | |
| Electrowetting + dielectrophoresis | PEGDA, gelatin methacryloyl (GelMA), Matrigel, polyacrylamide | Photopolymerization, temperature change, chemical crosslinking | 600–3000 | Multicompartment cuboidal and hexagonal | Cell encapsulation (NIH 3T3) | [142] | |
| Glass, electrodes, Parylene‐C, FluoroPEL PFC M1104V | Dielectrophoresis | GelMA | Photopolymerization | 400 | Spherical | Cell encapsulation (HEK 293) | [145] |
DMF devices typically consist of a top and bottom plate connected to trap droplets between them. The first layer of the bottom plate includes a substrate (usually glass) topped with patterned electrodes (most commonly made of indium tin oxide or chromium) designed to produce the actuation electrodes using photolithography or wet etching techniques [142, 145]. A dielectric layer (typically Parylene‐C) is then deposited on the electrodes followed by a superficial hydrophobic layer (e.g., Teflon or FluoroPel) that is used to create a large contact angle between the surface and a hydrophilic droplet [142, 144, 145]. The top layer also consists of a substrate layer topped with electrodes and a hydrophobic layer; however, the electrodes are unpatterned to serve as reference electrodes to the bottom plate [142, 146]. The top and bottom plate are then joined together and connected to external control systems via wires to control and transmit the applied electric signal (Figure 5A,B) [146].
FIGURE 5.

Digital microfluidic devices for microgel fabrication. (A) Schematic of the top and cross‐sectional views of a digital electromicrofluidic platform capable of manipulating suspended particles, liquid droplets, and crosslinked microgels between parallel plates with electrodes and dielectric layers covered with hydrophobic surfaces. Adapted with permission from the literature [142] under a Creative Commons Attribution NonCommercial License 4.0 (CC BY‐NC). (B) Schematic of the materials and design of passive dispensing devices, including the use of hydrophilic sites to aid in droplet formation. Adapted with permission from the literature [141]. Copyright 2014 Springer Nature. (C) Images and schematics of core and shell phase movements illustrating the process of core‐shell microgel fabrication using passive dispensing. Adapted with permission from the literature [144] under a Creative Commons Attribution NonCommercial License 4.0 (CC BY‐NC).
Different techniques can be used to control droplet movement on DMF devices, including but not limited to electro‐wetting‐on‐dielectric (EWOD), dielectrophoresis (DEP), and passive dispensing. EWOD and DEP are both active manipulation techniques. EWOD manipulates conductive droplets by applying a voltage to an electrode adjacent to the droplet, resulting in a spontaneous hydrophobic surface that essentially pulls the droplet onto its surface via a reduction in the droplet's contact angle [146]. The change in the contact angle can be controlled by the amount of voltage used, and the contact angle retreats to the original angle when the voltage is removed [146]. The EWOD technique is however only successful for manipulating conductive materials, with DEP being required for the manipulation of dielectric droplets. DEP moves droplets without significantly altering the contact angle by applying non‐uniform electric fields on the actuation electrodes that force the dielectric droplet to move to higher electric field areas on the DMF device [142, 146]. Alternately, passive dispensing in which hydrophilic sites are patterned onto a hydrophobic surface by removing small areas of a hydrophobic coating can be used [141]. In this case, small volumes of fluid are transported across the hydrophilic sites using an active strategy (e.g., applying driving potentials), with microgels passively produced via surface tension effects [147]. By changing the design or shape of the hydrophilic site, the shape of the resulting microgel can be controlled. For example, Eydelnant et al. fabricated star‐ and heart‐shaped microgels by implementing star‐ and heart‐shaped hydrophilic sites onto their DMF device [141].
Regardless of the droplet movement technique used, the ability of DMF techniques to systematically move and merge volumes of different fluids makes such techniques ideal to fabricate microgels with defined morphologies. Single emulsion microgels are typically made by merging hydrogel precursor droplets with crosslinking agents or by creating single material droplets on the DMF device that are immediately polymerized via thermal or UV methods [141, 143]. Alternately, core‐shell microgels can be fabricated by first driving the core phase across the hydrophilic site followed by driving the shell phase across the same hydrophilic site to create a coating around the core phase (Figure 5C) [144].
Compared to continuous‐flow microfluidic systems, DMF offers a fundamentally different mode of droplet manipulation in which discrete droplets are individually generated, transported, merged, split, and mixed through electrowetting rather than continuous pressure‐driven flow. Consequently, the two platforms exhibit distinct performance characteristics in terms of droplet generation, manipulation, and processing. Continuous‐flow devices typically generate droplets ranging from several micrometers to several hundred micrometers at production rates of hundreds to thousands of droplets per second, making them well suited for high‐throughput manufacturing of monodisperse microgels. In contrast, DMF generally operates with larger droplets typically in the nanoliter‐to‐microliter volume range (corresponding to droplet diameters of several hundred micrometers to a few millimeters) and produces droplets sequentially, resulting in substantially lower throughput [148]. However, the ability to address each droplet independently enables precise control over composition, reagent addition, incubation time, and multistep processing, making DMF particularly attractive for applications requiring programmable reaction sequences or screening of multiple formulations [149].
With respect to viscosity tolerance, continuous‐flow microfluidic devices often experience unstable droplet breakup or channel clogging when processing highly viscous hydrogel precursor solutions, particularly as gelation progresses. Although electrowetting efficiency in DMF can also decrease with increasing viscosity [148], the absence of narrow droplet‐generation junctions generally allows more reliable handling of moderately to highly viscous formulations and reduces the risk of blockage. Furthermore, DMF is particularly advantageous for rapidly gelling systems because gelation can be initiated only after droplet dispensing and mixing, thereby preventing the premature crosslinking and microchannel clogging commonly encountered in continuous‐flow microfluidic systems that typically mandates the use of delayed crosslinking strategies, and/or downstream gelation to avoid clogging during fabrication [150]. Therefore, continuous‐flow microfluidics remains the preferred choice for scalable production of uniform microgels, while DMF is better suited to programmable, low‐volume fabrication involving complex chemistries, rapid gelation reactions, and/or highly customized formulations. Furthermore, since droplet manipulation in DMF platforms is commonly performed without requiring an immiscible continuous oil phase, digital microfluidics can substantially reduce post‐processing associated with oil and surfactant removal, a key potential advantage for cell encapsulation‐based applications.
2.5. Valve‐Based Microfluidic Devices
Valve‐based microfluidic platforms are comprised of multiple layers of one of the previously described microfluidic devices but including a thin membrane layer between the layers that can act as a (micro)valve be used to sort microgels, improve droplet production, and/or immobilize individual microgels.
Table 5 summarizes examples of microgels that have been fabricated using valve‐based microfluidic devices. The opening and closing of valves is often controlled with software to control the frequency and duration of actuation [124, 151], with sensors in some cases incorporated to open and close valves based on microgel properties. For example, a pneumatic valve was incorporated into the outlet region of a flow‐focusing chip to sort microgels depending on their fluorescent intensity; if the fluorescence was high, the valve switched to guide the microgels into a separate channel where they could be collected separately from low fluorescent microgels, enabling up to 98% accuracy in sorting at a throughput of at 50 Hz (Figure 6A) [151].
TABLE 5.
Valve‐based microfluidic devices for the fabrication of microgels made from different materials having various sizes and morphologies for diverse applications.
| Microfluidic device material | Microgel Fabrication mechanism | Microgel material | Crosslinking mechanism | Microgel size (µm) | Microgel morphology | Application | Reference |
|---|---|---|---|---|---|---|---|
| PDMS | Flow focusing | Alginate | Ionic crosslinking | ∼50–80 | Spherical (W/O) | Microgel sorting, cell encapsulation | [151] |
| 90–120 | Spherical (W/O) | Single cell analysis | [152] | ||||
| PDMS | Y‐shaped, flow focusing | Poly(N‐isopropylacrylamide) (PNIPAM) + polypyrrole nanoparticles | Redox reaction | ∼100 | Spherical, core‐shell (W/O) | Delivery of chemotherapeutic drugs to cells | [153] |
| Redox reaction | ∼60 | Spherical, core‐shell (W/O) | Remote modulation of neural activities | [154] | |||
| Redox reaction | ∼17–55 | Spherical, core‐shell (W/O) | Programmable drug release | [155] | |||
| Glass | Coaxial + solenoid valve | Alginate + dextran (shell), carboxy‐methylcellulose (core) | Ionic crosslinking | 360 | Spherical, core‐shell (W/W) | Cell encapsulation (pADSC) | [124] |
| PlasCLEAR | Coaxial | Alginate (shell), Matrigel (core) | Photopolymerization | 136 | Spherical, core‐shell (W/W) | Cell encapsulation (hNSC) | [19] |
FIGURE 6.

Valve‐based and tubular microfluidic techniques for microgel fabrication. (A) Microscopic image of a valve‐based device utilizing a pneumatic valve to (i) detect and (ii) sort microgels depending on whether it had a high (positive) or low (negative) fluorescent intensity. Adapted from the literature [151]. Copyright 2021, with permission from Elsevier. (B) (a) Schematic of a solenoid valve‐based coaxial device and (b) microscope image of droplet formation when switching the valve on and off. Adapted with permission from the literature [124]. Copyright 2019 American Chemical Society. (C) Image of a two‐layer pneumatic valve‐based device used to capture (press‐on) and release (press‐off) cell‐encapsulated microgels. Reprinted with permission from the literature [152]. Copyright 2019 Wiley. (D) Schematic of a tubular device with a flow‐focusing junction and tubing to produce microgels. Adapted from the literature [162]. Copyright 2018 ASME International. (E) Schematic of a tubular device with a T‐junction and attached tubing for microgel fabrication with four observation points: (i) after microgel formation, (ii) at the end of the channel, (iii) at the outlet of the channel, and (iv) at the bottom of the collecting vial. Adapted from the literature [157]. Copyright 2020, with permission from Elsevier.
Valve‐based designs can help to address some of the drawbacks of other types of microfluidic devices. For example, in glass capillary droplet formation when both phases are aqueous, the interfacial tension between the fluids may be reduced thus hinder droplet formation. To overcome this issue, Zhu et al. implemented a solenoid valve in the tubing to connect the shell phase fluid to the capillary to fabricate all‐aqueous core‐shell microgels (Figure 6B) [124]. By temporally opening the valve, the shell phase supply was stopped, allowing the continuous phase to pinch the dispersed phase into droplets at a controlled and consistent rate. Valve‐based devices are also useful for microgel immobilization applications in which it is desirable to analyze and treat individual droplets on‐chip as they exit the microfluidic device. For example, trap‐release regions were implemented on the outlet channel of a flow‐focusing chip using 12 pneumatic microvalves to immobilize cell‐loaded microgels (Figure 6C) [152]; microgels entered the traps by following the path of least resistance and are subsequently immobilized by the closing of a microvalve, with the valve later opened to release the microgels after all the necessary assays have been conducted. Modular microvalve platforms have also been shown to enable the production and in situ trapping of thermoresponsive poly(N‐isopropylacrylamide) (PNIPAM) microgels containing polypyrrole nanoparticles inside a microfluidic channel, with irradiation by an off‐chip laser inducing a volume phase transition in the microgel to control flow inside a microfluidic device in a manner directly applicable to applications including treating cancer cells by delivering pulsatile doses of a chemotherapeutic drug [153], enabling remote modulation of neural activities [154], and facilitating programmable drug release [155]. The trapped microgel could be triggered to open the valve within just 1–2 s, while the closing response time was around 6–8 s [153].
While valve‐based microfluidic devices can address some key challenges in controlling microfluidic processes, the incorporation of valves into microfluidic devices significantly increases both fabrication complexity and cost. As such, valves are typically incorporated only when required to enable sorting, actuation, or other functions that cannot be achieved using continuous or even digital flow‐based devices. In addition, the precise fluid manipulation afforded by valve‐based microfluidic devices facilitates controlled droplet handling and can simplify downstream processing by minimizing sample loss during collection and transfer. However, additional washing and purification steps are inevitably required when oil phases or surfactants are used during droplet generation.
2.6. Tubular Microfluidics
Previously described microchannel‐based techniques can be modified to replace channels with tubing that directly connects the syringe pumps to a junction and the junction to the outlet collection. In this method, the platform employs no microfluidic device or chip but is instead made by connecting tubing and connectors that together function as an integrated microfluidic device in which multiple flow streams can meet or converge to form microgels. This technique, referred to as tubular microfluidics, offers improved flexibility and both time and cost efficiency when compared to chip‐based and capillary microfluidics [156]. Table 6 summarizes existing tubular microfluidic devices used for microgel fabrication.
TABLE 6.
Tubular microfluidic platforms for the fabrication of microgels made from different materials having various sizes and morphologies for diverse applications.
| Microfluidic device material | Microgel Fabrication mechanism | Microgel material | Crosslinking mechanism | Microgel size (µm) | Microgel morphology | Application | Reference |
|---|---|---|---|---|---|---|---|
| Polyether ether ketone (PEEK) | Flow focusing | Poly(ionic liquid) | Photopolymerization | 517 | Spherical (W/O) | pH/magnetically responsive, heavy metal removal | [163] |
| Polyethylene glycol diacrylate (PEGDA) | Photopolymerization | N/A | Spherical (W/O) | Vibrational energy harvester | [158] | ||
| PEGDA | Photopolymerization | 600–1200 | Spherical (W/O) | Drug delivery system | [164] | ||
| T‐junction | Alginate | Ionic crosslinking | 33 | Spherical (W/O) | Red blood cell mimics | [157] | |
| Eight‐armed poly(ethylene glycol) (8‐arm PEG) | Thiol‐norbornene photoclick reaction | 1395–2150 | Rod shaped (W/O) | Antibody encapsulation and release (bevacizumab) | [165] | ||
| Polytetrafluoroethylene (PTFE) | T‐junction | Gelatin methacryloyl (GelMA), PEGDA, Matrigel | Photopolymerization | ∼50–800 | Spherical, rod shaped (W/O) | Precision therapeutics, regeneration of tissues, optoelectronics | [159] |
| PTFE + polydimethylsiloxane (PDMS) | T‐junction | Collagen type 1, ultra‐long single‐stranded DNA | DNA interlocking | ∼600–800 | Spherical (W/O) | Injectable therapeutics for regenerative medicine | [160] |
| Tygon + metal | T‐junction | Hydroxyethyl methacrylate‐dextran | Photopolymerization | ∼275–310 | Spherical, core‐shell (W/O) | Microreactors, drug delivery | [161] |
Typically, fluoropolymer tubing and polyether ketone junctions are used in tubular microfluidics due to their compatibility with a wide range of solvents [157, 158]. For example, polytetrafluoroethylene (PTFE) tubing has been used to produce microgels with different morphologies due to its non‐wetting and highly solvent‐resistant properties, allowing the use of organic chemicals or harsh thermal conditions [159]; combinations of PTFE with PDMS can also be used [160]. Tubular microfluidic devices based on Tygon tubing have also been demonstrated to produce monodisperse microgels of a few hundreds of micrometers in diameter in addition to enabling layer‐by‐layer coating of microgels with negatively charged platinum nanoparticles and a positively charged diazoresin, yielding microcapsules that can be used as drug delivery systems or microreactors [161].
Tubular microfluidic devices are advantageous in that both the tubing and junction pieces are readily available to purchase ready‐to‐use, eliminating the time and cost for device fabrication [157]. Further, the tubing and junctions are detachable, allowing for the facile design of junction geometries including flow focusing and T‐junctions and attachments for the continuous, dispersed, and outlet tubing to be easily interchanged as needed (Figure 6D,E) [156, 157, 162]. However, the resulting microgels are generally larger than those produced by chip‐based or capillary‐based microfluidic devices, as capillary devices can be fabricated with much smaller features and channel dimensions, while the droplet size in tubular microfluidic platforms is largely constrained by the tubing diameter. Tubular microfluidic devices are also well suited for continuous microgel production, facilitating the integration of collection, washing, and purification into a streamlined workflow with the potential for automated and/or continuous downstream processing. However, when oil phases or surfactants are used during droplet generation, additional purification remains necessary, which can be readily integrated into the continuous production process to minimize manual handling and improve manufacturing efficiency.
Overall, the studies summarized in Tables 1, 2, 3, 4, 5, 6 reveal several practical considerations for selecting a microfluidic platform for microgel fabrication. Chip‐based devices remain the most versatile platform, supporting the widest range of natural and synthetic hydrogel precursors, crosslinking mechanisms, and microgel morphologies while maintaining high size uniformity. Capillary‐based devices are particularly suitable for producing core‐shell, multicompartment, and higher‐order emulsion microgels because their coaxial configurations enable the controlled introduction of multiple fluid phases. Capillary devices are also advantageous for fabricating microgels from hydrogel precursors that require the use of organic solvents, which are often incompatible with the polymeric materials commonly used to fabricate chip‐based microfluidic devices. 3D printed devices are advantageous when rapid prototyping, customized three‐dimensional geometries, device parallelization, or simplified device fabrication is required. Digital microfluidics is better suited to programmable, low‐volume fabrication involving individual droplet manipulation, sequential reagent addition, and multistep processing including rapid in situ gelation processes, although its throughput is generally lower than that of continuous‐flow platforms. Valve‐based devices provide additional control over droplet generation, immobilization, sorting, and release but at the cost of increased device complexity and reduced production throughput. Tubular microfluidic systems offer a comparatively simple, flexible, and cost‐effective option for continuous microgel production, as they eliminate the need for cleanroom‐based chip fabrication. However, their relatively simple geometry limits precise control over droplet formation and makes them better suited for precursor materials with slower or well‐controlled gelation kinetics. Thus, platform selection should be guided by the required material compatibility, crosslinking kinetics, structural complexity, desired morphology, production throughput, and device fabrication constraints.
3. Microgel Material, Crosslinking Mechanisms, and Morphologies
The choice of microfluidic device type and fabrication strategy is determined not only by the inherent advantages and disadvantages of each technique (i.e., cost, ease of fabrication, size control, throughput, etc.) but also the chemical nature of the polymer(s) and crosslinker(s) used to fabricate the microgel and the desired morphology of the ultimate microgel. In the following section, the most common microgel materials and crosslinking strategies are summarized and linked to the morphologies produced using different combinations of microgel chemistry and microfluidic device design.
3.1. Microgel Materials
3.1.1. Naturally Derived Polymers
3.1.1.1. Alginate
Alginates are polysaccharides made up of α‐l‐guluronic and ß‐d‐mannuronic acid monomers typically extracted from brown algae that has been used in a variety of general and biomedical applications [52, 83]. Its common use in microfluidic microgel fabrication is driven by its good record of tissue compatibility linked to its ease of gelation, with ionic cross‐linking via divalent cations such as calcium being by far the most commonly utilized method [120, 166] (see section 3.2.1 for a more detailed description of the alginate‐calcium crosslinking chemistry). Gelation rates can be controlled by using solutions of divalent cation‐containing salts with lower solubilities and/or lowering the temperature or pH at which gelation occurs [120, 166]. Successful fabrication of calcium‐alginate microgels requires introducing calcium into an alginate droplet without inducing premature clogging in the flow channel, a challenge given the speed of alginate‐calcium crosslinking. Figure 7A shows an example of a solution to this challenge by on‐chip picoinjection of aqueous calcium chloride (CaCl2) in emulsified aqueous sodium alginate (Na‐alginate) droplets, avoiding mixing outside the droplet itself and thus channel clogging.
FIGURE 7.

Common polymers used to fabricate microgels via microfluidics. (A) Optical micrograph illustrating the production of calcium‐alginate microgels via ionic crosslinking. Adapted from the literature [240] with permissions from the Royal Society of Chemistry. (B) Optical microscopy image of gelatin microgels formed via temperature changes after oil extraction and resuspension in cell culture media. Adapted from the literature [98]. Copyright 2017, with permission from Elsevier. (C) Brightfield image of GelMA microgels made via photopolymerization 16 wt% GelMA solution. Adapted with permission from the literature [174]. Copyright 2019 Wiley. (D) SEM image of porous methacrylated dextran microgels fabricated via photopolymerization. Adapted with permission from the literature [183] under a Creative Commons Attribution NonCommercial License 4.0 (CC BY‐NC). (E) SEM image of chitosan‐based microspheres formed via combined chemical crosslinking using glutaraldehyde and solvent extraction. Adapted with permission from the literature [210]. Copyright 2012 Wiley. (F) Optical image of pure PEGDA microparticles in the absence of electric fields (voltage – 0 kV) formed via photopolymerization. Adapted from the literature [216]. Copyright 2021, with permission from Elsevier. (G) Optical microscopy image of PNIPAM microgels formed via photopolymerization from a 12% w/v NIPAM solution. Adapted with permission from the literature [237]. Copyright 2022 Wiley.
3.1.1.2. Agarose
Agarose is a polysaccharide made up of alternating monomers derived from 1,4‐linked 3,6‐anhydro‐α‐l‐galactose and 1,3‐linked β‐d‐galactose derivatives. Agarose is unique in that its gelation is thermoreversible, enabling gelation at a minimally sub‐physiological temperature 32°C that is compatible with encapsulated cells [167, 168, 169]. Like the PEG derivatives, agarose offers excellent cytocompatibility but also minimal cell adhesiveness that is necessary for tissue formation. As such, significant work has been invested in chemically functionalizing agarose to enhance cell adhesion [170] and/or blending agarose with other biopolymers such as chitosan [167] or peptides [168] to increase cell adhesiveness and mechanical properties [167, 171]. Agarose also typically forms a brittle gel, although this brittleness offers opportunities to create smaller microgels by shear if desired for specific applications [172].
3.1.1.3. Gelatin
Gelatin is a protein derived from denatured collagen and is commonly used in biomedical applications due to its cytocompatibility, degradability, and low immunogenicity. The key advantage of gelatin is that it contains the cell adhesive arginine–glycine–aspartic acid (RGD) motif, enabling significantly improved cell adhesion to the scaffold than possible with the previously reviewed materials that have no direct cell adhesion mechanism [173, 174]. Solid [175] or porous [176] microgels can also be produced by mediating the thermoresponsive properties of gelatin (which gels at lower temperatures) with other crosslinking techniques. For example, gelatin microgels crosslinked with genipin, a naturally derived crosslinker, have been used to encapsulate mesenchymal stem cells (MSCs) with high viability [177]; alternately, microgels formed by enzymatic crosslinking of gelatin droplets swell to almost four times their initial diameter, resulting in the formation of microporous microgels with pores large enough for cell migration as shown in Figure 7B [176]. However, by far the most popular method for gelatin crosslinking is via the photopolymerization of methacrylated gelatin (GelMA), which links the advantageous cell adhesive properties of gelatin with the facile photocrosslinking properties of PEGDA, POEGMA, and other free radical‐polymerizable synthetic polymers [174, 178, 179]. Figure 7C shows core‐shell microgels produced using of 16 wt% GelMA crosslinked via photopolymerization, resulting in dense crosslinking in the microgel shell. Current research is focused on improving the stability of gelatin‐based microgels via two‐step crosslinking strategies (e.g., combining the reversible thermo‐cross‐linking of gelatin with irreversible photo‐cross‐linking of GelMA [180]) or combining GelMA with different materials that can reinforce the microgel mechanics even at physiological temperature at which gelatin forms low viscosity solutions (e.g., combining GelMA and agarose for scaffold bioprinting [178]).
3.1.1.4. Dextran
Dextran is a naturally derived hydrophilic polysaccharide made up of chains of α‐1,6‐linked glucopyranose residues. Due to the hydroxyl functional groups present on dextran polymers, additional chemical modifications can be easily implemented to facilitate crosslinking (e.g., via emulsification‐crosslinking [181], surfactant‐free crosslinking [182], or photo‐crosslinking using UV irradiation [183]) to fabricate dextran microgels. Notably, while the high hydrophilicity and non‐fouling nature of dextran promotes its high cytocompatibility, these characteristics also generally limit cell adhesion in the absence of bioactive ligands [184, 185, 186, 187], making dextran‐based microgels generally more useful for applications excluding cells. Both porous and non‐porous microgels made of dextran have been fabricated, with Figure 7D showing an example of a porous dextran‐based microgels prepared by modifying dextran (100 kDa) with glycidyl methacrylate (GMA) to yield methacrylated dextran (dex‐MA) amenable to photocrosslinking into a microgel [183].
3.1.1.5. Collagen
Collagen, most typically collagen I, is an extracellular matrix (ECM) protein that has been widely used in tissue engineering applications [188, 189, 190] due to its strong cell adhesion [190] and remodeling [160] properties coupled with its tunable porosity and softness as achievable by varying the pH, temperature, and/or ionic strength during gelation and/or introducing additional cross‐linkers such as glutaraldehyde or carbodiimides [189, 191]. The enzymatic degradability of collagen coupled with the variety of assembly strategies available to control the rate at which collagenase will induce degradation in the collagen also offers a key advantage in many biomedical applications [192]. Collagen‐based microgels have particularly found widespread use in bioprinting and biofabrication applications, with recent studies focusing on scalable production of collagen microgels with pore size exceeding those typically achievable in microgels to facilitate the printability of microgel‐based bioinks [193]. A major drawback, however, is the relatively poor mechanical strength of collagen‐based microgels, although a variety of approaches including the addition of nanomaterials such as graphene oxide [194] and/or blending collagen with other matrix of crosslinking materials (e.g., azide/alkyne‐functionalized collagen [191], collagen with sodium alginate [195], and collagen–fibrin [196]) have been explored to enhance the stability and mechanics of collagen‐based microgels. Collagen can also be difficult to process due to its limited solubility under physiological conditions and its time, pH, and temperature‐dependent self‐assembly properties [197], all of which complicate its use in reproducible collagen microgel production. Microfluidic devices, however, can help to address some of these processing challenges. For example, using a microfluidic device to precisely control the acidification of a collagen–alginate precursor solution and calcium diffusion across a chitosan membrane enabled the rapid gelation of collagen‐alginate microgels within seconds to form aligned and stable fibrillar microgels measuring 30–200 µm [198].
3.1.1.6. Hyaluronic Acid
Hyaluronic acid (HA) is a glycosaminoglycan present in most tissues (but typically commercially extracted from rooster combs) that is particularly important in cell spreading and migration and is thus commonly used in tissue reconstruction applications [17, 39, 199]. HA is highly hygroscopic and can form physical (hydrogen‐bonded) gels at high concentrations, although further chemical crosslinking (typically via methacrylation similar to GelMA or by using common crosslinking agents such as glutaraldehyde, epoxy compounds, multifunctional hydrazides, or carbodiimides [200]) is required to stabilize HA over more extended periods. HA is highly enzymatically labile, which can restrict its lifetime in vivo, and is bioactive in ways not always desirable often resulting in the functionalization of HA‐based microgels with other matrix components such as PEG to improve hemocompatibility [17] or platelet lysate [201], gelatin [202], or collagen [203] to improve cell adhesion. However, the cell spreading attributes of HA can make it a highly useful component of microgels designed for cell encapsulation. For example, photo‐crosslinkable microgels based on tyramine‐ and dopamine‐modified HA have been used to encapsulate human umbilical cord‐derived mesenchymal stem cells (hUC‐MSCs) via redox reactions mediated by visible light (450 nm), avoiding the need for UV polymerization that may cause chromosomal and genetic instability [204] while also better protecting cells under high oxidative stress to maintain high cell viability/plasticity [205].
3.1.1.7. Chitosan
Chitosan is a cationic polysaccharide made of N‐acetyl‐2‐amino‐2‐deoxy‐d‐glucopyranose and 2‐amino‐2‐deoxy‐d‐glucopyranose monomers joined by (1 → 4)‐β‐glycosidic bonds and prepared via the deacetylation of chitin derived from crustacean shells [206, 207]. Chitosan is unique among carbohydrates in that it is cationic, providing potential for enhanced cell adhesion via charge interactions (although also introducing potential drawbacks around non‐specific protein adsorption and downstream inflammatory tissue responses) in addition to providing generally low cytotoxicity and the potential for oxidative degradation [207, 208, 209, 210]. However, native chitosan is insoluble at neutral pH, requiring the use of acidic solvents that can compromise the viability of encapsulated cells. Chemical modifications such as carboxymethylation or oligolactate functionalization have thus attracted attention to alter the solubility profile of chitosan while preserving its other key properties [206]. Although genipin crosslinking is most commonly used to form chitosan microgels [208], ionic crosslinking with calcium phosphate [211] or sodium tripolyphosphate [212] can also be used to form microgels, with the latter approaches also incorporating phosphorus into the microgel that can be beneficial to promote the remineralization of bone including demineralized enamel surfaces caused by dental caries. In addition, chemical crosslinking of chitosan with glutaraldehyde with simultaneous water extraction from the droplets using n‐octanol as the solidification bath has been shown to enable the formation of monodisperse microgels with controllable structures [210]. Figure 7E shows the resulting core‐shell chitosan microgels crosslinked with glutaraldehyde with a solid shell and porous core.
3.1.2. Synthetic Polymers
3.1.2.1. Poly(ethylene glycol diacrylate) (PEGDA)
Poly(ethylene glycol diacrylate) (PEGDA) is a derivative of the widely used antifouling polymer poly(ethylene glycol) (PEG) that is often used for hydrogel fabrication due to its capacity for photo/thermal‐initiated free radical polymerization [84] and its difunctional nature that allows it to act as its own crosslinker, eliminating the need for a secondary crosslinker and resulting in typically high mechanical strength microgels relevant for cell encapsulation and tissue scaffolding applications [84, 213]. For example, Pan et al. explored the use of PEGDA hydrogels to fabricate microtissues that resemble hair follicles, enabling the implantation of dermal cells that promoted hair follicle regeneration to reverse the process of hair loss [214]. The base poly(ethylene glycol) polymer is also well‐known for its antifouling properties that can help to suppress fibrotic responses to implanted microgels [215]. Coupling the photopolymerization and electrohydrodynamics in a 3D hybrid microfluidic device can further enable the formation of PEGDA microgels with various controllable sizes/shapes (Figure 7F) [216]. However, while both oxidation of the PEG chain and hydrolysis of the ester linking the acrylate group to the PEG backbone are possible mechanisms of degradation, both occur relatively slowly in vivo, making PEGDA‐based hydrogels primarily relevant for longer‐lasting implants and/or cell‐based therapeutics in which the degradation of the scaffold is neither required or desirable. The antifouling properties also result in relatively low cell adhesion to PEGDA‐based scaffolds, potentially compromising at least in part the viability of adhesion‐dependent cells without the incorporation of cell adhesion‐specific ligands.
3.1.2.2. Poly(ethylene glycol methacrylate) (POEGMA)
Poly(ethylene glycol methacrylate), like PEGDA, is a PEG derivative but has only one free radical polymerizable (meth)acrylate group, enabling its potential to be crosslinked via other (in principle, degradable) chemistries while retaining the same key antifouling benefits of PEGDA [217, 218]. Furthermore, by changing the length of the PEG side chain on the OEGMA monomer, the swelling properties of the polymers can be tuned, including enabling the production of thermoresponsive microgels with short PEG side chains (2‐3 ethylene oxide repeat units [219]) or highly antifouling microgels with longer PEG side chains (up to 40 ethylene oxide repeat unit monomers are commercially available). As such, while photopolymerization is the main crosslinking mechanism used to form PEGMA microgels, thermally induced physical gelation is also possible with short side‐chain POEGMA polymers [220]. POEGMA hydrogels are prepared via conventional (or controlled/living) free‐radical polymerization [221, 222, 223], allowing for the use of a range of different comonomers to create microgel scaffolds with a range of desired functionalities (e.g., methacrylic acid groups to enable the addition of polymerizable functional groups [221] or cell adhesion ligands to overcome the generally low cell adhesion to POEGMA‐based microgels [224]). POEGMA‐based microgels have particularly been applied to stabilize enzymes against denaturation [218], although POEGMA‐based microgels have also been explored for drug delivery [225, 226] and as building blocks to form biomaterials for biomedical applications [227] due to their bioinert properties and non‐cytotoxicity.
3.1.2.3. Poly(N‐isopropylacrylamide) (PNIPAM)
Poly(N‐isopropylacrylamide)‐based microgels leverage the inherent lower critical solution temperature (LCST) properties of PNIPAM to fabricate microgels that can swell and shrink based on temperature changes around physiological temperature (∼32°C for PNIPAM homopolymers, although modifiable by copolymerization) [218, 228, 229, 230, 231]. This swelling/shrinking response has most commonly been leveraged to enable on‐demand drug release [229, 230, 231]; however, the switch from a more hydrophobic interface above the LCST to a more hydrophilic interface below the LCST also offers potential to reversibly switch cell adhesion to microgels, enabling temperature‐triggered cell release and/or enhanced cell adhesion relative to PEG‐based microgels at physiological temperature. Given the potential of PNIPAM to be free radical polymerized like PEGDA or POEGMA, crosslinking is most typically performed by copolymerizing difunctional crosslinkers during heat or light‐initiated free radical polymerization process. However, to introduce degradability into PNIPAM networks, dynamic covalent chemistry has also been applied [232]. Recent studies have explored the application of PNIPAM‐based microgels in nanoparticle delivery [233], thermo‐triggered burst release of drugs [234], biomedicine [235], biosensors [236, 237], personal care [238], or gene delivery [239], taking advantage of the thermo‐induced volume change, good biocompatibility, and potential to tune of the density and swelling of the PNIPAM microgels. For example, immobilizing DNAzymes (i.e., catalytic DNA) into PNIPAM microgels was reported to result in the formation of recyclable, stable, and low‐cost DNAzyme/pNIPAM microgel catalysts in which the catalytic activity of the DNAzyme is thermally regulated by the swelling/shrinking of the PNIPAM microgel (Figure 7G) [237]. However, residual NIPAM monomer is cytotoxic and can be challenging to fully remove from a gel phase, representing a potential translational barrier in in vivo applications.
3.2. Crosslinking Mechanisms
3.2.1. Ionic Crosslinking
Ionic crosslinking involves the interaction of oppositely charged polymers or polymers and multi‐valent ions. Alginate–calcium interactions are the most common example of ionic interactions used to crosslink microgels, although other alkali earth salts based on strontium or barium can also be used to enhance the strength of the ionic interaction and thus slow gel degradation [126, 241].
Ionic crosslinking can be performed on a microfluidic chip via a range of different strategies including internal gelation, external gelation, rapid in‐droplet mixing, droplet merging, and competitive ligand exchange [242]. In internal (in situ) gelation, the dispersed phase is typically an aqueous solution of a charged polymer containing a poorly soluble divalent cation salt such as calcium carbonate [243] or barium carbonate [244] while the continuous phase consists of a mixture of an inert oil and an organic acid (e.g., acetic acid) that dissociates at the droplet interface, releasing protons (H+) that promote dissolution of the carbonate salts inside the droplet to induce crosslinking. Although internal gelation usually leads to homogenous gelation throughout the microgel volume, it may result in a decrease in the pH below physiological pH that can negatively impact cell viability [245]; adding a stochiometric amount of acetic acid off‐chip to the microgels upon collection (an external gelation method) can reduce the amount of time cells are exposed to a low pH environment [246].
External gelation can be achieved via several methods including adding an oil‐soluble crosslinking agent (e.g., calcium acetate) to the oil flow [247], adding a crosslinking agent (e.g., calcium chloride) to the collection bath [248], emulsifying an aqueous crosslinker solution (e.g., calcium chloride) in an oil phase [249], and/or dispersing a powdered crosslinking medium (e.g., Dulbecco's modified Eagle's medium salts) in the oil flow [250]. On‐chip crosslinking can be challenging given that gelation typically begins immediately upon mixing of the two ionic solutions, resulting in frequent clogging of the microchannels or at minimum reduced control over the dispersity of the generated microgels [126, 241]. To circumvent such issues, external ionic gelation can also be conducted using salts such as calcium carbonate (CaCO3) that are functionally insoluble at neutral pH but can be dissolved at moderately acidic pH [40, 126], allowing for controlled formation of the droplets without gelation but rapid switching following droplet formation to induce gelation [120, 241].
In rapid in‐droplet gelation, ionic crosslinking occurs after rapidly mixing two aqueous phases, usually a polymer solution and a crosslinking solution, with a third phase containing cell media commonly mixing with the two phases to suspend cells [251]. Ionic crosslinking occurs quickly upon mixing to produce a suspension of crosslinked microgels in cell culture media. Rapid‐in droplet mixing can be used to tune the number of cells per microgel and crosslinking density by adjusting the composition and flow rates of the input aqueous streams.
In droplet merging, the crosslinking solution is either directly injected into polymer droplets or the geometry of the device is designed to enable the polymer droplets and crosslinking droplets to merge [252]. Digital microfluidics is particularly suitable to this method given its capacity to manipulate droplet‐by‐droplet motion, enabling rapid gelation in addition to tunable microgel shapes (e.g., spheres, rods, and threads) by varying the flow rate of the input flow streams [73].
Competitive ligand exchange (CLEX), first reported by Håti et al. [237], leverages the differences in binding affinities between polymers, anionic chelators, and inorganic cations to drive microgel fabrication, as shown schematically in Figure 8A. The selective choice of chelating species and ions in two separate solutions results in CLEX between the chelating species and ionotropic polymers [52, 237], with both the chelation strength of the chelator and the pH used to facilitate kinetic and temporal control of crosslinking and thus microgel formation. Such kinetic control serves both to prevent clogging in microfluidic channels and permit the regulation of gel strength by careful release of crosslinking ions, leading to microgels with high monodispersity that remain cell‐friendly [52, 237, 261]. However, this approach requires judicious selection of each component, with the chelator–cation interaction strength particularly critical to ensure sufficient availability of the cation crosslinking species to induce ionotropic gelation.
FIGURE 8.

Microgel crosslinking mechanisms. (A) Schematic of the CLEX ionic crosslinking mechanism. Adapted with permission from the literature [43]. Copyright 2021 Wiley. (B) Schematic of the photocrosslinking mechanism of GelMA using Irgacure 2959 photoinitiator. Adapted from the literature [242]. (C) Schematic of the pH‐responsive crosslinking of core‐shell microparticles in which the shell collapses at lower pH along the interface between the shell surface and water‐rich core. Adapted from the literature [270]. (D) Schematic of dynamic Michael‐type addition crosslinking reactions. Reprinted from the literature [292]. Copyright 2016, with permission from Elsevier. (E) Schematic of the formation of glycerol/PEGDA‐glycerol Janus microgels via phase separation, where (a and b) show microscopy images of lotus seedpod Janus microgels, and (c) illustrates glycerol/PEGDA‐glycerol droplet hanging on the air‐liquid paraffin interface. Reprinted with permission from the literature [284]. Copyright 2022 American Chemical Society.
3.2.2. Photopolymerization
Photopolymerization uses the interaction of UV or visible light with photo‐sensitive molecules to generate radicals and thus polymerize either monomers or functionalized polymers containing double bonds to form microgels [84, 133, 253, 254, 255]. Methacrylate (e.g., PEGMA), acrylate (e.g., PEGDA), acrylamide (PAAm), or acrylamido (e.g., PNIPAM) functional groups are most commonly used for photopolymerization, although any unsaturated functionality could in principle be used in this context. While direct photopolymerization in which the photoinitiator and monomer are present within the same phase is most common [84, 256] water‐in‐oil‐in‐water (W/O/W) emulsions have also been reported for photopolymerization‐induced microgel crosslinking to minimize the use of oil phase and facilitate the washing process required to isolate the microgels into an aqueous dispersion [257]. Photopolymerization is also possible in different solvents, with water being the most common for microgel formation but DMSO also reported [258].
While monomer‐based photopolymerizations are suitable for many applications of microgels, the toxicity of many monomers can be problematic in cell encapsulation applications. In such cases, water soluble pre‐polymers that have been modified to include photopolymerizable moieties (most typically (meth)acrylate groups) can serve as alternative precursor materials with improved cell compatibility. Microfluidic approaches have been used to produce microgels using a variety of such modified pre‐polymers including dextran‐hydroxyethyl methacrylate [259], 6‐armed acrylated PEG [125], poly(N‐isopropylacrylamide‐dimethylmaleimide) [260], and poly(ethylene glycol) norbornene (PEG‐NB) [165].
Photopolymerization can offer relatively quick curing rates (although is typically somewhat slower than fast ionic interactions such as alginate‐calcium), does not require temperature or pH changes, and can be controlled temporally given that initiation occurs only upon the direct localized application of UV or visible light [254, 255]. However, depending on the wavelength, power, and duration of the irradiation applied, damage to cells (and DNA) encapsulated in microgels can occur [261]. Minimizing irradiation power while still ensuring sufficient crosslinking, for example by using visible light initiators that can be activated without the use of DNA‐damaging UV light or using transparent microfluidic chips that minimally filter the incident light, can all improve cell viability [242, 262]. More cytocompatible photo‐initiators include Irgacure 2959, 1173, 819, or 651 (Figure 8B), riboflavin phosphate, camphorquinone, and eosin Y, the latter three of which are activated by visible light [263].
3.2.3. Temperature and pH Changes
Temperature can be used as the primary gelation strategy for thermoresponsive materials (e.g., by cooling agarose [264] or gelatin [98] or heating PNIPAM [258]), while pH changes can be used as the primary gelation mechanism for materials with pH responsiveness (e.g., chitosan [265] or collagen [198]). However, given that the resulting gels are only physically crosslinked under non‐physiological conditions, temperature, and pH are rarely used as the sole crosslinking mechanisms for biomedical applications but rather as methods to manipulate crosslink density, mechanics, or stability of the microgel under different relevant physiological conditions [95, 266, 267]. For example, increasing the temperature causes PNIPAM microgels to deswell [266, 267, 268] while GelMA microgels can be templated by thermal crosslinking and then stabilized via photopolymerization to enhance mechanics and stability [95]. Microgels with multi‐responsive properties can also be highly beneficial in a range of different biological and biomedical applications. For example, microgels prepared by copolymerization of pH‐ionizable acrylic acid (AAc) and NIPAM causes microgels to swell and exhibit both reduced thermoresponsiveness and higher transition temperatures at pH values at which the carboxylic acid groups are ionized [267, 269]. As an alternate example, Figure 8C depicts a crosslinking mechanism of a core‐shell capsule consisting of a pH‐responsive aqueous core containing Eudragit S100 (methacrylic acid–methyl methacrylate copolymer) encapsulated within a polylactic acid shell [270]. At pH > 7 (at which most methacrylic acid moieties are ionized), the core of the capsule is a colorless liquid due to the hydrophilic nature of the Eudragit polymers; at pH < 7 (at which the ─COOH groups in methacrylic acid begin to protonate), the center becomes a red colored crosslinked gel mediated by increasingly strong hydrogen bonding interactions, enabling switchable diffusion properties from the microgel potentially useful for on/off drug release applications.
3.2.4. Dynamic Covalent/Click Crosslinking
Dynamic covalent chemistry describes a suite of crosslinking strategies that can occur in situ upon mixing of two functional groups that spontaneously and reversibly react in water under physiological pH/temperature conditions to form a covalent crosslink. Functionalization of precursor polymers with such functional groups, or the mixing of one such precursor polymer with a difunctional small molecule crosslinker containing a complementary functional group, can lead to gelation with either no or cell‐friendly byproducts (in many cases water) [271]. Relative to other crosslinking strategies, the spontaneous nature of dynamic covalent chemistry results in rapid gelation without the need for external irradiation or non‐physiological conditions while the reversibility of dynamic covalent chemistry allows for both cell remodeling and degradation of the scaffold that is typically not possible with strategies such as photopolymerization [272, 273, 274].
The most common dynamic covalent chemistries used for microgel fabrication include hydrazone bond formation [275], thiol‐Michael addition [206], thiol‐ene chemistry [165], and oxime chemistry [276]. Hydrazone crosslinking in which a hydrazide‐functionalized polymer reacts with an aldehyde and/or ketone‐functionalized polymer has been in particular applied in microfluidic microgel applications. For example, Karvinen et al. examined the fabrication of hyaluronan‐polyvinyl alcohol (HA‐PVL) and alginate‐polyvinyl alcohol (AL‐PVL) hydrogels using hydrazone crosslinking [275], while our group has reported the formation of PNIPAM‐based microgels using on‐chip mixing of hydrazide and aldehyde‐functionalized precursor polymers to form thermoresponsive microgels [230]. The high reversibility of the hydrazone bond (particularly under weakly acidic conditions) is beneficial for controlling degradation, although the density of aldehyde groups in the precursor polymer must be carefully controlled to ensure high cell compatibility in cell encapsulation applications. Michael‐type addition reactions, which occur via a nucleophilic addition pathway in which the nucleophile (Michael donor) reacts with the electrophile (Michael acceptor), are also widely used in this context (Figure 8D) [206, 277], with thiol‐Michael additions involving the addition of a thiol nucleophile to an acrylate‐based electrophile being particularly widely used [206]. Michael‐type addition reactions are regioselective, effective, and can proceed under physiological conditions, making them suitable for cell encapsulation [206, 277, 278, 279]. For example, thiol‐Michael additions using PEG norbornene have been demonstrated to offer cell compatibility advantages over the photopolymerization of PEGDA [58], with the improved cell viability attributed to Michael crosslinking avoiding the formation of reactive oxygen species formed upon photopolymerization in the presence of oxygen [280]. However, while Michael adducts are in principle reversible, the conditions for reversibility are difficult to achieve in physiological systems [278, 281].
The key challenge with the use of dynamic covalent or click chemistry in microfluidic applications is avoiding premature gelation within the chip, with similar strategies as those used to perform alginate‐calcium crosslinking often pursued to suppress on‐chip gelation issues. However, by tuning the chemistry chosen and the degree of functionalization of the precursor polymers, gelation times can be tuned to make the chemistry compatible with a range of mixing strategies (borrowing ideas already shown to improve print quality in bioprinting applications [282]). Pre‐functionalized polymers are also required, which may increase the cost of this strategy relative to direct polymerization methods (e.g., photopolymerization) [199, 283].
3.2.5. Phase Separation
Phase separation occurs when one or more component of a solution becomes immiscible due to changing solution conditions, most commonly in biomedical applications driven by changes in pH, temperature, or molecular weight (e.g., polymerization) [284, 285]. Given that the most common type of phase separation includes a precipitation‐type transition, the risk of channel clogging is particularly acute when using phase separation as a driving force for microgel fabrication via microfluidics. However, with careful control over the experimental parameters, the ability of microfluidic chips to precisely control mixing can enable on‐chip microgel fabrication. As an example, an air–liquid interface can be used in a microfluidic setup to induce droplet phase separation via solvent evaporation to produce Janus microgels based on PEGDA‐glycerol (Figure 8E) [284]. By adjusting parameters such as the glycerol/PEGDA volume ratio and the initial solvent content, Janus microgels can be formed with different morphologies including filbert‐shaped, half lotus seedpod single‐phase, lotus seedpod single‐phase, lotus seedpod‐shaped, multiple‐bulge, and half gourd‐shaped. As another example, in a two‐stage phase separation process, pectin‐coated whey isolate protein microgels were formed by first co‐dissolving the combination of heat‐denatured whey isolated protein and pectin at pH 7 and then changing the pH to 5, resulting in a thermodynamic incompatibility that drives electrostatic repulsion such that the whey protein isolate becomes a dispersed phase inside a low methoxyl pectin‐rich continuous phase [12]. The pH is then re‐adjusted to 7 to enable adsorption of the continuous phase polymer into the dispersed phase polymer to form microgels via a combination of both segregative (pH 7) and aggregative (pH 5) phenomena.
Precipitation can also be used to drive microgel fabrication, with the two‐step solvent evaporation from emulsion droplets (SEED) approach being particularly relevant to the formation of core‐shell microgels [286]. In this approach, polymers are first dissolved in a solvent and emulsified with a stabilizer; following, the solvent is evaporated through a continuous aqueous phase using ultrasonication‐based heating, causing the polymer to precipitate to form microgels. In addition to driving microgel formation, the SEED process also removes impurities as is essential for pharmacological and biomedical applications [286].
3.2.6. Enzymatic Crosslinking
Enzymatic crosslinking interactions are of interest in cell encapsulation given their potential to occur under cell‐friendly conditions [287, 288, 289, 290]. Horseradish peroxidase (HRP)‐catalyzed crosslinking in which phenol‐containing polymers are crosslinked with H2O2 (acting as a crosslinking agent) are particularly popular [288, 289, 290, 291]. Microfluidics offers a particular advantage in its context given its capacity to regulate the spatiotemporal concentration of H2O2 which, if improperly controlled, can result in cytotoxicity, inactivation of HRP, and highly inhomogeneous crosslinking within the microgel [289, 290]. Indirectly supplying H2O2 via redox reactions between thiol groups and disulfide bonds with a reducing agent like glucose can offer an appealing solution to limit instantaneous H2O2 concentrations and thus mitigate such issues [290]. HRP‐based chemistry can also be used to create H2O2‐sensitive polymer microgels (HSM); for example, incorporating dextran‐tyramine (peroxidase substrate) and HRP (catalytic substrate) into a poly(oligo(ethylene glycol) methacrylate) microgel network leads to the formation of microgels that can shrink upon H2O2‐induced crosslinking [287].
3.3. Microgel Structures and Morphology
3.3.1. Single Phase Spherical
Spherical microgels consisting of a single gel phase are the most common type of microgel formed via microfluidics, with the surface tension between the water (typically but not always the dispersed phase) and the oil (typically but not always the continuous phase) inherently driving the formation of spheres to minimize surface area. Microfluidics offers the potential to precisely control the microgel size, with the high monodispersity of spheres achievable relative to other techniques critical for monitoring and predicting behavior in response to external stimuli, controlling rheological properties, tuning translational mobility, and regulating drug release kinetics [293, 294]. Although the stability of the W/O emulsions typically used to make single phase microgels (as shown in Figure 9A) can depend on various factors including the material(s) used, the emulsification technique used, and the storage conditions, W/O emulsions are often less stable than O/W emulsions [295]. As such, careful optimization of interfacial stabilizer(s) should be done to ensure the emulsion is sufficiently stable while minimizing total surfactant content to minimize any potential downstream surfactant toxicity. Pickering (nanoparticle) emulsifiers offer an appealing alternative in this context, as they typically have lower cytotoxicity relative to small molecule amphiphiles. For example, Stock et al. demonstrated the stabilization of W/O emulsions using charged silica nanospheres (SNs) in combination with PNIPAM microgels, with the presence of both nanoparticles enable highly effective emulsion stabilization [296].
FIGURE 9.

Controlling microgel structure and morphology via microfluidics. (A) Schematic of the process of W/O emulsion formation. Adapted from the literature [62] under a Creative Commons Attribution license 4.0 (CC BY). (B) Optical microscopy images of PEDGA microgels fabricated using different UV irradiation times under a UV light intensity of 75 mW/cm2. Adapted from the literature [299]. (C) Schematic of a co‐flow microfluidic device for core‐shell microbead formation with microscopy images of core‐shell microbeads produced at different flow rates of the outer phase (oil). Adapted from the literature [326]. Copyright 2025, with permission from Elsevier. (D) Schematic of the PDMS device to form double emulsion droplets consisting of one or two hydrophobic magnetic cores (black) encapsulated in a hydrophilic monomer droplet (white) suspended in fluorocarbon oil (gray). Scale bar = 50 µm. Reproduced with permission from the literature [78]. Copyright 2009 Wiley. (E) Brightfield images of non‐spherical microgels fabricated using W/W/O double emulsion formation using two immiscible aqueous solutions. Scale bar = 20 µm. Adapted from the literature [308] under a Creative Commons Attribution license 4.0 (CC BY). (F) Schematic of a microfluidic device capable of producing Janus microgels made of three streams of PNIPAM (colorless in the center and green‐ and red‐tagged on the left and right), and microscopy images of the resulting Janus microgels produced under different flow rates. Adapted with permission from the literature [77]. Copyright 2010 American Chemical Society. (G) SEM image of PNIPAM microgel with an open‐celled porous structure. Adapted with permission from the literature [317]. Copyright 2014 American Chemical Society.
Although spherical microgels are most common, the combination of continuous shear and in situ crosslinking during microgel fabrication can lead to the formation of asymmetrical microgels even if spherical microgels are targeted. For example, Wang et al. explored crosslinking sodium alginate droplets with CaCl2 nanoparticles dissolved in the oil phase acting as a pre‐crosslinking reagent [294]. Microgels with an asymmetric shape could be produced as the droplets were deformed while dripping into a collection bath and passing through the interface of two phases due to a combination of gravity, interfacial tension, and tangential stress, resulting in the formation of tailed microgels.
3.3.2. Core‐Shell
Core‐shell type microgel morphologies in which the core and shell are comprised of either different materials or the same material that has been differentially crosslinked can offer significantly more diverse overall microgel properties relevant to drug delivery, sensing, and controlled release applications [297, 298]. In some cases, single phase emulsions can lead to core‐shell microgels based on differential crosslinking of the inside and outside of the microgel. For example, Chen et al. demonstrated that PEGDA droplets can be fully crosslinked within 60 s using a UV source to form single‐phase spherical microgels while shorter crosslinking times (30 s) led to a core‐shell morphology (Figure 9B) [299]. Alternately, core‐shell microgels can be formed using two miscible but distinct polymers, for example using prepolymerized precursors of poly(N‐isopropylacrylamide) (PNIPAM) that do not intermix during the timescale of microfluidic microgel fabrication [94]. However, more commonly, core‐shell microgels comprised of different core and shell materials can be fabricated via a range of microfluidic geometries such as that shown in Figure 9C, in which a double emulsion system is used [78]; in the specific system shown in Figure 9C, a hydrophobic monomer core was encapsulated within a hydrophilic monomer droplet that is then suspended in oil to template the microgels, with the flow rate of each phase regulating the morphology and relative dimensions of the resulting microgel.
Core‐shell microgels are particularly useful for adding an antifouling polymer shell to other functional materials to minimize inflammatory responses and/or regulate diffusion in and out of the microgel independently of the internal crosslink density of the shell. Furthermore, the core and the shell can be designed to be responsive to two different stimuli. For example, Lapeyre et al. fabricated microgels with a thermo‐responsive core and a thermo/glucose‐responsive shell in which the temperature‐responsive core helps tune the mechanical behavior while the glucose‐responsive shell mediated insulin diffusion out of the gel as a function of the surrounding glucose concentration [300].
3.3.3. Multi‐Phase Spherical
Multi‐phase microgels can be made by exploiting many microfluidic technologies that have been developed for creating higher‐order emulsions and coupling those technologies with gelation steps. Double emulsions in which an inner fluid is flowed into an immiscible second fluid to create a primary emulsion that is then added into a third fluid are particularly widely explored in this context. Microgels with water‐in‐oil‐in‐water (W/O/W) or oil‐in‐water‐in‐oil (O/W/O) templating structures (as illustrated in Figure 9D) can be formed using microfluidic technologies with precise control over the microgel size and shell thicknesses [301, 302, 303]. For example, Guerzoni et al. used a microfluidic W/O/W double emulsion to produce hollow sphere particles and microgels with PBS in the innermost layer, photopolymerized six‐armed acrylated star‐shaped poly(ethylene oxide‐stat‐propylene oxide) as the middle layer, and a mixture of water and surfactant as the continuous phase, resulting in hollow microgels with internal macroporous domains useful for drug loading/release [125]. Alternately, polyacrylamide (pAAm) microgels can be loaded into the inner oil drop in an oil‐in‐water‐in‐oil (O/W/O) emulsion using a double flow‐focusing microfluidic device to produce anisotropic and non‐spherical polyacrylate–polyacrylamide microparticles with controlled size and shape [304], with the position of the microgels and the inner oil droplets tunable by the size and packing of the microgels as well as the flow rates of the input fluids. A similar type of microfluidic device can be used to form either O/W/O or W/O/W emulsions for microgel production. For instance, Jans et al. employed a 3D printed microfluidic device for high‐throughput production of W/O/W or O/W/O emulsions to enable microgel formation based on six arm star‐shaped (PE‐stat‐PP) acrylate‐terminated precursor solution [134], demonstrating production rates as high as 1.2 L/h that translate to ∼10 million monodisperse microgels per hour.
3.3.4. Non‐Spherical
Unlike spherical microgels, non‐spherical microgels have a larger surface area and thus can act as a model for complex macromolecules, mimic asymmetric biological features (e.g., red blood cells), and undergo differential mobility in shear fields [128, 305, 306]. Various strategies can be used to generate non‐spherical microgels that are uniquely facilitated by the confinement and shear effects of a microfluidic chip relative to other alternative approaches. Initial attempts at generating such microgels primarily used on‐chip methods in which the microgel shape was changed by confining the curing area [307]. Keller et al. proposed an alternate way to form asymmetrical non‐spherical microgels on‐chip utilizing an aqueous two‐phase system to generate double emulsions using PEGDA:dextran, PEGDA:Ficoll 400, and PEGDA:ammonium sulfate as the non‐miscible aqueous phases (Figure 9E) [308]. Asymmetrical microgels can be formed upon photopolymerization of a polymerizable phase in the presence of the other phase to template the asymmetric shape; alternately, the same flow‐focusing microfluidic device could be used to form asymmetric Janus microgels by incorporating crosslinkable polymers into both phases of the double emulsion, although this process requires immediate curing and has often low throughput.
Off‐chip strategies have also been applied to create asymmetric microgels. Hu et al. crosslinked sodium alginate droplets off‐chip by adding them to a solution of barium acetate and glycerol [128], with a variety of non‐spherical shapes such as tear drops achievable by controlling the velocity and concentration of sodium alginate droplets upon contact of the gelation solution. Alternately, Wang et al. added microgels half‐coated with gold to a mixture of two thiolated ssDNA molecules with complementary sequences in which thiol binding to the gold layer induced DNA aggregation and subsequent rearrangement of the gold layer on the microgels to produce non‐spherical microgels [309]. Morphologies including tear drop, lamp‐like, and mushroom‐like microgels based on alginate [128], golf ball and various asymmetrical shapes based on poly(ethylene glycol) diacrylate and polyvinyl alcohol (PVA) [308], rectangles and triangles based on PEGDA and diacrylate PLA‐b‐PEG‐b‐PLA [310], and rods, disks, and ellipsoids based on polytripropyleneglycol diacrylate (polyTPGDA) [49] have also been reported using various microfluidic strategies. Despite these advancements, producing highly complex or multi‐compartmentalized non‐spherical particles with consistent anisotropy and morphology remains challenging, especially in terms of controlling the structural stability of these morphologies during production.
3.3.5. Janus
Janus microgels are amphiphilic structures with two physically/chemically distinct hemispheres that are responsive to two different stimuli [13, 77, 101, 311]. Unlike single phase microgels that (de)swell in response to a stimulus, Janus microgels can often maintain their compartmentalized structure upon stimulation [101], although this behavior depends on factors such as crosslinking density and interfacial adhesion strength. Changes in the hydrophilicity of one or both hemisphere(s) in response to temperature and/or pH changes may also induce deformation or interfacial rearrangement due to asymmetric swelling [13, 101]. As shown in Figure 9F, Janus microgels can be formed using microfluidic devices with three multiple inlet channels and a flow‐focusing channel for the continuous phase (i.e., oil) [77]. For example, in one study three different solutions of PNIPAM tagged with different dyes were input through the three inlet channels that converge at the first of two cross junctions; these solutions flow under laminar flow conditions until they reach the second (oil) cross junction at which point monodisperse droplets are formed and rapidly photocrosslinked to lock in the Janus morphology. Liquid streams with high viscosity are most commonly used to limit cross‐mixing while producing such droplets; however, this limits the possible volumes and morphologies of the two phases of the Janus particle that may hinder their possible applications [312]. The use of aqueous two‐phase systems (ATPS) offers an alternative low interfacial tension approach to Janus microgel fabrication while at the same time eliminating the use of organic solvent to simplify microgel purification toward subsequent biological applications [312].
While most reported Janus microgels have an overall spherical structure with differential chemistries/crosslinking densities on different faces of the microgel, non‐spherical Janus microgels have also been produced including hollow and complex Janus microgels using poly(N‐isopropylacrylamide) (PNIPAM) [77], bowling‐pin and snowman morphologies using chitosan [313], chain‐like or mesh‐like superstructures [90] or disk‐shaped microgels [91] using poly(ethylene glycol) diacrylate, snowman‐shaped microgels using PNIPAM [93], and stimuli responsive embedded‐shape microgels using PNIPAM–PEGDA [101].
3.3.6. Macro/Microporous
While hydrogels have inherent porosity, that porosity is most typically on the scale of a few to tens of nanometers that permits diffusion of small molecules and (in many cases) macromolecules but not cells or larger‐order structures into the gel phase. Such larger scale micro/macroporosity is highly beneficial for drug delivery applications (enhanced interfacial surface area) and tissue regeneration applications (providing space for cell spreading and/or promoting easier diffusion of both nutrients and wastes in and out of the encapsulated cells) [314, 315, 316]. The kinetics of environmentally responsive microgel phase transitions can also be accelerated as microgel porosity is increased; for example, Mou et al. demonstrated that porous PNIPAM microgels (Figure 9G) exhibited ∼2‐fold faster phase transitions relative to conventional PNIPAM microgels [317]. Again, the geometry, mechanism, and dimensions of microfluidic devices can significantly aid in generating controllable porosity within microgels as well as between microgels, with T‐junction [318, 319], co‐flow [320, 321], and flow‐focusing [94, 95, 322, 323, 324, 325] geometries all having been used in conjunction with precursor polymer solutions in the dispersed phase to yield microporous microgels [92, 94, 317, 318, 325] or in the continuous phase to yield microporous scaffolds [95, 319, 322, 323, 324].
Overall, the resulting microgel morphology is governed not only by the selected microfluidic platform but also by the interplay between material properties and gelation kinetics. For example, rapid crosslinking mechanisms such as ionic gelation of alginate or photopolymerization of methacrylated polymers generally stabilize droplets immediately after formation and therefore favor the production of highly spherical microgels with narrow size distributions. In contrast, slower gelation processes such as Michael‐type addition reactions or thermally induced gelation, provide greater opportunities for droplet deformation or secondary processing before complete network formation, enabling the fabrication of rod‐shaped, disk‐like, or ellipsoid microgels. Materials exhibiting phase separation or multiple immiscible precursor phases can be combined with controlled interfacial gelation to generate Janus, core‐shell, or multicompartment microgels, while porous microgels are typically achieved through fabrication strategies that introduce controlled internal voids within the hydrogel network. Consequently, material selection and crosslinking strategy together determine the gelation rate, interfacial stability, and mechanical integrity of the precursor droplets, which collectively govern the attainable microgel morphology and its suitability for downstream applications.
4. Applications
Given the wide scope of microgel chemistries, crosslinking strategies, and morphologies that can be accessed using microfluidics as outlined in Section 3, microfluidics offers key advantages for fabricating microgels for diverse applications. In this section, the various uses of microgels fabricated using microfluidics‐based approaches including applications in cell encapsulation, tissue engineering, bioactive agent delivery, food and nutrition, sensors, particle removal, and advanced materials fabrication will be explored.
4.1. Cell Encapsulation
Cell encapsulation into microgels is typically pursued for one of two reasons: (1) to analyze cell behavior in vitro within a ECM‐mimicking 3D microenvironment, often (although not always) prioritizing the encapsulation of single cells to allow for more targeted probing of cell‐scaffold interactions; or (2) to fabricate implantable cell therapeutics intended to maintain cell viability for extended periods to produce therapeutic proteins for disease treatment, typically incorporating multiple cells per microgel. For in vitro applications, significant effort has been invested in developing methods to enable single cell encapsulation; however, the resulting cell‐laden microgels also require efficient purification protocols that remove residual oil and surfactants while minimizing mechanical stress and processing time to preserve cell viability and function. While the complete removal of surface‐bound oil droplets and surfactant residues remains challenging, it is generally more efficient to perform the purification steps on chip, for example by exploiting channel wetting in parallel microchannels [327], electrical field [328], deterministic lateral displacement [79], or integrated microfluidic filtration platforms [329]. Sun et al. developed a pneumatic valve‐based microfluidic platform that allows for the encapsulation of single cells followed by immobilization of the microgel using a trap‐release unit that allowed for the passage of fluid over the microgel, enabling biological analysis of the encapsulated cells on‐chip (Figure 10A) [152]. Other cell analysis studies use the microgel itself as the analysis platform, aiming to minimize the errors observed in bulk cell analysis methods that can introduce heterogeneous population interferences or mechanical damage from bulk manipulations. For example, Cai et al. generated disc‐like shapes that allowed for the visualization and observation of single cells for cell analysis [88] while Hsu et al. investigated cellular secretions from individual cells by encapsulating a single cell inside a smart hydrogel microparticle capable of capturing the cell secretions (Figure 10B) [330].
FIGURE 10.

Microfluidics‐fabricated microgels for cell encapsulation applications. (A) Brightfield and fluorescent images of a pneumatic valve‐based microfluidic platform for on‐chip cell analysis demonstrating single HCT‐116 cell immobilization, staining, and observation with FDA/PI fluorescence. Adapted with permission from the literature [152]. Copyright 2019 Wiley. (B) Schematic of co‐encapsulation platform for cells with hydrogel particle immunosensors allowing for the detection of protein secretions from single cells. Temperature‐induced shrinkage of the hydrogel particle allows for signal enhancement to facilitate the detection of low quantities of cell secretions. Adapted with permission from the literature [330]. Copyright 2018 Wiley. (C) Schematic (a) and performance demonstration (b–d) of multicompartmental magnetic particles with the ability to encapsulate multiple cell lines. Cell viability for HepG2 and HUVEC cells over the 5‐day period is shown in (e). Adapted with permission from the literature [87]. Copyright 2020 Wiley.
Multi‐cell‐laden microgels may be made directly by mixing multiple cell types in the precursor solutions or by using compartmentalization strategies enabled by the capacity of microfluidics to create higher‐order emulsion structures [58, 126]. For example, self‐releasing double emulsion droplets comprised of alginate droplets surrounded by a mineral oil drop dispersed in an aqueous CaCl2 solution have been used to encapsulate yeast cells, with the self‐separation of the alginate‐based microgel drop permitting the collection of the cell‐laden droplet without the need for additional solvents or separation processes [126]. Encapsulation of multiple cell‐lines into a single microgel is also of interest and can be used to study cell–cell interactions, with or without compartmentalization of the different cell lines and/or spatiotemporal monitoring and analysis of the secretions within the microgels. For example, Sabhachandani et al. fabricated a three‐cell (cancer, fibroblast, and lymphocyte) spheroid using alginate and puramatrix to better model the effects of an immunomodulatory drug on a real tumor (Figure 10C) [85], Sun et al. co‐encapsulated β cells and mesenchymal stem cells (MSCs) with demonstrated potential for clinical β cell transplantation for diabetes treatment [331], and Wu et al. reported multicompartmental microgels containing up to 20 compartments in which different cell lines can be encapsulated into different compartments and be monitored simultaneously to track cell–cell signaling [87].
Other examples of microfluidic cell‐encapsulating microgels facilitating good cell viability have also been developed for drug screening applications [69, 100, 120, 124]. Spherical microgels have been used for the fabrication of three‐dimensional (3D) tumor spheroid microgels for mimicking tumors and enabling in vitro evaluation of the efficiency of cancer drugs or therapies. For example, Antunes et al. produced spherical 3D microgels in air (solvent‐free conditions) consisting of hyaluronan‐methacrylate (HA‐MA) and gelatin‐methacrylate (GelMA) that included tumor‐specific extracellular matrix, demonstrating their potential for making accurate in vitro performance predictions for cost‐effective and tumor‐mimetic in vitro therapeutic screening [332]; alternately, George et al. showed the potential of alginate microgels to enable the screening of drug susceptibility on human breast cancer cells (MCF‐7) [143]. Other types of screening can also be enabled by microfluidic microgels. For example, Kolb et al. reported the development of microfluidic microniches created by a flow focusing microfluidic device in which an initial cell aggregate is first encapsulated in an enzymatically crosslinked matrix metalloproteinase (MMP)‐degradable PEG hydrogel followed the encapsulation of those microgels in a thin film of a non‐degradable gel formed via Michael‐type addition of vinylsulfone (VS)‐terminated 8arm‐PEG and thiol (TH)‐terminated 4arm‐PEG via a second microfluidic step [333]. Maleimide‐activated Protein A incorporated into the microgel shell enabled in situ functionalization with Fc‐fusion proteins, enabling the screening of phenotypic effects from growth factors based on RNA sequencing.
4.2. Tissue Engineering
Tissue engineering and tissue regeneration applications are often limited by cell viability following cell administration to the body, typically related to either the shear stress imparted during injection [114], the lack of suitable adhesion sites/protection during the cell conditioning process that limits effective engraftment [334], and/or the lack of cell retention at the desired engraftment site [335]. To combat these limitations, the cells must be protected throughout the processing step and then subsequently released locally following minimally invasive delivery to the desired site. Microgels are ideally suited to address this challenge, with microfluidic‐generated microgels allowing for more uniform bead sizes and more controllable microenvironments to support the viability of even more sensitive cells [336]. For example, GelMA microgels have been developed to deliver bone marrow‐derived mesenchymal stem cells while simultaneously encapsulating bone morphogenic protein‐2 growth factor to improve the stemness and viability of the encapsulated cells [9]. Altering the shape of the microgels can also offer practical benefits. For instance, Guerzoni et al. generated “rod‐shaped mini‐tissue” microgels for the delivery of normal dermal human fibroblasts that enabled the delivery of more cells within a single microgel while still retaining injectability via shear streaming along the major axis of the rods [16]. Using rod‐shaped structures as building blocks can also facilitate the creation of macroscopic scaffolds with diverse pore structures and orientations difficult to access with spherical or bulk hydrogel building blocks.
Cell encapsulated microgels have attracted particular recent interest in the context of 3D printing as bioinks that can gel by “jamming” the microgels together at high particle concentrations. Microgels in the jammed state are densely packed and thus show solid‐like mechanics under low shear but a solid‐to‐liquid transition under higher shear once the yield stress associated with inter‐microgel interactions is overcome [337]. The high porosity of the resulting printed structures (corresponding to the space between the individual packed microgel particles) is highly beneficial for maintaining space for cell spreading/expansion and nutrient diffusion while also providing opportunities to incorporate additional materials to modify the mechanical properties of the overall structure [338]. Indeed, based on their unique mechanical properties, jammed microgel structures have been used both as bioinks to build structures as well as support baths for 3D printing other types of hydrogel structures (Figure 11A) [82, 338].
FIGURE 11.

Microfluidics‐fabricated microgels for tissue engineering applications. (A) Jammed microgels for 3D printing applications showing (a) extrusion‐based printing onto a glass surface, (b) printing of the microgels with a spiral pattern into a support hydrogel and (c) live/dead images of encapsulated 3T3 fibroblasts in microgels alone (i), after extrusion printing onto a surface (ii) or after printing into the hydrogel support (iii). Adapted with permission from the literature [82]. Copyright 2019 Wiley. (B) SEM images (a and b) and confocal images (c) with cell staining of actin in green and nuclei in blue of C2C12 cell‐loaded gelatin microgels loaded into electrospun fibers. Adapted from the literature [98]. Copyright 2017, with permission from Elsevier. (C) Schematic of a neuronal capsule (a) with fluorescence confocal microscopy using DAPI staining of the nuclei (b) and tubulin subunit beta3 staining of mature neurites (c). Scale bars = 50 µm. Adapted from the literature [19] with permissions from the Royal Society of Chemistry. (D) Organoid construction into microgel spheroids with spiral‐compartmental geometries via co‐culture of HUVECS and HMSCs. Adapted with permission from the literature [139]. Copyright 2018 Wiley.
Microgels have also been applied for in vitro tissue growth to address challenges inherent with conventional 2D cell culture including difficulty in culture sampling, challenges involving the detachment of cells from the dish substrate, low survival rates of cells in tissue fabrication processes like electrospraying and electrospinning (Figure 11B), and a limited ability to mimic the three‐dimensional nature of native tissues [19, 339]. Multiple cell types have been used in this context, including Madin Darby canine kidney cells encapsulated into microgels exhibiting unique shapes to investigate kidney epithelialization [141], human pluripotent stem cells to develop embryo models [48], and neural stem cells encapsulated in sodium alginate shells coated with Matrigel to create 3D human spherical neuronal micro tissues (Figure 11C) [19].
Microfluidics also offers potential to mimic certain structures and patterns in extracellular matrix [139, 142, 340]. Microfluidic devices have been used to create fiber‐shaped tissue constructs with multiple layers [138] and microgels with spiral internal structures [139], with the latter particularly of interest for improving cell‐to‐cell signaling and nutrient diffusion within the precise geometry defined by the microfluidic fabrication method. The unique spiral configuration was initially tested with L929 cells and then expanded to multi‐cell applications using human umbilical vein endothelial cells and mesenchymal stem cells to validate the mechanisms of osteogenesis and angiogenesis in an organoid application (Figure 11D) [139]. Cellular patterns can also be fabricated by manipulating the pre‐fabricated microgels using either electrical manipulation [142, 146] or railed microfluidic channels [340] to enable the use of microgels as building blocks for tissue engineering matrices [146].
4.3. Delivery of Bioactive Agents
The control over microgel morphology enabled by microfluidics presents several opportunities to improve the loading and/or control the release of a range of different types of therapeutics. Several research groups have demonstrated unique methods to encapsulate a model drug [11, 40, 131] or bioactive [62, 125] into their microgel vehicle of choice. Direct encapsulation of a drug into a single phase spherical microgel typically results in first‐order release kinetics; for example, our group has reported the use of hydrazone chemistry to form microgels by crosslinking PNIPAM with different carbohydrates, enabling tunable swelling and deswelling (and thus porosity and drug–microgel interactions) to mediate the release of bupivacaine hydrochloride upon temperature changes [11]. Cai et al. showed similar kinetics control as a function of pH using pH‐dependent alginate microgels that delivered doxorubicin that could effectively kill human breast cancer cells (MCF‐7) [140]. Changing the shape or internal morphology of the microgel can promote significantly different release profiles. As an example of shape modification, Hu et al. fabricated non‐spherical alginate microgels with varying shapes by combining microfluidic droplet generation with external ionic crosslinking, leading to varying release kinetics for encapsulated iopamidol (Figure 12A) [40]. As an example of internal morphology engineering, Jeong et al. generated liposomes‐in‐microgel particles in which the model drug (pyrene) was loaded into the bilayer of the liposome, promoting both sustained release profiles and increased liposomal stability. Pre‐fabricated porous microgels have also been shown to template the antisolvent precipitation of hydrophobic active pharmaceutical ingredients (API), with the resulting core‐shell crystalline API particles allowing for controllable drug loading and further tuning of release profiles [164].
FIGURE 12.

Microfluidic‐fabricated microgels for bioactive delivery applications. (A) Cumulative release profiles of iopamidol‐loaded microgels demonstrating the various release kinetics profiles achievable with different microgel shapes. Reproduced from the literature [40] under a Creative Commons Attribution license 4.0 (CC BY). (B) Schematic of dopamine‐functionalized pH‐dependent microgels loaded with bevacizumab (Bev) for anti‐angiogenesis and docetaxel (DTX) for cancer chemotherapy. Adapted with permission from the literature [99]. Copyright 2020 American Chemical Society. C) The performance of protease‐degradable microgels prepared by mixing VPM (protease‐degradable) and DTT (protease‐insensitive) crosslinkers showing (a) release of IgG at various VPM and DTT ratios and (b) release of vascular endothelial growth factor (VEGF) with or without added collagenase. The resulting microgels significantly increased the number of blood vessels generated in a mouse model, as shown by (c) image analysis and (d) lectin‐labeled vessel fluorescence microscopy. Adapted from the literature [97]. Copyright 2017, with permission from Elsevier. (D) Microscale mixing within microgel droplets through (a) the reactive mixing of CMC‐A (hydrazide‐functionalized) and DEX‐B (aldehyde‐functionalized) polymers within the flow channel, with the dark stream representing the hydrazide polymer solution and the light stream representing the aldehyde polymer solution, (b and c) microscopy images of the resulting microgels, and (d) the cumulative release kinetic profile of bupivacaine hydrochloride from on‐chip loaded microgels. Adapted with permission from the literature [11]. Copyright 2012 Wiley.
The mild microgel fabrication conditions enabled by microfluidics are particularly relevant to the encapsulation of proteins and peptides. Several groups have successfully encapsulated proteins in microgels to achieve controlled release depending on the morphology and structure of the microgel [65, 75, 86, 135]. Co‐delivery of protein/antibody therapeutics with small molecule drugs can also be facilitated using microgels. For example, Chen et al. developed tumor‐adhesive and pH‐degradable PVA microgels decorated with dopamine moieties (to increase tumor adhesion) that co‐encapsulated bevacizumab and docetaxel, facilitating a dual anti‐angiogenesis and cancer chemotherapy against a 4T1‐Luc breast tumor mouse model (Figure 12B) [99]. Microgel shells have also been used for effective protein delivery; for example, vascular endothelial growth factor (VEGF) was encapsulated within a 4‐arm poly(ethylene glycol)‐maleimide (PEG‐4MAL) microgel shell containing protease‐degradable peptide crosslinkers to allow for triggered protein release as a function of protease concentration at a rate tunable by to the ratio of degradable to non‐degradable crosslinkers (Figure 12C) [97]. The creation of degradable microgels via dynamic covalent chemistry enabled by controlled reactive precursor polymer mixing within microfluidic chips can also enable on‐chip encapsulation of bioactive drugs coupled with tunable release regulated by both degradation and diffusion. For example, Kesselman et al. used a microfluidic device to synthesize monodisperse, covalently cross‐linked microgels via on‐chip mixing of hydrazide‐functionalized carboxymethyl cellulose (CMC‐A) and aldehyde‐functionalized dextran (DEX‐B) that can enable controlled release of bupivacaine while retaining the potential for in situ degradation (Figure 12D) [11].
4.4. Food and Nutrition
Food‐grade microgels prepared with edible proteins and polysaccharides are of interest within food and nutrition applications [56, 60]. Conventional microgel fabrication and loading strategies similar to those outlined for pharmaceutical release in Section 4.3 are typically used, with the protection of the bioactive during subsequent processing and storage and the potential of the microgel to mask the often undesirable flavor of many food additives representing additional advantages of encapsulation in this context [341]. For example, Marengo et al. used a PMMA microfluidic device with cross‐junction microchannels to fabricate egg white/carrageenan microparticles crosslinked either chemically using glutaraldehyde or physically using microwave radiation‐induced crosslinking [56], enabling encapsulation of the hydrophilic food dye yellow sunset. The capacity of microfluidics to enable scalable and reproducible higher‐order emulsion fabrication represents an additional advantage for encapsulating food‐grade oils and nutritional extracts that typically have low water solubility and thus bioavailability. For example, capillary‐based microfluidic devices have been used to fabricate microgels to encapsulate oils rich in omega‐3 fatty acids including echium and fish oils to improve their oxidative stability [122, 342] and the anti‐oxidant jabuticaba extract beneficial to intestinal health [119].
4.5. Sensors
As biosensors, microgels produced via microfluidics strategies can offer advantages such as increased detection sensitivity, reduced sample volumes, and improved compatibility with on‐site analysis [64, 89]. Poly(ethylene glycol) diacrylate‐based microgels have been particularly exploited in this context given the low biofouling enabled by the highly water binding PEG‐based microgel interface, helping to reduce non‐specific binding in complex biological fluids and thus more sensitive/selective sensor outputs. For example, Celetti et al. incorporated the Strep‐tagII peptide sequence into PEGDA microgels to selectively capture streptavidin from a complex medium of various proteins [64], while Debroy et al. fabricated PEGDA microgels with crosslinking density gradients for the selective detection of neutravidin using a model biotin–avidin binding assay [89]. Engineering the pore size and/or chemistry of the microgel can also promote improved encapsulation of a variety of potential sensing ligands. For example, Rahman et al. developed pH‐sensing poly(ionic liquid)‐based microgels that encapsulated commercially available pH indicators that did not leach out of the microgels over time, enabling stable pH sensing [163].
The capacity of microfluidics to effectively encapsulate other phases into microgels also can provide specific benefits in biosensing applications. Magnetic nanoparticles are particularly useful in biosensing to enable facile separation of the microgels from the biological sample, enabling simple and fast washing of non‐specifically adsorbed proteins from the sensor prior to analysis to maximize signal:noise [78, 103]. Various groups have developed magnetic microgels in the Janus form [77, 90], microgels that have multiple magnetic cores [78], or barcoded particles [103] to enhance separation while retaining other microgel benefits. For example, magnetic barcoded hydrogel microgels consisting of a mixture of PEGDA with rhodamine A, magnetic beads, and DNA probe oligonucleotide were fabricated using a modified stop flow lithography technique to enable the generation of particles with three distinct chemical regions enabling high sensitivity to the targeted biologic (complementary oligonucleotides) and improved the magnetization to allow for ease of separation for analysis (Figure 13A) [103]. Alternately, gold nanoparticle encapsulation may be useful in sensing applications to enable surface‐enhanced Raman scattering substrate for on‐site detection of molecules. For example, Kim et al. used a capillary microfluidic device to generate monodisperse double emulsion droplets in which the core consisted of gold nanoparticles (Au NPs) and PEGDA hydrogel precursors while the shell consisted of mineral oil. By selectively pumping water out of the droplets under hypertonic conditions, a 30× increase in gold nanoparticle density within the droplet was achieved without significant nanoparticle aggregation. Following photopolymerization of the droplet to immobilize the concentrated gold nanoparticles in place and subsequent removal of the oil phase to release the resulting microgels into water, the microgels enabled a surface‐enhanced Raman scattering signal two orders of magnitude higher than microgels prepared without hypertonic concentration enrichment (Figure 13B) [121].
FIGURE 13.

Microfluidic‐fabricated microgels for sensor applications. (A) (a) Schematic of magnetic barcoded microgel particles based on PEGDA hydrogel, (b) their bulk separation with the use of a hand magnet, and (c) the orientation of an individual magnetic barcoded particle in response to a hand magnet. Scale bar = 50 µm. Adapted with permission from the literature [103]. Copyright 2010 American Chemical Society. (B) PEGDA microgels with high concentrations of gold nanoparticles to enable surface‐enhanced Raman scattering for detection of small molecules showing (a) a schematic for the detection of tricyclazole in whole milk, (b) Raman spectra from the microgels suspended in whole milk with tricyclazole, and (c) the Raman intensity at a wavenumber of 1083 cm−1 as a function of tricyclazole concentration (c). Reprinted with permission from the literature [121]. Copyright 2019 Wiley. (C) Schematic for fabricating silica‐coated hyaluronic acid/PEG microgels as protection vehicles for cell‐based biosensors for monitoring cell growth, with sensing validated using quorum sensing. Reprinted from the literature [18]. Copyright 2021, with permission from Elsevier.
Cell‐based biosensing applications are also enabled by microfluidic microgels, providing improved long‐term cell viability in addition to protecting the biosensor in harsher conditions. For example, Zhao et al. used hyaluronic acid/PEG microgels obtained via the Michael addition reaction between thiol‐functionalized hyaluronic acid (SH‐HA) and hyperbranched poly(ethylene glycol) diacrylate (HB‐PEGDA) to encapsulate genetically engineered cells that were subsequently coated with a mesoporous silica shell that both prevents the cell from escaping and allows for communication between the encapsulated cell its environment. These structures enabled effective sensing of signaling molecules secreted by a Pseudomonas aeruginosa at an infection site by the autoinducer‐triggered expression of enhanced green fluorescent protein (eGFP) by the encapsulated cells (Figure 13C) [18].
4.6. Pollutant or Toxin Removal
Microgels fabricated via microfluidic techniques can be ideal for a variety of pollutant removal applications based on their tunable porous network structures, high internal free volumes and thus adsorption capacities, and highly controllable shapes [72, 130]. Heavy metal removal, as demonstrated for Cu2+ and Ni2+ using alginate microgels [72] and hexavalent chromium using poly(ionic liquid) microgel beads [163], is a particularly relevant application of microgels in which ion exchange‐based mechanisms (e.g., exchanging the Ca2+ crosslinker with Cu2+ and Ni2+ ions in alginate microgels [72] or the bromide counterion of the PIL microgels with negatively charged anions of chromium at low pH values [163]) can drive effective remediation. Polar impurities in oils represent other environmental threats suitable for microfluidic microgel remediation. For example, Sun et al. used a capillary‐based microfluidic device to encapsulate graphene oxide (a 2D hydrophilic material with a high surface area for sorption applications but poor oil dispersibility) into PEGDA microgels, allowing for effective dispersion in oil to enhance the removal of polar contaminants [130]. By further incorporating hollow cores and additional magnetic nanoparticles into the microgel templates during fabrication, the graphene oxide composite microgels gained hierarchical porous structures and magnetically controllable movement capabilities that further enhanced ease of microgel collection and recovery.
The absorptive capacity of microgels can also be employed in health applications. For example, Vibrio cholerae causes secretory diarrhea when its virulence factor, the cholera toxin, binds to the glycosphingolipid receptor GM1a; consequently, GM1a‐functionalized microgels with a pore network structure that permits in‐diffusion of the cholera toxin, exhibits stability in the pH of the intestine, and has an appropriate size to prevent cellular uptake by the intestinal epithelial cells [96] can be used to competitively bind the cholera toxin and prevent the toxicity effects of the bacterium.
4.7. Other Applications
In addition to the more common applications described in the previous sections, microfluidics can enable the fabrication of microgels suitable for a broad range of other applications. For example, the fabrication of thermally stable microgels with high capability to immobilize water molecules can be applied for the transportation of waste materials [102]. Microgels fabricated to swell and de‐swell based on changes to their surrounding environment, such as fluctuations in pH and ionic strength [11] or cyclic changes in temperature [230], can be used as valves in microfluidic reactors or as switchable optical materials, in the latter case particularly taking advantage of the monodispersity of microgels produced via microfluidic strategies to promote ordered packing that can enhance optical responses [343]. Multi‐layer microgels in which each layer is sensitive to a different stimulus (e.g., pH, temperature, and ionic strength) can enable the fabrication of optical switches responsive to the microgel environment (Figure 14A) [94]. The ability to control microgel size, mechanics (e.g., crosslink density), and morphology enables effective mimicking of specific cellular attributes without the use of cells, beneficial to make microreactors for cell‐free protein synthesis based on clay microgels exhibiting pore sizes in the range of 5−10 µm (Figure 14B) [344]. Microfluidics can enable the assembly of colloids into granules of tunable sizes and morphologies, for example, the assembly of silica microsphere‐filled poly(acrylamide)‐based microgels with both homogenous and Janus structures relevant to the transport and processing of pharmaceuticals or ceramics (Figure 14C [345]). Microgels with electromechanical properties are also of interest to harvest energy normally lost energy during classic industrial processes; for example, electrostatic energy harvesters have been reported based on microfluidics‐generated poly(ionic liquid) microgels, with the high uniformity of sizes/morphologies enabled by microfluidics key to enabling consistent energy harvesting responses [158, 162]. It is anticipated that other applications will emerge as microfluidic fabrication of microgels continues to expand as a field into non‐traditional areas.
FIGURE 14.

Other applications of microgels fabricated via microfluidics: (A) Thermoresponsive core‐shell microgels with varying core and shell temperature sensitivity shown through fluorescence images (a) and numerically by particle diameter (b). Adapted with permission from the literature [94]. Copyright 2010 American Chemical Society. (B) Schematic of clay microgels mimicking cell structures for cell‐free protein synthesis (a) and fluorescence microscopy of a reported enhanced green fluorescent protein (green) after 5 min (b) or 3 h (c). Adapted with permission from the literature [344]. Copyright 2018 American Chemical Society. (C) Scanning electron micrographs of (a) dried spherical and (b) discoid colloid‐filled hydrogel granules with (c) a dried and freeze‐fractured granule showing higher magnification view of silica microspheres inside the granule (top right). Adapted with permission from the literature [345]. Copyright 2006 American Chemical Society.
From an application perspective, the optimal microgel design depends on the functional requirements of the intended application. For instance, highly monodisperse spherical microgels are generally preferred for cell encapsulation as they provide uniform nutrient and oxygen transport while minimizing mechanical stress on encapsulated cells. In contrast, core‐shell, multicompartment, and porous microgels are commonly used for drug delivery because they enable improved control over drug loading, protection, and sustained or sequential release of therapeutic agents. For tissue engineering, although various microgels morphologies may be employed, non‐spherical, porous, Janus, and interconnected microgels can often facilitate improved cell migration, extracellular matrix deposition, cell alignment, vascularization, and modular assembly into larger tissue constructs. On the other hand, compartmentalized and stimuli‐responsive microgels can improve sensing performance by enabling selective analyte recognition, signal amplification, or rapid responses to environmental change are thus often preferred in sensing applications. Consequently, the selection of a microfluidic fabrication strategy for a given application should be based not only on fabrication efficiency and production throughput but also on the microgel architecture best suited to achieve the desired biological or functional performance.
5. Conclusions and Future Perspectives
In this review, we summarized in detail different materials, crosslinking mechanisms, and microfluidic techniques employed for producing microgels with a range of morphologies relevant to a diverse set of biomedical and technological applications. The unique features provided by microfluidic technologies including supervisor control over fluid handling/mixing, high control over microgel size/shape/morphology, and the ability to manipulate multiphase fluid flows within precisely designed microchannels is essential to leveraging in most cases already‐established material/crosslinker combinations to create new functional microgel materials. The capacity to multiplex microfluidic synthesis is highly beneficial for scale‐up of microgel synthesis without the challenges of conventional volumetric reactor scale‐up processes (e.g., mixing, heat transfer), enabling the formation of microgels in various quantities ranging from small‐scale research settings to large‐scale manufacturing processes in which millions of microgels can be produced in only a few seconds using the exact same geometries as used for lab‐scale development. Microfluidic platforms also offer flexibility in designing microgels based on a wide range of materials as well as various crosslinking mechanisms that can be triggered over precise timescales challenging to achieve using conventional techniques, facilitating the production of tailored microgels with specific properties and functionalities and high control over physicochemical properties such as mechanical strength and responsiveness to external stimuli.
While considerable research advancements have been made in employing microfabrication and microfluidic technologies for the fabrication of microgels, there are still several challenges that must be tackled to expand the practicality of these approaches. Primarily, further development of microfabrication techniques, microfluidic device designs, hydrodynamics technologies, and production strategies is required to achieve effective and reproducible control over microgel morphology, structure, and properties, while balancing production throughput with the increasing structural complexity of advanced microgel architectures. This is particularly true in the context of in situ gelation processes that remain somewhat challenging to implement on microfluidic platforms given the required balance of processibility (i.e., avoiding device clogging) and stable gelation (i.e., avoiding droplet coalescence prior to microgel formation) on similar timescales. Second, although microfluidic technologies are in principle ideal for scale‐up based on multiplexing, the practicality of such scale‐up for large scale commercial purposes is still in its infancy and is limited by the high cost of the microfabrication techniques required to produce the small features required for microfluidic microgel fabrication. As such, there is a need for cheaper and faster device fabrication alternatives (e.g., higher resolution 3D prototyping methods) to enable commercially viable scaling beyond moderate‐scale biomedical processes that have higher cost tolerances and can be suitably serviced using existing fabrication approaches. Third, while microfluidic techniques offer in principle high versatility in material selection, the compatibility of those materials with conventional microfluidic devices or fabrication procedures can pose challenges; for example, the use of organic solvents in PDMS devices can induce swelling that can potentially cause the microchannels to clog or result in inconsistent microgel production. Developing scalable non‐PDMS‐based device designs and fabrication materials that exhibit greater stability and compatibility is thus essential to expand the types of materials that can be reliably produced.
Finally, while the individual production of microgels has been well‐established, the subsequent fabrication of those microgels into larger‐scale organized scaffolds remains in its infancy despite its significant potential to produce large‐scale tissue constructs with microvascularized network channels, an application currently limited by the types of materials and crosslinking strategies that can be implemented in a microfluidic context that offer the cell interactions and differential degradability required to form microvascularized constructs. In particular, integrating downstream purification processes including the efficient removal of residual oil phases, surfactants, and solvent residues while preserving the functionality of encapsulated cells or bioactive cargos will be important for facilitating practical translation and large‐scale manufacturing. Emerging microfluidic‐based separations strategies, including on‐chip membrane filtration, deterministic lateral displacement, continuous solvent exchange, and integrated phase‐transfer systems, offer promise for addressing the purification bottleneck that can limit the functionality and/or throughput of microgels in many biomedical applications (e.g., tissue engineering to maintain cell viability or drug delivery to prevent premature drug release).
Overall, despite significant progress in this field, more research efforts need to be focused on broadening the microfluidic processes available for microgel fabrication, expanding the diversity of microfluidic device designs and thus microgel morphologies accessible (in particular anisotropic morphologies with high tunability and reproducibility), and improving scalability without sacrificing control over microgel size, shape, and structure to truly exploit the power of microfluidic microgel generation in medium/larger‐scale industrial applications. Future advances should also emphasize integrated and automated manufacturing strategies that leverage emerging artificial intelligence and machine learning tools for microfluidic device design, process optimization, and real‐time quality control. Such approaches could integrate microgel generation with downstream processing while promoting standardized characterization methods for evaluating microgel properties and fabrication performance, thereby facilitating the development of automated platforms for the production, assessment of optimization of microgels. Ultimately, continued progress will increasingly rely on application‐driven design in which microfluidic platform selection, material systems, crosslinking mechanisms, and microgel architectures are considered collectively to achieve the functional requirements of specific biomedical and technological applications.
Author Contributions
A.A. and T.H. conceptualized the article and secured funding. A.A., L.N., C.P., and N.I. wrote the first draft. A.A., L.N., A.L.C., B.A.K., and T.H. contributed to the subsequent drafts. All authors revised the manuscript and approved the final version.
Funding
The authors acknowledge funding support from the Natural Sciences and Engineering Research Council of Canada (NSERC, Discovery Grants RGPIN‐2017‐06455 and RGPIN‐2025‐07190) and Mitacs (Accelerate Grant IT27833).
Conflicts of Interest
The authors declare no conflicts of interest.
Acknowledgements
The authors acknowledge funding support from the Natural Sciences and Engineering Research Council of Canada (NSERC, Discovery Grants RGPIN‐2017‐06455 and RGPIN‐2025‐07190) and Mitacs (Accelerate Grant IT27833).
Contributor Information
Afshin Abrishamkar, Email: afshin.abrishamkar@utoronto.ca.
Todd Hoare, Email: hoaretr@mcmaster.ca.
Data Availability Statement
Data sharing not applicable to this article as no datasets were generated or analyzed during the current study.
References
- 1. Cui C., Gao H.‐L., Wang Z.‐Y., et al., “Controlled Desiccation of Preprinted Hydrogel Scaffolds Toward Complex 3D Microarchitectures,” Advanced Materials 35, no. 5 (2023): 2207388. [DOI] [PubMed] [Google Scholar]
- 2. Campbell S. B. and Hoare T., “Externally Addressable Hydrogel Nanocomposites for Biomedical Applications,” Current Opinion in Chemical Engineering 4 (2014): 1–10. [Google Scholar]
- 3. Hoare T. R. and Kohane D. S., “Hydrogels in Drug Delivery: Progress and Challenges,” Polymer 49, no. 8 (2008): 1993–2007. [Google Scholar]
- 4. Catoira M. C., Fusaro L., Di Francesco D., and Ramella M., “Overview of Natural Hydrogels for Regenerative Medicine Applications,” Journal of Materials Science: Materials in Medicine 30, no. 10 (2019): 115. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5. Madduma‐Bandarage U. S. K. and Madihally S. V., “Synthetic Hydrogels: Synthesis, Novel Trends, and Applications,” Journal of Applied Polymer Science 138, no. 19 (2021): 50376. [Google Scholar]
- 6. Maitra J. and Shukla V. K., “Cross‐Linking in Hydrogels: A Review,” American Journal of Polymer Science 4, no. 2 (2014): 25–31. [Google Scholar]
- 7. Slaughter B. V., Khurshid S. S., Fisher O. Z., Khademhosseini A., and Peppas N. A., “Hydrogels in Regenerative Medicine,” Advanced Materials 21, no. 32‐33 (2009): 3307–3329. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8. Hu Y., Wang S., Abbaspourrad A., and Ardekani A. M., “Fabrication of Shape Controllable Janus Alginate/pNIPAAm Microgels via Microfluidics Technique and Off‐Chip Ionic Cross‐linking,” Langmuir 31, no. 6 (2015): 1885–1891. [DOI] [PubMed] [Google Scholar]
- 9. Zhao X., Liu S., Yildirimer L., et al., “Injectable Stem Cell‐Laden Photocrosslinkable Microspheres Fabricated Using Microfluidics for Rapid Generation of Osteogenic Tissue Constructs,” Advanced Functional Materials 26, no. 17 (2016): 2809–2819. [Google Scholar]
- 10. Xiao C.‐D., Shen X.‐C., and Tao L., “Modified Emulsion Solvent Evaporation Method for Fabricating Core–Shell Microspheres,” International Journal of Pharmaceutics 452, no. 1 (2013): 227–232. [DOI] [PubMed] [Google Scholar]
- 11. Kesselman L. R. B., Shinwary S., Selvaganapathy P. R., and Hoare T., “Synthesis of Monodisperse, Covalently Cross‐Linked, Degradable “Smart” Microgels Using Microfluidics,” Small 8, no. 7 (2012): 1092–1098. [DOI] [PubMed] [Google Scholar]
- 12. Duval S., Chung C., and McClements D. J., “Protein‐Polysaccharide Hydrogel Particles Formed by Biopolymer Phase Separation,” Food Biophysics 10, no. 3 (2015): 334–341. [Google Scholar]
- 13. Umeda Y., Kobayashi T., Hirai T., and Suzuki D., “Effects of pH and Temperature on Assembly of Multiresponsive Janus Microgels,” Colloid and Polymer Science 289, no. 5 (2011): 729–737. [Google Scholar]
- 14. Karg M., Pich A., Hellweg T., et al., “Nanogels and Microgels: From Model Colloids to Applications, Recent Developments, and Future Trends,” Langmuir 35, no. 19 (2019): 6231–6255. [DOI] [PubMed] [Google Scholar]
- 15. Nguyen T. P. T., Li F., Shrestha S., et al., “Cell‐Laden Injectable Microgels: Current Status and Future Prospects for Cartilage Regeneration,” Biomaterials 279 (2021): 121214. [DOI] [PubMed] [Google Scholar]
- 16. Guerzoni L. P. B., Rose J. C., Gehlen D. B., et al., “Cell Encapsulation in Soft, Anisometric Poly(ethylene) Glycol Microgels Using a Novel Radical‐Free Microfluidic System,” Small 15, no. 20 (2019): 1900692. [DOI] [PubMed] [Google Scholar]
- 17. Chen Q., Passos A., Balabani S., et al., “Semi‐Interpenetrating Network Hyaluronic Acid Microgel Delivery Systems in Micro‐Flow,” Journal of Colloid and Interface Science 519 (2018): 174–185. [DOI] [PubMed] [Google Scholar]
- 18. Zhao S., Wen H., Ou Y., Li M., Wang L., and Zhou H., “A New Design for Living Cell‐Based Biosensors: Microgels With a Selectively Permeable Shell That Can Harbor Bacterial Species,” Sensors and Actuators B: Chemical 334 (2021) 129648. [Google Scholar]
- 19. Alessandri K., Feyeux M., Gurchenkov B., et al., “A 3D Printed Microfluidic Device for Production of Functionalized Hydrogel Microcapsules for Culture and Differentiation of Human Neuronal Stem Cells (hNSC),” Lab on a Chip 16, no. 9 (2016): 1593–1604. [DOI] [PubMed] [Google Scholar]
- 20. Saralidze K., Koole L. H., and Knetsch M. L. W., “Polymeric Microspheres for Medical Applications,” Materials 3, no. 6 (2010): 3537–3564. [Google Scholar]
- 21. Mohamed M. G. A., Ambhorkar P., Samanipour R., Yang A., Ghafoor A., and Kim K., “Microfluidics‐Based Fabrication of Cell‐Laden Microgels,” Biomicrofluidics 14, no. 2 (2020): 021501. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22. Xu Q., Hashimoto M., Dang T. T., et al., “Preparation of Monodisperse Biodegradable Polymer Microparticles Using a Microfluidic Flow‐Focusing Device for Controlled Drug Delivery,” Small 5, no. 13 (2009): 1575–1581. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23. Dendukuri D., Pregibon D. C., Collins J., Hatton T. A., and Doyle P. S., “Continuous‐Flow Lithography for High‐Throughput Microparticle Synthesis,” Nature Materials 5, no. 5 (2006): 365–369. [DOI] [PubMed] [Google Scholar]
- 24. Yeh J., Ling Y., Karp J. M., et al., “Micromolding of Shape‐Controlled, Harvestable Cell‐Laden Hydrogels,” Biomaterials 27, no. 31 (2006): 5391–5398. [DOI] [PubMed] [Google Scholar]
- 25. Pal V., Singh Y. P., Gupta D., et al., “High‐Throughput Microgel Biofabrication via Air‐Assisted Co‐Axial Jetting for Cell Encapsulation, 3D Bioprinting, and Scaffolding Applications,” Biofabrication 15, no. 3 (2023): 035001. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26. Strozyk M. S., de Aberasturi D. J., Gregory J. V., Brust M., Lahann J., and Liz‐Marzán L. M., “Spatial Analysis of Metal–PLGA Hybrid Microstructures Using 3D SERS Imaging,” Advanced Functional Materials 27, no. 33 (2017): 1701626. [Google Scholar]
- 27. Li W., Zhang L., Ge X., et al., “Microfluidic Fabrication of Microparticles for Biomedical Applications,” Chemical Society Reviews 47, no. 15 (2018): 5646–5683. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28. Abrishamkar A., Nilghaz A., Saadatmand M., Naeimirad M., and deMello A. J., “Microfluidic‐Assisted Fiber Production: Potentials, Limitations, and Prospects,” Biomicrofluidics 16, no. 6 (2022): 061504. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29. Wang J., Li Y., Wang X., et al., “Droplet Microfluidics for the Production of Microparticles and Nanoparticles,” Micromachines 8, no. 1 (2017): 22. [Google Scholar]
- 30. Abrishamkar A., Microfluidic Environments: A Useful Platform for Synthesis, Study and Processing of Crystalline Materials (ETH Zurich, 2018). [Google Scholar]
- 31. Riahi R., Tamayol A., Shaegh S. A. M., Ghaemmaghami A. M., Dokmeci M. R., and Khademhosseini A., “Microfluidics for Advanced Drug Delivery Systems,” Current Opinion in Chemical Engineering 7 (2015): 101–112. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32. Pandey C. M., Augustine S., Kumar S., et al., “Microfluidics Based Point‐of‐Care Diagnostics,” Biotechnology Journal 13, no. 1 (2018): 1700047. [DOI] [PubMed] [Google Scholar]
- 33. Calvo Galve N., Abrishamkar A., Sorrenti A., et al., “Unveiling Pathway Complexity in the Growth of a Spin‐Crossover MOF via Engineered Liquid–Liquid Interfacial Reactions,” ChemRxiv 2019, no. 0226 (2019), https://chemrxiv.org/doi/pdf/10.26434/chemrxiv.7764842.v1?redirectToLatest=false. [Google Scholar]
- 34. Naeimirad M., Zadhoush A., Abrishamkar A., Pishevar A., and Leal A. A., “Melt‐Spun Liquid Core Fibers: Physical and Morphological Characteristics,” Iranian Polymer Journal 25, no. 5 (2016): 397–403. [Google Scholar]
- 35. Young E. W. K. and Simmons C. A., “Macro‐ and Microscale Fluid Flow Systems for Endothelial Cell Biology,” Lab Chip 10, no. 2 (2010): 143–160. [DOI] [PubMed] [Google Scholar]
- 36. Abrishamkar A., Suarez‐Garcia S., Sevim S., et al., “Pathway Selection as a Tool for Crystal Defect Engineering: a Case Study with a Functional Coordination Polymer,” Applied Materials Today 20 (2020): 100632. [Google Scholar]
- 37. Calvo Galve N., Abrishamkar A., Sorrenti A., et al., “Exploiting Reaction‐Diffusion Conditions to Trigger Pathway Complexity in the Growth of a MOF,” Angewandte Chemie 133, no. 29 (2021): 16056–16063. [DOI] [PubMed] [Google Scholar]
- 38. Chung B. G., Lee K.‐H., Khademhosseini A., and Lee S.‐H., “Microfluidic Fabrication of Microengineered Hydrogels and Their Application in Tissue Engineering,” Lab Chip 12, no. 1 (2012): 45–59. [DOI] [PubMed] [Google Scholar]
- 39. Choi J. H., Kim J. S., Kim W. K., et al., “Evaluation of Hyaluronic Acid/Agarose Hydrogel for Cartilage Tissue Engineering Biomaterial,” Macromolecular Research 28, no. 11 (2020): 979–985. [Google Scholar]
- 40. Hu Y., Wang Q., Wang J., Zhu J., Wang H., and Yang Y., “Shape Controllable Microgel Particles Prepared by Microfluidic Combining External Ionic Crosslinking,” Biomicrofluidics 6, no. 2 (2012): 26502–265029. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41. Rodríguez‐San‐Miguel D., Abrishamkar A., Navarro J. A. R., et al., “Crystalline Fibres of a Covalent Organic Framework Through Bottom‐up Microfluidic Synthesis,” Chemical Communications 52, no. 59 (2016): 9212–9215. [DOI] [PubMed] [Google Scholar]
- 42. Abrishamkar A., Rodríguez‐San‐Miguel D., Rodríguez Navarro J. A., et al., “Microfluidic‐Based Synthesis of Covalent Organic Frameworks (COFs): a Tool for Continuous Production of COF Fibers and Direct Printing on a Surface,” Journal of Visualized Experiments, no. 125 (2017): 56020, https://www.jove.com/t/56020/microfluidic‐based‐synthesis‐covalent‐organic‐frameworks‐cofs‐tool. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43. Dubay R., Urban J. N., and Darling E. M., “Single‐Cell Microgels for Diagnostics and Therapeutics,” Advanced Functional Materials 31, no. 44 (2021): 2009946. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44. Rubio‐Martinez M., Imaz I., Domingo N., et al., “Freezing the Nonclassical Crystal Growth of a Coordination Polymer Using Controlled Dynamic Gradients,” Advanced Materials 28, no. 37 (2016): 8150–8155. [DOI] [PubMed] [Google Scholar]
- 45. Puigmartí‐Luis J., “Microfluidic Platforms: a Mainstream Technology for the Preparation of Crystals,” Chemical Society Reviews 43, no. 7 (2014): 2253–2271. [DOI] [PubMed] [Google Scholar]
- 46. Bhatia S. N. and Ingber D. E., “Microfluidic Organs‐on‐Chips,” Nature Biotechnology 32, no. 8 (2014): 760–772. [DOI] [PubMed] [Google Scholar]
- 47. Herland A., Maoz B. M., Das D., et al., “Quantitative Prediction of Human Pharmacokinetic Responses to Drugs via Fluidically Coupled Vascularized Organ Chips,” Nature Biomedical Engineering 4, no. 4 (2020): 421–436. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48. Schindler M., Siriwardena D., Kohler T. N., et al., “Agarose Microgel Culture Delineates Lumenogenesis in Naive and Primed Human Pluripotent Stem Cells,” Stem Cell Reports 16, no. 5 (2021): 1347–1362. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49. Xu S., Nie Z., Seo M., et al., “Generation of Monodisperse Particles by Using Microfluidics: Control Over Size, Shape, and Composition,” Angewandte Chemie 117, no. 5 (2005): 734–738. [DOI] [PubMed] [Google Scholar]
- 50. Abrishamkar A., “A COMSOL Multiphysics® Model of Droplet Formation at a Flow Focusing Device,” in Proceedings of the COMSOL Conference, Rotterdam, The Netherlands (2013).
- 51. Lagus T. P. and Edd J. F., “A Review of the Theory, Methods and Recent Applications of High‐Throughput Single‐Cell Droplet Microfluidics,” Journal of Physics D: Applied Physics 46, no. 11 (2013): 114005. [Google Scholar]
- 52. Ahmed H. and Stokke B. T., “Fabrication of Monodisperse Alginate Microgel Beads by Microfluidic Picoinjection: a Chelate Free Approach,” Lab on a Chip 21, no. 11 (2021): 2232–2243. [DOI] [PubMed] [Google Scholar]
- 53. Cinel V. D. P., Taketa T. B., de Carvalho B. G., et al., “Microfluidic Encapsulation of Nanoparticles in Alginate Microgels Gelled via Competitive Ligand Exchange Crosslinking,” Biopolymers 112, no. 7 (2021): 23432. [DOI] [PubMed] [Google Scholar]
- 54. Abbasi N., Navi M., Nunes J. K., and Tsai S. S. H., “Controlled Generation of Spiky Microparticles by Ionic Cross‐Linking Within an Aqueous Two‐Phase System,” Soft Matter 15, no. 16 (2019): 3301–3306. [DOI] [PubMed] [Google Scholar]
- 55. Abrishamkar A., Paradinas M., Bailo E., et al., “Microfluidic Pneumatic Cages: A Novel Approach for In‐Chip Crystal Trapping, Manipulation and Controlled Chemical Treatment,” Journal of Visualized Experiments, no. 113 (2016): 54193, https://www.jove.com/t/54193/microfluidic‐pneumatic‐cages‐novel‐approach‐for‐chip‐crystal‐trapping. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 56. Marengo R. C., Olivares M. L., and Berli C. L. A., “Generation of Egg White/Carrageenan Microparticles by Droplet‐Based Microfluidics,” Journal of Food Engineering 259 (2019): 21–28. [Google Scholar]
- 57. Lee J. N., Park C., and Whitesides G. M., “Solvent Compatibility of Poly(dimethylsiloxane)‐Based Microfluidic Devices,” Analytical Chemistry 75, no. 23 (2003): 6544–6554. [DOI] [PubMed] [Google Scholar]
- 58. Jiang Z., Xia B., McBride R., and Oakey J., “A Microfluidic‐Based Cell Encapsulation Platform to Achieve High Long‐Term Cell Viability in Photopolymerized PEGNB Hydrogel Microspheres,” Journal of Materials Chemistry B 5, no. 1 (2017): 173–180. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 59. Lu H., Blokhuis A., Turk‐MacLeod R., et al., “Small‐Molecule Autocatalysis Drives Compartment Growth, Competition and Reproduction,” Nature Chemistry 16, no. 1 (2024): 70–78. [DOI] [PubMed] [Google Scholar]
- 60. Lacroix A., Hayert M., Bosc V., and Menut P., “Batch Versus Microfluidic Emulsification Processes to Produce Whey Protein Microgel Beads From Thermal or Acidic Gelation,” Journal of Food Engineering 312 (2022): 110738. [Google Scholar]
- 61. Sui X., Shui L., Cui J., et al., “Redox‐Responsive Organometallic Microgel Particles Prepared from Poly(ferrocenylsilane)s Generated Using Microfluidics,” Chemical Communications 50, no. 23 (2014): 3058–3060. [DOI] [PubMed] [Google Scholar]
- 62. Lai W. F. and Wong W. T., “Property‐Tuneable Microgels Fabricated by Using Flow‐Focusing Microfluidic Geometry for Bioactive Agent Delivery,” Pharmaceutics 13, no. 6 (2021): 787. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 63. Seiffert S. and Weitz D. A., “Microfluidic Fabrication of Smart Microgels From Macromolecular Precursors,” Polymer 51, no. 25 (2010): 5883–5889. [Google Scholar]
- 64. Celetti G., Natale C. D., Causa F., Battista E., and Netti P. A., “Functionalized Poly(ethylene Glycol) Diacrylate Microgels by Microfluidics: In Situ Peptide Encapsulation for in Serum Selective Protein Detection,” Colloids and Surfaces B: Biointerfaces 145 (2016): 21–29. [DOI] [PubMed] [Google Scholar]
- 65. Zykwinska A., Marquis M., Sinquin C., Cuenot S., and Colliec‐Jouault S., “Assembly of HE800 Exopolysaccharide Produced by a Deep‐Sea Hydrothermal Bacterium Into Microgels for Protein Delivery Applications,” Carbohydrate Polymers 142 (2016): 213–221. [DOI] [PubMed] [Google Scholar]
- 66. Shang L., Cheng Y., and Zhao Y., “Emerging Droplet Microfluidics,” Chemical Reviews 117, no. 12 (2017): 7964–8040. [DOI] [PubMed] [Google Scholar]
- 67. Nan L., Zhang H., Weitz D. A., and Shum H. C., “Development and Future of Droplet Microfluidics,” Lab on a Chip 24, no. 5 (2024): 1135–1153. [DOI] [PubMed] [Google Scholar]
- 68. Dang T.‐D., Kim Y. H., Kim H. G., and Kim G. M., “Preparation of Monodisperse PEG Hydrogel Microparticles Using a Microfluidic Flow‐Focusing Device,” Journal of Industrial and Engineering Chemistry 18, no. 4 (2012): 1308–1313. [Google Scholar]
- 69. Tan W. H. and Takeuchi S., “Monodisperse Alginate Hydrogel Microbeads for Cell Encapsulation,” Advanced Materials 19, no. 18 (2007): 2696–2701. [Google Scholar]
- 70. Abate A. R., Poitzsch A., Hwang Y., Lee J., Czerwinska J., and Weitz D. A., “Impact of Inlet Channel Geometry on Microfluidic Drop Formation,” Physical Review E 80, no. 2 Pt 2 (2009): 026310. [DOI] [PubMed] [Google Scholar]
- 71. Sharratt W. N., Lopez C. G., Sarkis M., et al., “Ionotropic Gelation Fronts in Sodium Carboxymethyl Cellulose for Hydrogel Particle Formation,” Gels 7, no. 2 (2021): 44. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 72. Duc T. H., Vu T. K., Dang C.‐T., et al., “Synthesis and Application of Hydrogel Calcium Alginate Microparticles as a Biomaterial to Remove Heavy Metals From Aqueous media,” Environmental Technology & Innovation 22 (2021): 101400. [Google Scholar]
- 73. Liu K., Ding H.‐J., Liu J., Chen Y., and Zhao X.‐Z., “Shape‐Controlled Production of Biodegradable Calcium Alginate Gel Microparticles Using a Novel Microfluidic Device,” Langmuir 22, no. 22 (2006): 9453–9457. [DOI] [PubMed] [Google Scholar]
- 74. Mora‐Boza A., Mancipe Castro L. M., Schneider R. S., et al., “Microfluidics Generation of Chitosan Microgels Containing Glycerylphytate Crosslinker for In Situ Human Mesenchymal Stem Cells Encapsulation,” Materials Science and Engineering: C 120 (2021): 111716. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 75. Yu L., Sun Q., Hui Y., Seth A., Petrovsky N., and Zhao C.‐X., “Microfluidic Formation of Core‐Shell Alginate Microparticles for Protein Encapsulation and Controlled Release,” Journal of Colloid and Interface Science 539 (2019): 497–503. [DOI] [PubMed] [Google Scholar]
- 76. Jeyhani M., Thevakumaran R., Abbasi N., Hwang D. K., and Tsai S. S. H., “Microfluidic Generation of All‐Aqueous Double and Triple Emulsions,” Small 16, no. 7 (2020): 1906565. [DOI] [PubMed] [Google Scholar]
- 77. Seiffert S., Romanowsky M. B., and Weitz D. A., “Janus Microgels Produced From Functional Precursor Polymers,” Langmuir 26, no. 18 (2010): 14842–14847. [DOI] [PubMed] [Google Scholar]
- 78. Chen C.‐H., Abate A. R., Lee D., Terentjev E. M., and Weitz D. A., “Microfluidic Assembly of Magnetic Hydrogel Particles With Uniformly Anisotropic Structure,” Advanced Materials 21, no. 31 (2009): 3201–3204. [Google Scholar]
- 79. Tottori N., Tang Y., Kanno Y., and Nisisako T., “Continuous Production and Extraction of Monodisperse Alginate Microgels via Deterministic Lateral Displacement,” Soft Matter 22, no. 7 (2026): 1483–1493. [DOI] [PubMed] [Google Scholar]
- 80. Ou Y., Han Z., Cai S., et al., “Biomaterials With Droplet Microfluidics,” Nature Reviews Bioengineering 4, no. 4 (2026): 353–370. [Google Scholar]
- 81. Headen D. M., García J. R., and García A. J., “Parallel Droplet Microfluidics for High Throughput Cell Encapsulation and Synthetic Microgel Generation,” Microsystems & Nanoengineering 4, no. 1 (2018): 17076. [Google Scholar]
- 82. Highley C. B., Song K. H., Daly A. C., and Burdick J. A., “Jammed Microgel Inks for 3D Printing Applications,” Advanced Science 6, no. 1 (2019): 1801076. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 83. Amici E., Tetradis‐Meris G., de Torres C. P., and Jousse F., “Alginate Gelation in Microfluidic Channels,” Food Hydrocolloids 22, no. 1 (2008): 97–104. [Google Scholar]
- 84. Krutkramelis K., Xia B., and Oakey J., “Monodisperse Polyethylene Glycol Diacrylate Hydrogel Microsphere Formation by Oxygen‐Controlled Photopolymerization in a Microfluidic Device,” Lab on a Chip 16, no. 8 (2016): 1457–1465. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 85. Sabhachandani P., Sarkar S., Mckenney S., Ravi D., Evens A. M., and Konry T., “Microfluidic Assembly of Hydrogel‐Based Immunogenic Tumor Spheroids for Evaluation of Anticancer Therapies and Biomarker Release,” Journal of Controlled Release 295 (2019): 21–30. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 86. Mazutis L., Vasiliauskas R., and Weitz D. A., “Microfluidic Production of Alginate Hydrogel Particles for Antibody Encapsulation and Release,” Macromolecular Bioscience 15, no. 12 (2015): 1641–1646. [DOI] [PubMed] [Google Scholar]
- 87. Wu Z., Zheng Y., Lin L., Mao S., Li Z., and Lin J.‐M., “Controllable Synthesis of Multicompartmental Particles Using 3D Microfluidics,” Angewandte Chemie International Edition 59, no. 6 (2020): 2225–2229. [DOI] [PubMed] [Google Scholar]
- 88. Cai B., Guo F., Zhao L., et al., “Disk‐Like Hydrogel Bead‐Based Immunofluorescence Staining Toward Identification and Observation of Circulating Tumor Cells,” Microfluidics and Nanofluidics 16, no. 1‐2 (2013): 29–37. [Google Scholar]
- 89. Debroy D., Li‐Oakey K. D., and Oakey J., “Engineering Functional Hydrogel Microparticle Interfaces by Controlled Oxygen‐Inhibited Photopolymerization,” Colloids and Surfaces B: Biointerfaces 180 (2019): 371–375. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 90. Yuet K. P., Hwang D. K., Haghgooie R., and Doyle P. S., “Multifunctional Superparamagnetic Janus Particles,” Langmuir 26, no. 6 (2010): 4281–4287. [DOI] [PubMed] [Google Scholar]
- 91. Lewis C. L., Lin Y., Yang C., et al., “Microfluidic Fabrication of Hydrogel Microparticles Containing Functionalized Viral Nanotemplates,” Langmuir 26, no. 16 (2010): 13436–13441. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 92. Krüger A. J. D., Bakirman O., Guerzoni L. P. B., and Jans A., “Compartmentalized Jet Polymerization as a High‐Resolution Process to Continuously Produce Anisometric Microgel Rods With Adjustable Size and Stiffness,” Advanced Materials 31, no. 49 (2019): 1903668. [DOI] [PubMed] [Google Scholar]
- 93. Ghosh S. and Schurtenberger P., “Microfluidic Production of Snowman‐Shaped Janus Hydrogel Particles,” Colloids and Surfaces A: Physicochemical and Engineering Aspects 573 (2019): 205–210. [Google Scholar]
- 94. Seiffert S., Thiele J., Abate A. R., and Weitz D. A., “Smart Microgel Capsules From Macromolecular Precursors,” Journal of the American Chemical Society 132, no. 18 (2010): 6606–6609. [DOI] [PubMed] [Google Scholar]
- 95. Sheikhi A., de Rutte J., Haghniaz R., et al., “Microfluidic‐Enabled Bottom‐Up Hydrogels From Annealable Naturally‐Derived Protein Microbeads,” Biomaterials 192 (2019): 560–568. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 96. Boesveld S., Jans A., Rommel D., et al., “Microgels Sopping up Toxins—GM1a‐Functionalized Microgels as Scavengers for Cholera Toxin,” ACS Applied Materials & Interfaces 11, no. 28 (2019): 25017–25023. [DOI] [PubMed] [Google Scholar]
- 97. Foster G. A., Headen D. M., González‐García C., Salmerón‐Sánchez M., Shirwan H., and García A. J., “Protease‐Degradable Microgels for Protein Delivery for Vascularization,” Biomaterials 113 (2017): 170–175. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 98. Weidenbacher L., Abrishamkar A., Rottmar M., et al., “Electrospraying of Microfluidic Encapsulated Cells for the Fabrication of Cell‐Laden Electrospun Hybrid Tissue Constructs,” Acta Biomaterialia 64 (2017): 137–147. [DOI] [PubMed] [Google Scholar]
- 99. Chen X., Qian H., Qiao H., et al., “Tumor‐Adhesive and pH‐Degradable Microgels by Microfluidics and Photo‐Cross‐Linking for Efficient Antiangiogenesis and Enhanced Cancer Chemotherapy,” Biomacromolecules 21, no. 3 (2020): 1285–1294. [DOI] [PubMed] [Google Scholar]
- 100. Liu Y., Nambu N. O., and Taya M., “Cell‐Laden Microgel Prepared Using a Biocompatible Aqueous Two‐Phase Strategy,” Biomedical Microdevices 19, no. 3 (2017): 55, https://ieeexplore.ieee.org/abstract/document/6196805. [DOI] [PubMed] [Google Scholar]
- 101. Haney B., Werner J. G., Weitz D. A., and Ramakrishnan S., “Stimuli Responsive Janus Microgels With Convertible Hydrophilicity for Controlled Emulsion Destabilization,” Soft Matter 16, no. 15 (2020): 3613–3620. [DOI] [PubMed] [Google Scholar]
- 102. Chen W., Yang Y., Rinadi C., Zhou D., and Shen A. Q., “Formation of Supramolecular Hydrogel Microspheres via Microfluidics,” Lab on a Chip 9, no. 20 (2009): 2947–2951. [DOI] [PubMed] [Google Scholar]
- 103. Bong K. W., Chapin S. C., and Doyle P. S., “Magnetic Barcoded Hydrogel Microparticles for Multiplexed Detection,” Langmuir 26, no. 11 (2010): 8008–8014. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 104. Jang W., Kim D. Y., Mun S. J., Choi J. H., Roh Y. H., and Bong K. W., “Direct Functionalization of Cell‐Adhesion Promoters to Hydrogel Microparticles Synthesized by Stop‐Flow Lithography,” Journal of Polymer Science 60, no. 11 (2022): 1767–1777. [Google Scholar]
- 105. Suh S. K., Bong K. W., Hatton T. A., and Doyle P. S., “Using Stop‐Flow Lithography to Produce Opaque Microparticles: Synthesis and Modeling,” Langmuir 27, no. 22 (2011): 13813–13819. [DOI] [PubMed] [Google Scholar]
- 106. Bong K. W., Kim J. J., Cho H., Lim E., Doyle P. S., and Irimia D., “Synthesis of Cell‐Adhesive Anisotropic Multifunctional Particles by Stop Flow Lithography and Streptavidin–Biotin Interactions,” Langmuir 31, no. 48 (2015): 13165–13171. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 107. Panda P., Ali S., Lo E., et al., “Stop‐flow Lithography to Generate Cell‐Laden Microgel Particles,” Lab on a Chip 8, no. 7 (2008): 1056–1061. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 108. Suh S. K., Yuet K., Hwang D. K., Bong K. W., Doyle P. S., and Hatton T. A., “Synthesis of Nonspherical Superparamagnetic Particles: In Situ Coprecipitation of Magnetic Nanoparticles in Microgels Prepared by Stop‐Flow Lithography,” Journal of the American Chemical Society 134, no. 17 (2012): 7337–7343. [DOI] [PubMed] [Google Scholar]
- 109. Bong K. W., Bong K. T., Pregibon D. C., and Doyle P. S., “Hydrodynamic Focusing Lithography,” Angewandte Chemie International Edition 49, no. 1 (2010): 87–90. [DOI] [PubMed] [Google Scholar]
- 110. Ye Y. M., Nishi M., Yang W. Q., Takinoue M., and Miyamoto N., “Synthesis of Photocatalytic Niobate Nanosheet/Polymer Composite Microgel Particles Through Microfluidic Approach,” Key Engineering Materials 804 (2019): 75–82. [Google Scholar]
- 111. Tarameshlou M., Jafari S. H., Rezaeian I., and Khonakdar H. A., “A Microfluidic Approach to Synthesize Monodisperse Poly(2‐hydroxyethyl Methacrylate) Based Spherical Microgels via Water in Water Emulsion Technique,” International Journal of Polymeric Materials and Polymeric Biomaterials 63, no. 17 (2014): 884–890. [Google Scholar]
- 112. Kamperman T., van Loo B., Gurian M., Henke S., Karperien M., and Leijten J., “On‐the‐Fly Exchangeable Microfluidic Nozzles for Facile Production of Various Monodisperse Micromaterials,” Lab on a Chip 19, no. 11 (2019): 1977–1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 113. Bong K. W., Lee J., and Doyle P. S., “Stop Flow Lithography in Perfluoropolyether (PFPE) Microfluidic Channels,” Lab Chip 14, no. 24 (2014): 4680–4687. [DOI] [PubMed] [Google Scholar]
- 114. Chai N., Zhang J., Zhang Q., et al., “Construction of 3D Printed Constructs Based on Microfluidic Microgel for Bone Regeneration,” Composites Part B: Engineering 223 (2021): 109100. [Google Scholar]
- 115. Benson B. R., Stone H. A., and Prud'homme R. K., “An “Off‐the‐Shelf” Capillary Microfluidic Device That Enables Tuning of the Droplet Breakup Regime at Constant Flow Rates,” Lab on a Chip 13, no. 23 (2013): 4507–4511. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 116. Shah R. K., Kim J.‐W., Agresti J. J., Weitz D. A., and Chu L.‐Y., “Fabrication of Monodisperse Thermosensitive Microgels and Gel Capsules in Microfluidic Devices,” Soft Matter 4, no. 12 (2008): 2303. [Google Scholar]
- 117. Kanai T., Lee D., Shum H. C., and Weitz D. A., “Fabrication of Tunable Spherical Colloidal Crystals Immobilized in Soft Hydrogels,” Small 6, no. 7 (2010): 807–810. [DOI] [PubMed] [Google Scholar]
- 118. Shah R. K., Kim J.‐W., and Weitz D. A., “Janus Supraparticles by Induced Phase Separation of Nanoparticles in Droplets,” Advanced Materials 21, no. 19 (2009): 1949–1953. [Google Scholar]
- 119. Santos T. P., Costa A. L. R., Michelon M., Costa L. P., and Cunha R. L., “Development of a Microfluidic Route for the Formation of Gellan‐Based Microgels Incorporating Jabuticaba (Myrciaria cauliflora) Extract,” Journal of Food Engineering 276 (2020): 109884. [Google Scholar]
- 120. Liu Z., Zhang H., Zhan Z., et al., “Mild Formation of Core–Shell Hydrogel Microcapsules for Cell Encapsulation,” Biofabrication 13, no. 2 (2021): 025002. [DOI] [PubMed] [Google Scholar]
- 121. Kim Y. H., Kim D. J., Lee S., Kim D.‐H., Park S.‐G., and Kim S.‐H., “Microfluidic Designing Microgels Containing Highly Concentrated Gold Nanoparticles for SERS Analysis of Complex Fluids,” Small 15, no. 52 (2019): 1905076. [DOI] [PubMed] [Google Scholar]
- 122. Comunian T. A., Ravanfar R., de Castro I. A., Dando R., Favaro‐Trindade C. S., and Abbaspourrad A., “Improving Oxidative Stability of Echium Oil Emulsions Fabricated by Microfluidics: Effect of Ionic Gelation and Phenolic Compounds,” Food Chemistry 233 (2017): 125–134. [DOI] [PubMed] [Google Scholar]
- 123. Chu L.‐Y., Utada A. S., Shah R. K., Kim J.‐W., and Weitz D. A., “Controllable Monodisperse Multiple Emulsions,” Angewandte Chemie International Edition 46, no. 47 (2007): 8970–8974. [DOI] [PubMed] [Google Scholar]
- 124. Zhu K., Yu Y., Cheng Y., Tian C., Zhao G., and Zhao Y., “All‐Aqueous‐Phase Microfluidics for Cell Encapsulation,” ACS Applied Materials & Interfaces 11, no. 5 (2019): 4826–4832. [DOI] [PubMed] [Google Scholar]
- 125. Guerzoni L. P. B., Bohl J., Jans A., et al., “Microfluidic Fabrication of Polyethylene Glycol Microgel Capsules With Tailored Properties for the Delivery of Biomolecules,” Biomaterials Science 5, no. 8 (2017): 1549–1557. [DOI] [PubMed] [Google Scholar]
- 126. Martinez C. J., Kim J. W., Ye C., et al., “A Microfluidic Approach to Encapsulate Living Cells in Uniform Alginate Hydrogel Microparticles,” Macromolecular Bioscience 12, no. 7 (2012): 946–951. [DOI] [PubMed] [Google Scholar]
- 127. Chen P. W., Erb R. M., and Studart A. R., “Designer Polymer‐Based Microcapsules Made Using Microfluidics,” Langmuir 28, no. 1 (2012): 144–152. [DOI] [PubMed] [Google Scholar]
- 128. Hu Y., Azadi G., and Ardekani A. M., “Microfluidic Fabrication of Shape‐Tunable Alginate Microgels: Effect of Size and Impact Velocity,” Carbohydrate Polymers 120 (2015): 38–45. [DOI] [PubMed] [Google Scholar]
- 129. Chen J., Li P., An R., et al., “Droplet Microfluidics‐Assisted Fabrication of Fe‐Alginate Microgels With Complex Morphology: Effect of the Composition of Droplets,” Lab on a Chip 25, no. 13 (2025): 3270–3286. [DOI] [PubMed] [Google Scholar]
- 130. Sun L., Wang J., Yu Y., Bian F., Zou M., and Zhao Y., “Graphene Oxide Hydrogel Particles From Microfluidics for Oil Decontamination,” Journal of Colloid and Interface Science 528 (2018): 372–378. [DOI] [PubMed] [Google Scholar]
- 131. Jeong E. S., Son H. A., Kim M. K., et al., “Fabrication of Monodisperse Liposomes‐in‐Microgel Hybrid Microparticles in Capillary‐Based Microfluidic Devices,” Colloids and Surfaces B: Biointerfaces 123 (2014): 339–344. [DOI] [PubMed] [Google Scholar]
- 132. Nguyen H. V., Nguyen H. Q., Nguyen V. D., and Seo T. S., “A 3D Printed Screw‐and‐Nut Based Droplet Generator With Facile and Precise Droplet Size Controllability,” Sensors and Actuators B: Chemical 296 (2019): 126676. [Google Scholar]
- 133. Femmer T., Jans A., Eswein R., et al., “High‐Throughput Generation of Emulsions and Microgels in Parallelized Microfluidic Drop‐Makers Prepared by Rapid Prototyping,” ACS Applied Materials & Interfaces 7, no. 23 (2015): 12635–12638. [DOI] [PubMed] [Google Scholar]
- 134. Jans A., Lölsberg J., Omidinia‐Anarkoli A., et al., “High‐Throughput Production of Micrometer Sized Double Emulsions and Microgel Capsules in Parallelized 3D Printed Microfluidic Devices,” Polymers 11, no. 11 (2019): 1887. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 135. Borro B. C., Bohr A., Bucciarelli S., et al., “Microfluidics‐Based Self‐Assembly of Peptide‐Loaded Microgels: Effect of Three Dimensional (3D) Printed Micromixer Design,” Journal of Colloid and Interface Science 538 (2019): 559–568. [DOI] [PubMed] [Google Scholar]
- 136. Kamperman T., Teixeira L. M., Salehi S. S., et al., “Engineering 3D Parallelized Microfluidic Droplet Generators With Equal Flow Profiles by Computational Fluid Dynamics and Stereolithographic Printing,” Lab on a Chip 20, no. 3 (2020): 490–495. [DOI] [PubMed] [Google Scholar]
- 137. Jung S., Song R., Kim J., Ko J. H., and Lee J., “Controlling the Release of Amphiphilic Liposomes From Alginate Hydrogel Particles for Antifouling Paint,” Langmuir 36, no. 6 (2020): 1515–1522. [DOI] [PubMed] [Google Scholar]
- 138. Morimoto Y., Kiyosawa M., and Takeuchi S., “Three‐Dimensional Printed Microfluidic Modules for Design Changeable Coaxial Microfluidic Devices,” Sensors and Actuators B: Chemical 274 (2018): 491–500. [Google Scholar]
- 139. Zhao H., Chen Y., Shao L., et al., “Airflow‐Assisted 3D Bioprinting of Human Heterogeneous Microspheroidal Organoids With Microfluidic Nozzle,” Small 14, no. 39 (2018): 1802630. [DOI] [PubMed] [Google Scholar]
- 140. Cai S., Shi H., Li G., Xue Q., and Zhao L., “3D‐Printed Concentration‐Controlled Microfluidic Chip With Diffusion Mixing Pattern for the Synthesis of Alginate Drug Delivery Microgels,” Nanomaterials 9, no. 10 (2019): 1451. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 141. Eydelnant I. A., Betty Li B., and Wheeler A. R., “Microgels on‐Demand,” Nature Communications 5 (2014): 3355. [DOI] [PubMed] [Google Scholar]
- 142. Chiang M.‐Y., Hsu Y.‐W., Hsieh H.‐Y., Chen S.‐Y., and Fan S.‐K., “Constructing 3D Heterogeneous Hydrogels From Electrically Manipulated Prepolymer Droplets and Crosslinked Microgels,” Science Advances 2 (2016): 1600964. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 143. George S. M. and Moon H., “Digital Microfluidic Three‐Dimensional Cell Culture and Chemical Screening Platform Using Alginate Hydrogels,” Biomicrofluidics 9, no. 2 (2015): 024116. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 144. Li B. B., Scott E. Y., Chamberlain M. D., et al., “Cell Invasion in Digital Microfluidic Microgel Systems,” Science Advances 6, no. 29 (2020): aba9589. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 145. Nestor B. A., Samiei E., Samanipour R., et al., “Digital Microfluidic Platform for Dielectrophoretic Patterning of Cells Encapsulated in Hydrogel Droplets,” RSC Advances 6, no. 62 (2016): 57409–57416. [Google Scholar]
- 146. Chaing M. Y. and Fan S. K., “Electric Manipulations of Hydrogel on a Digital Microfluidic Platform,” NEMS (2012): 407–410. [Google Scholar]
- 147. Eydelnant I. A., Uddayasankar U., Li B. B., Liao M. W., and Wheeler A. R., “Virtual Microwells for Digital Microfluidic Reagent Dispensing and Cell Culture,” Lab Chip 12, no. 4 (2012): 750–757. [DOI] [PubMed] [Google Scholar]
- 148. Chen Y., Zeng X., Shi Y., et al., “Fundamentals and Applications of Digital Microfluidics Based on Electrowetting‐on‐Dielectric,” Sensors and Actuators A: Physical 401 (2026): 117623. [Google Scholar]
- 149. Yang C., Gan X., Zeng Y., et al., “Advanced Design and Applications of Digital Microfluidics in Biomedical Fields: An Update of Recent Progress,” Biosensors and Bioelectronics 242 (2023): 115723. [DOI] [PubMed] [Google Scholar]
- 150. Hauck N., Neuendorf T. A., Männel M. J., et al., “Processing of Fast‐Gelling Hydrogel Precursors in Microfluidics by Electrocoalescence of Reactive Species,” Soft Matter 17, no. 45 (2021): 10312–10321. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 151. Jin S. H., Lee B., Kim J. S., and Lee C.‐S., “Improvement Strategy of a Microfluidic Sorter Using a Pneumatic Bilayer Valve,” Chemical Engineering Science 245 (2021): 116834. [Google Scholar]
- 152. Sun Y., Cai B., Wei X., et al., “A Valve‐Based Microfluidic Device for on‐Chip Single Cell Treatments,” Electrophoresis 40, no. 6 (2019): 961–968. [DOI] [PubMed] [Google Scholar]
- 153. Jadhav A. D., Yan B., Luo R.‐C., et al., “Photoresponsive Microvalve for Remote Actuation and Flow Control in Microfluidic Devices,” Biomicrofluidics 9, no. 3 (2015): 034114. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 154. Li W., Luo R., Lin X., et al., “Remote Modulation of Neural Activities via Near‐Infrared Triggered Release of Biomolecules,” Biomaterials 65 (2015): 76–85. [DOI] [PubMed] [Google Scholar]
- 155. Luo R.‐C., Ranjan S., Zhang Y., and Chen C.‐H., “Near‐Infrared Photothermal Activation of Microgels Incorporating Polypyrrole Nanotransducers Through Droplet Microfluidics,” Chemical Communications 49, no. 72 (2013): 7887–7889. [DOI] [PubMed] [Google Scholar]
- 156. Zhang C., Grossier R., Candoni N., and Veesler S., “Preparation of Alginate Hydrogel Microparticles by Gelation Introducing Cross‐Linkers Using Droplet‐Based Microfluidics: A Review of Methods,” Biomaterials Research 25, no. 1 (2021): 41. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 157. Zhang C., Grossier R., Lacaria L., Rico F., Candoni N., and Veesler S., “A Microfluidic Method Generating Monodispersed Microparticles With Controllable Sizes and Mechanical Properties,” Chemical Engineering Science 211 (2020): 115322. [Google Scholar]
- 158. Kudtarkar K., Johnson M., Iglesias P., Smith T. W., and Schertzer M. J., “Effects of Chemical Composition on the Electromechanical Properties of Microfluidically Synthesized Hydrogel Beads,” Journal of Fluids Engineering 140, no. 10 (2018): 101103. [Google Scholar]
- 159. Ma S., “Microfluidics Tubing as a Synthesizer for Ordered Microgel Networks,” Soft Matter 15, no. 19 (2019): 3848–3853. [DOI] [PubMed] [Google Scholar]
- 160. Zhao H., Wang Z., Jiang S., et al., “Microfluidic Synthesis of Injectable Angiogenic Microgels,” Cell Reports Physical Science 1, no. 5 (2020): 100047. [Google Scholar]
- 161. Gokmen M. T., De Geest B. G., Hennink W. E., and Du Prez F. E., ““Giant” Hollow Multilayer Capsules by Microfluidic Templating,” ACS Applied Materials & Interfaces 1, no. 6 (2009): 1196–1202. [DOI] [PubMed] [Google Scholar]
- 162. Kudtarkar K., Iglesias P., Smith T. W., and Schertzer M. J., “Effect of Metallization on the Electromechanical Properties of Microfluidically Synthesized Hydrogel Beads,” Journal of Fluids Engineering 141, no. 3 (2019): 031303. [Google Scholar]
- 163. Rahman M. T., Barikbin Z., Badruddoza A. Z. M., Doyle P. S., and Khan S. A., “Monodisperse Polymeric Ionic Liquid Microgel Beads With Multiple Chemically Switchable Functionalities,” Langmuir 29, no. 30 (2013): 9535–9543. [DOI] [PubMed] [Google Scholar]
- 164. Bora M., Hsu M. N., Khan S. A., and Doyle P. S., “Hydrogel Microparticle‐Templated Anti‐Solvent Crystallization of Small‐Molecule Drugs,” Advanced Healthcare Materials 11, no. 8 (2022): 2102252. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 165. Gregoritza M., Abstiens K., Graf M., and Goepferich A. M., “Fabrication of Antibody‐Loaded Microgels Using Microfluidics and Thiol‐ene Photoclick Chemistry,” European Journal of Pharmaceutics and Biopharmaceutics 127 (2018): 194–203. [DOI] [PubMed] [Google Scholar]
- 166. Lee K. Y. and Mooney D. J., “Alginate: Properties and Biomedical Applications,” Progress in Polymer Science 37, no. 1 (2012): 106–126. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 167. Zamora‐Mora V., Velasco D., Hernández R., Mijangos C., and Kumacheva E., “Chitosan/Agarose Hydrogels: Cooperative Properties and Microfluidic Preparation,” Carbohydrate Polymers 111 (2014): 348–355. [DOI] [PubMed] [Google Scholar]
- 168. Yamada Y., Yoshida C., Hamada K., Kikkawa Y., and Nomizu M., “Development of Three‐Dimensional Cell Culture Scaffolds Using Laminin Peptide‐Conjugated Agarose Microgels,” Biomacromolecules 21, no. 9 (2020): 3765–3771. [DOI] [PubMed] [Google Scholar]
- 169. Jessop Z. M., Gao N., Manivannan S., Al‐Sabah A., and Whitaker I. S., 3D Bioprinting for Reconstructive Surgery, ed. Thomas D. J., Jessop Z. M., and Whitaker I. S. (Woodhead Publishing, 2018), 277–304. [Google Scholar]
- 170. Jiang F., Xu X.‐W., Chen F.‐Q., et al., “Extraction, Modification and Biomedical Application of Agarose Hydrogels: A Review,” Marine Drugs 21, no. 5 (2023): 299. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 171. Gómez‐Mascaraque L. G., Méndez J. A., Fernández‐Gutiérrez M., Vázquez B., and San Román J., “Oxidized Dextrins as Alternative Crosslinking Agents for Polysaccharides: Application to Hydrogels of Agarose–Chitosan,” Acta Biomaterialia 10, no. 2 (2014): 798–811. [DOI] [PubMed] [Google Scholar]
- 172. Ghebremedhin M., Seiffert S., and Vilgis T. A., “Physics of Agarose Fluid Gels: Rheological Properties and Microstructure,” Current Research in Food Science 4 (2021): 436–448. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 173. Zoratto N., Di Lisa D., de Rutte J., et al., “In Situ Forming Microporous Gelatin Methacryloyl Hydrogel Scaffolds From Thermostable Microgels for Tissue Engineering,” Bioengineering & Translational Medicine 5, no. 3 (2020): 10180. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 174. Wang H., Liu H., Liu H., Su W., Chen W., and Qin J., “One‐Step Generation of Core–Shell Gelatin Methacrylate (GelMA) Microgels Using a Droplet Microfluidic System,” Advanced Materials Technologies 4, no. 6 (2019): 1800632. [Google Scholar]
- 175. Suraiya A. B., Hun M. L., Truong V. X., Forsythe J. S., and Chidgey A. P., “Gelatin‐Based 3D Microgels for In Vitro T Lineage Cell Generation,” ACS Biomaterials Science & Engineering 6, no. 4 (2020): 2198–2208. [DOI] [PubMed] [Google Scholar]
- 176. Hou S., Lake R., Park S., Edwards S., Jones C., and Jeong K. J., “Injectable Macroporous Hydrogel Formed by Enzymatic Cross‐Linking of Gelatin Microgels,” ACS Applied Bio Materials 1, no. 5 (2018): 1430–1439. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 177. Sung B., Krieger J., Yu B., and Kim M.‐H., “Colloidal Gelatin Microgels With Tunable Elasticity Support the Viability and Differentiation of Mesenchymal Stem Cells Under Pro‐Inflammatory Conditions,” Journal of Biomedical Materials Research Part A 106, no. 10 (2018): 2753–2761. [DOI] [PubMed] [Google Scholar]
- 178. Yang B., Liu T., Gao G., Zhang X., and Wu B., “Fabrication of 3D GelMA Scaffolds Using Agarose Microgel Embedded Printing,” Micromachines (Basel) 13, no. 3 (2022): 469. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 179. Wang Z., Tian Z., Menard F., and Kim K., “Comparative Study of Gelatin Methacrylate Hydrogels From Different Sources for Biofabrication Applications,” Biofabrication 9, no. 4 (2017): 044101. [DOI] [PubMed] [Google Scholar]
- 180. Yin J., Yan M., Wang Y., Fu J., and Suo H., “3D Bioprinting of Low‐Concentration Cell‐Laden Gelatin Methacrylate (GelMA) Bioinks With a Two‐Step Cross‐Linking Strategy,” ACS Applied Materials & Interfaces 10, no. 8 (2018): 6849–6857. [DOI] [PubMed] [Google Scholar]
- 181. Chen F., Huang G., and Huang H., “Preparation and Application of Dextran and Its Derivatives as Carriers,” International Journal of Biological Macromolecules 145 (2020): 827–834. [DOI] [PubMed] [Google Scholar]
- 182. Inger E., Sunol A. K., and Sahiner N., “Catalytic Activity of Metal‐Free Amine‐Modified Dextran Microgels in Hydrogen Release Through Methanolysis of NaBH4 ,” International Journal of Energy Research 44, no. 7 (2020): 5990–6001. [Google Scholar]
- 183. Bulut S., Jung S.‐H., Bissing T., et al., “Tuning the Porosity of Dextran Microgels With Supramacromolecular Nanogels as Soft Sacrificial Templates,” Small 19, no. 45 (2023): 2303783. [DOI] [PubMed] [Google Scholar]
- 184. Su H., Jia Q., and Shan S., “Synthesis and Characterization of Schiff Base Contained Dextran Microgels in Water‐in‐Oil Inverse Microemulsion,” Carbohydrate Polymers 152 (2016): 156–162. [DOI] [PubMed] [Google Scholar]
- 185. Salimi‐Kenari H., Imani M., Nodehi A., and Abedini H., “An Engineering Approach to Design of Dextran Microgels Size Fabricated by Water/Oil Emulsification,” Journal of Microencapsulation 33, no. 6 (2016): 511–523. [DOI] [PubMed] [Google Scholar]
- 186. Massia S. P., Stark J., and Letbetter D. S., “Surface‐Immobilized Dextran Limits Cell Adhesion and Spreading,” Biomaterials 21, no. 22 (2000): 2253–2261. [DOI] [PubMed] [Google Scholar]
- 187. Luanda A. and Badalamoole V., “Past, Present and Future of Biomedical Applications of Dextran‐Based Hydrogels: A Review,” International Journal of Biological Macromolecules 228 (2023): 794–807. [DOI] [PubMed] [Google Scholar]
- 188. Zhou C., Luo C., Liu S., et al., “Pearl‐Inspired Graphene Oxide‐Collagen Microgel With Multi‐Layer Mineralization Through Microarray Chips for Bone Defect Repair,” Materials Today Bio 15 (2022): 100307. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 189. Zhu J. and Kaufman L. J., “Collagen I Self‐Assembly: Revealing the Developing Structures That Generate Turbidity,” Biophysical Journal 106, no. 8 (2014): 1822–1831. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 190. Di Lullo G. A., Sweeney S. M., Korkko J., and Ala‐Kokko L., “Mapping the Ligand‐Binding Sites and Disease‐Associated Mutations on the Most Abundant Protein in the Human, Type I Collagen,” Journal of Biological Chemistry 277, no. 6 (2002): 4223–4231. [DOI] [PubMed] [Google Scholar]
- 191. Brunel L. G., Christakopoulos F., Kilian D., et al., “Embedded 3D Bioprinting of Collagen Inks Into Microgel Baths to Control Hydrogel Microstructure and Cell Spreading,” Advanced Healthcare Materials 13, no. 25 (2024): 2303325. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 192. David G., Biopolymer‐Based Formulations, ed. Pal K., (Elsevier, 2020), 881–906. [Google Scholar]
- 193. Singh S., Chu W. Y., Ostadsharif Memar R., De Carlo A., Veres T., and Günther A., “Scalable Preparation of Macroporous Collagen Microgels by Air Bubble‐Induced Breakup and Ice Templating,” Reaction Chemistry & Engineering 9 (2024): 2584–2598. [Google Scholar]
- 194. Santhosh M., Choi J.‐H., and Choi J.‐W., “Magnetic‐Assisted Cell Alignment Within a Magnetic Nanoparticle‐Decorated Reduced Graphene Oxide/Collagen 3D Nanocomposite Hydrogel,” Nanomaterials 9, no. 9 (2019): 1293. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 195. Liu D., Xuanyuan T., Liu X., Fu W., and Liu W., “Massive and Efficient Encapsulation of Single Cells in Monodisperse Droplets and Collagen–Alginate Microgels Using a Microfluidic Device,” Frontiers in Bioengineering and Biotechnology 11 (2023): 1281375. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 196. Peterson A. W., Caldwell D. J., Rioja A. Y., Rao R. R., Putnam A. J., and Stegemann J. P., “Vasculogenesis and Angiogenesis in Modular Collagen–Fibrin Microtissues,” Biomaterials Science 2, no. 10 (2014): 1497–1508. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 197. Guo Y., Liu Y., Zhang Z., et al., “Biopolymer Based Fibrous Aggregate Materials for Diagnosis and Treatment: Design, Manufacturing, and Applications,” Advanced Materials 37, no. 22 (2025): 2414877. [DOI] [PubMed] [Google Scholar]
- 198. Correa S. O., Luo X., and Raub C. B., “Microfluidic Fabrication of Stable Collagen Microgels With Aligned Microstructure Using Flow‐Driven Co‐Deposition and Ionic Gelation,” Journal of Micromechanics and Microengineering 30, no. 8 (2020): 085002. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 199. Heida T., Otto O., Biedenweg D., Hauck N., and Thiele J., “Microfluidic Fabrication of Click Chemistry‐Mediated Hyaluronic Acid Microgels: A Bottom‐Up Material Guide to Tailor a Microgel's Physicochemical and Mechanical Properties,” Polymers 12, no. 8 (2020): 1760. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 200. Prajapati V. D. and Maheriya P. M., Functional Polysaccharides for Biomedical Applications, ed. Maiti S. and Jana S. (Woodhead Publishing, 2019), 213–265. [Google Scholar]
- 201. Mendes B. B., Daly A. C., Reis R. L., Domingues R. M. A., Gomes M. E., and Burdick J. A., “Injectable Hyaluronic Acid and Platelet Lysate‐Derived Granular Hydrogels for Biomedical Applications,” Acta Biomaterialia 119 (2021): 101–113. [DOI] [PubMed] [Google Scholar]
- 202. Coppoolse J. M. S., Van Kooten T. G., Heris H. K., et al., “An In Vivo Study of Composite Microgels Based on Hyaluronic Acid and Gelatin for the Reconstruction of Surgically Injured Rat Vocal Folds,” Journal of Speech, Language, and Hearing Research 57, no. 2 (2014): S658–S673. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 203. Heris H. K., Daoud J., Sheibani S., Vali H., Tabrizian M., and Mongeau L., “Investigation of the Viability, Adhesion, and Migration of Human Fibroblasts in a Hyaluronic Acid/Gelatin Microgel‐Reinforced Composite Hydrogel for Vocal Fold Tissue Regeneration,” Advanced Healthcare Materials 5, no. 2 (2016): 255–265. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 204. Liu Y., Wong C.‐W., Chang S.‐W., and Hsu S.‐H., “An Injectable, Self‐Healing Phenol‐Functionalized Chitosan Hydrogel With Fast Gelling Property and Visible Light‐Crosslinking Capability for 3D Printing,” Acta Biomaterialia 122 (2021): 211–219. [DOI] [PubMed] [Google Scholar]
- 205. Hao S., Tian C., Bai Y., et al., “Photo‐Crosslinkable Hyaluronic Acid Microgels With Reactive Oxygen Species Scavenging Capacity for Mesenchymal Stem Cell Encapsulation,” International Journal of Biological Macromolecules 243 (2023): 124971. [DOI] [PubMed] [Google Scholar]
- 206. Guaresti O., Basasoro S., González K., Eceiza A., and Gabilondo N., “In Situ Cross‐Linked Chitosan Hydrogels via Michael Addition Reaction Based on Water‐Soluble Thiol–Maleimide Precursors,” European Polymer Journal 119 (2019): 376–384. [Google Scholar]
- 207. Jiang R., Li J., Qiang Z., Wang L., Wang T., and Shi S., “Synthesis and In Situ Gelation Behavior of Thermoresponsive Poly(N‐isopropylacrylamide)/Chitosan Microgels,” Journal of Macromolecular Science, Part B 60, no. 2 (2021): 136–152. [Google Scholar]
- 208. Erickson C., Stager M., Riederer M., Payne K. A., and Krebs M., “Emulsion‐Free Chitosan–Genipin Microgels for Growth Plate Cartilage Regeneration,” Journal of Biomaterials Applications 36, no. 2 (2021): 289–296. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 209. Majcher M. J., Babar A., Lofts A., et al., “In Situ‐Gelling Starch Nanoparticle (SNP)/O‐carboxymethyl Chitosan (CMCh) Nanoparticle Network Hydrogels for the Intranasal Delivery of an Antipsychotic Peptide,” Journal of Controlled Release 330 (2021): 738–752. [DOI] [PubMed] [Google Scholar]
- 210. Xu J.‐H., Zhao H., Lan W.‐J., and Luo G.‐S., “A Novel Microfluidic Approach for Monodispersed Chitosan Microspheres With Controllable Structures,” Advanced Healthcare Materials 1, no. 1 (2012): 106–111. [DOI] [PubMed] [Google Scholar]
- 211. Simeonov M., Gussiyska A., Mironova J., et al., “Novel Hybrid Chitosan/Calcium Phosphates Microgels for Remineralization of Demineralized Enamel – A Model Study,” European Polymer Journal 119 (2019): 14–21. [Google Scholar]
- 212. Zamora‐Mora V., Velasco D., Hernández R., and Mijangos C., “Chitosan Microgels Obtained by On‐Chip Crosslinking Reaction Employing a Microfluidic Device,” Optofluidics, Microfluidics and Nanofluidics 1, no. 1 (2014): 56–61. [Google Scholar]
- 213. Hakim Khalili M., Zhang R., Wilson S., Goel S., Impey S. A., and Aria A. I., “Additive Manufacturing and Physicomechanical Characteristics of PEGDA Hydrogels: Recent Advances and Perspective for Tissue Engineering,” Polymers 15, no. 10 (2023): 2341. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 214. Pan J., Yung Chan S., Common J. E. A., et al., “Fabrication of a 3D Hair Follicle‐Like Hydrogel by Soft Lithography,” Journal of Biomedical Materials Research Part A 101, no. 11 (2013): 3159–3169. [DOI] [PubMed] [Google Scholar]
- 215. Zhang Y., An D., Pardo Y., et al., “High‐Water‐Content and Resilient PEG‐Containing Hydrogels With Low Fibrotic Response,” Acta Biomaterialia 53 (2017): 100–108. [DOI] [PubMed] [Google Scholar]
- 216. Pullagura B. K., Amarapalli S., and Gundabala V., “Coupling Electrohydrodynamics With Photopolymerization for Microfluidics‐Based Generation of Polyethylene Glycol Diacrylate (PEGDA) Microparticles and Hydrogels,” Colloids and Surfaces A: Physicochemical and Engineering Aspects 608 (2021): 125586. [Google Scholar]
- 217. Cao C., Yang K., Wu F., Wei X., Lu L., and Cai Y., “Thermally Induced Swellability and Acid‐Liable Dynamic Properties of Microgels of Copolymers Based on PEGMA and Aldehyde‐Functionalized Monomer,” Macromolecules 43, no. 22 (2010): 9511–9521. [Google Scholar]
- 218. Tehrani S. M., Lu Y., and Winnik M. A., “PEGMA‐Based Microgels: A Thermoresponsive Support for Enzyme Reactions,” Macromolecules 49, no. 22 (2016): 8711–8721. [Google Scholar]
- 219. Xu F., Dawson C., Lamb M., et al., “Hydrogels for Tissue Engineering: Addressing Key Design Needs Toward Clinical Translation,” Frontiers in Bioengineering and Biotechnology 10 (2022): 849831. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 220. Xin S., Wyman O. M., and Alge D. L., “Assembly of PEG Microgels Into Porous Cell‐Instructive 3D Scaffolds via Thiol‐Ene Click Chemistry,” Advanced Healthcare Materials 7, no. 11 (2018): 1800160. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 221. Becer C. R., Hahn S., Fijten M. W. M., Thijs H. M. L., Hoogenboom R., and Schubert U. S., “Libraries of Methacrylic Acid and Oligo(ethylene Glycol) Methacrylate Copolymers With LCST Behavior,” Journal of Polymer Science Part A: Polymer Chemistry 46, no. 21 (2008): 7138–7147. [Google Scholar]
- 222. Dong H. and Matyjaszewski K., “Thermally Responsive P(M(EO)2 MA‐co‐OEOMA) Copolymers via AGET ATRP in Miniemulsion,” Macromolecules 43, no. 10 (2010): 4623–4628. [Google Scholar]
- 223. Bakaic E., Smeets N. M. B., and Hoare T., “Injectable Hydrogels Based on Poly(ethylene glycol) and Derivatives as Functional Biomaterials,” RSC Advances 5, no. 45 (2015): 35469–35486. [Google Scholar]
- 224. Wilms D., Müller J., Urach A., Schröer F., and Schmidt S., “Specific Binding of Ligand‐Functionalized Thermoresponsive Microgels: Effect of Architecture, Ligand Density, and Hydrophobicity,” Biomacromolecules 23, no. 9 (2022): 3899–3908. [DOI] [PubMed] [Google Scholar]
- 225. Smeets N. M. B. and Hoare T., “Designing Responsive Microgels for Drug Delivery Applications,” Journal of Polymer Science Part A: Polymer Chemistry 51, no. 14 (2013): 3027–3043. [Google Scholar]
- 226. Cai T., Marquez M., and Hu Z., “Monodisperse Thermoresponsive Microgels of Poly(ethylene Glycol) Analogue‐Based Biopolymers,” Langmuir 23, no. 17 (2007): 8663–8666. [DOI] [PubMed] [Google Scholar]
- 227. Sivakumaran D., Bakaic E., Campbell S. B., et al., “Fabricating Degradable Thermoresponsive Hydrogels on Multiple Length Scales via Reactive Extrusion, Microfluidics, Self‐Assembly, and Electrospinning,” JoVE, no. 134 (2018): 54502, https://www.jove.com/t/54502/fabricating‐degradable‐thermoresponsive‐hydrogels‐on‐multiple‐length. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 228. Trongsatitkul T. and Budhlall B. M., “Temperature Dependence of Serum Protein Adsorption in PEGylated PNIPAm Microgels,” Colloids and Surfaces B: Biointerfaces 103 (2013): 244–252. [DOI] [PubMed] [Google Scholar]
- 229. Dupin D., Fujii S., Armes S. P., Reeve P., and Baxter S. M., “Efficient Synthesis of Sterically Stabilized pH‐Responsive Microgels of Controllable Particle Diameter by Emulsion Polymerization,” Langmuir 22, no. 7 (2006): 3381–3387. [DOI] [PubMed] [Google Scholar]
- 230. Sivakumaran D., Mueller E., and Hoare T., “Microfluidic Production of Degradable Thermoresponsive Poly(N‐isopropylacrylamide)‐Based Microgels,” Soft Matter 13, no. 47 (2017): 9060–9070. [DOI] [PubMed] [Google Scholar]
- 231. Tatry M. C., Laurichesse E., Perro A., Ravaine V., and Schmitt V., “Kinetics of Spontaneous Microgels Adsorption and Stabilization of Emulsions Produced Using Microfluidics,” Journal of Colloid and Interface Science 548 (2019): 1–11. [DOI] [PubMed] [Google Scholar]
- 232. Li X., Montague E. C., Pollinzi A., Lofts A., and Hoare T., “Design of Smart Size‐, Surface‐, and Shape‐Switching Nanoparticles to Improve Therapeutic Efficacy,” Small 18, no. 6 (2022): 2104632. [DOI] [PubMed] [Google Scholar]
- 233. Liu L., Wang W., Ju X.‐J., Xie R., and Chu L.‐Y., “Smart Thermo‐Triggered Squirting Capsules for Nanoparticle Delivery,” Soft Matter 6, no. 16 (2010): 3759–3763. [Google Scholar]
- 234. Liu Y.‐M., Wu W., Ju X.‐J., et al., “Smart Microcapsules for Direction‐Specific Burst Release of Hydrophobic Drugs,” RSC Advances 4, no. 87 (2014): 46568–46575. [Google Scholar]
- 235. Rommel D., Häßel B., Pietryszek P., et al., “Thermally Assisted Microfluidics to Produce Chemically Equivalent Microgels With Tunable Network Morphologies,” Angewandte Chemie International Edition 64, no. 1 (2025): 202411772. [DOI] [PubMed] [Google Scholar]
- 236. Jung Y.‐D., Khan M., and Park S.‐Y., “Fabrication of Temperature‐ and pH‐Sensitive Liquid‐Crystal Droplets With PNIPAM‐b‐LCP and SDS Coatings by Microfluidics,” Journal of Materials Chemistry B 2, no. 30 (2014): 4922–4928. [DOI] [PubMed] [Google Scholar]
- 237. Xu X., He P.‐P., Du X., and Guo W., “Reversible and Remote Thermoregulation of a Recyclable DNAzyme/pNIPAM Microgel Catalyst Formed via a Microfluidic Device,” Advanced Sustainable Systems 6, no. 6 (2022): 2100265. [Google Scholar]
- 238. Jelken J., Jung S.‐H., Lomadze N., et al., “Tuning the Volume Phase Transition Temperature of Microgels by Light,” Advanced Functional Materials 32, no. 2 (2022): 2107946. [Google Scholar]
- 239. Sivakumaran D., Mueller E., and Hoare T., “Temperature‐Induced Assembly of Monodisperse, Covalently Cross‐Linked, and Degradable Poly(N‐isopropylacrylamide) Microgels Based on Oligomeric Precursors,” Langmuir 31, no. 21 (2015): 5767–5778. [DOI] [PubMed] [Google Scholar]
- 240. Madrigal J. L., Stilhano R. S., Siltanen C., et al., “Microfluidic Generation of Alginate Microgels for the Controlled Delivery of Lentivectors,” Journal of Materials Chemistry B 4, no. 43 (2016): 6989–6999. [DOI] [PubMed] [Google Scholar]
- 241. Utech S., Prodanovic R., Mao A. S., Ostafe R., Mooney D. J., and Weitz D. A., “Microfluidic Generation of Monodisperse, Structurally Homogeneous Alginate Microgels for Cell Encapsulation and 3D Cell Culture,” Advanced Healthcare Materials 4, no. 11 (2015): 1628–1633. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 242. Chen M., Bolognesi G., and Vladisavljević G. T., “Crosslinking Strategies for the Microfluidic Production of Microgels,” Molecules 26, no. 12 (2021): 3752. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 243. Damiati S., “In Situ Microfluidic Preparation and Solidification of Alginate Microgels,” Macromolecular Research 28, no. 11 (2020): 1046–1053. [Google Scholar]
- 244. Capretto L., Mazzitelli S., Balestra C., Tosi A., and Nastruzzi C., “Effect of the Gelation Process on the Production of Alginate Microbeads by Microfluidic Chip Technology,” Lab on a Chip 8, no. 4 (2008): 617–621. [DOI] [PubMed] [Google Scholar]
- 245. Håti A. G., Bassett D. C., Ribe J. M., and Sikorski P., “Versatile, Cell and Chip Friendly Method to Gel Alginate in Microfluidic Devices,” Lab on a Chip 16, no. 19 (2016): 3718–3727. [DOI] [PubMed] [Google Scholar]
- 246. Akbari S. and Pirbodaghi T., “Microfluidic Encapsulation of Cells in Alginate Particles via an Improved Internal Gelation Approach,” Microfluidics and Nanofluidics 16, no. 4 (2014): 773–777. [Google Scholar]
- 247. Costa A. L. R., Gomes A., Ushikubo F. Y., and Cunha R. L., “Gellan Microgels Produced in Planar Microfluidic Devices,” Journal of Food Engineering 209 (2017): 18–25. [Google Scholar]
- 248. Wang Y. and Wang J., “Mixed Hydrogel Bead‐Based Tumor Spheroid Formation and Anticancer Drug Testing,” Analyst 139, no. 10 (2014): 2449–2458. [DOI] [PubMed] [Google Scholar]
- 249. Liu Y., Tottori N., and Nisisako T., “Microfluidic Synthesis of Highly Spherical Calcium Alginate Hydrogels Based on External Gelation Using an Emulsion Reactant,” Sensors and Actuators B: Chemical 283 (2019): 802–809. [Google Scholar]
- 250. Tsuda Y., Morimoto Y., and Takeuchi S., “Monodisperse Cell‐Encapsulating Peptide Microgel Beads for 3D Cell Culture,” Langmuir 26, no. 4 (2010): 2645–2649. [DOI] [PubMed] [Google Scholar]
- 251. Kalyanaraman M., 2009 First Annual ORNL Biomedical Science & Engineering Conference (2009).
- 252. Zhao L. B., Pan L., Zhang K., et al., “Generation of Janus Alginate Hydrogel Particles With Magnetic Anisotropy for Cell Encapsulation,” Lab on a Chip 9, no. 20 (2009): 2981–2986. [DOI] [PubMed] [Google Scholar]
- 253. Ortiz de Solorzano I., Mendoza G., Arruebo M., and Sebastian V., “Customized Hybrid and NIR‐Light Triggered Thermoresponsive Drug Delivery Microparticles Synthetized by Photopolymerization in a One‐Step Flow Focusing Continuous Microreactor,” Colloids and Surfaces B: Biointerfaces 190 (2020): 110904. [DOI] [PubMed] [Google Scholar]
- 254. He H., Li L., and Lee L. J., “Photopolymerization and Structure Formation of Methacrylic Acid Based Hydrogels: The Effect of Light Intensity,” Reactive and Functional Polymers 68, no. 1 (2008): 103–113. [Google Scholar]
- 255. Lu S., “Photopolymerization of Multilaminated Poly(HEMA) Hydrogels for Controlled Release,” Journal of Controlled Release 57, no. 3 (1999): 291–300. [DOI] [PubMed] [Google Scholar]
- 256. Xia B., Jiang Z., Debroy D., Li D., and Oakey J., “Cytocompatible Cell Encapsulation via Hydrogel Photopolymerization in Microfluidic Emulsion Droplets,” Biomicrofluidics 11, no. 4 (2017): 044102. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 257. Liu E. Y., Jung S., Weitz D. A., Yi H., and Choi C.‐H., “High‐Throughput Double Emulsion‐Based Microfluidic Production of Hydrogel Microspheres With Tunable Chemical Functionalities Toward Biomolecular Conjugation,” Lab on a Chip 18, no. 2 (2018): 323–334. [DOI] [PubMed] [Google Scholar]
- 258. Hua M., Du Y., Song J., Sun M., and He X., “Surfactant‐Free Fabrication of pNIPAAm Microgels in Microfluidic Devices,” Journal of Materials Research 34, no. 1 (2019): 206–213. [Google Scholar]
- 259. De Geest B. G., Urbanski J. P., Thorsen T., and Demeester J., “Synthesis of Monodisperse Biodegradable Microgels in Microfluidic Devices,” Langmuir 21, no. 23 (2005): 10275–10279. [DOI] [PubMed] [Google Scholar]
- 260. Seiffert S. and Weitz D. A., “Controlled Fabrication of Polymer Microgels by Polymer‐analogous Gelation in Droplet Microfluidics,” Soft Matter 6, no. 14 (2010): 3184–3190. [Google Scholar]
- 261. Henke S., Leijten J., Kemna E., et al., “Enzymatic Crosslinking of Polymer Conjugates is Superior Over Ionic or UV Crosslinking for the On‐Chip Production of Cell‐Laden Microgels,” Macromolecular Bioscience 16, no. 10 (2016): 1524–1532. [DOI] [PubMed] [Google Scholar]
- 262. Del Giudice F., Curtis D. J., and Aufderhorst‐Roberts A., “A New Approach for On‐Chip Production of Biological Microgels Using Photochemical Cross‐Linking,” Analytical Chemistry 96, no. 25 (2024): 10140–10144. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 263. Tang T., Liu C., Min Z., et al., “Microfluidic Fabrication of Gelatin Acrylamide Microgels Through Visible Light Photopolymerization for Cell Encapsulation,” ACS Applied Bio Materials 6, no. 6 (2023): 2496–2504. [DOI] [PubMed] [Google Scholar]
- 264. Shi Y., Gao X., Chen L., et al., “High Throughput Generation and Trapping of Individual Agarose Microgel Using Microfluidic Approach,” Microfluidics and Nanofluidics 15, no. 4 (2013): 467–474. [Google Scholar]
- 265. Greco A., Gabold B., Chen S., et al., “Microfluidic Mixing as Platform Technology for Production of Chitosan Nanoparticles Loaded With Different Macromolecules,” European Journal of Pharmaceutics and Biopharmaceutics 188 (2023): 170–181. [DOI] [PubMed] [Google Scholar]
- 266. Islam M. R., Tumbarello M., and Lyon L. A., “Deswelling Induced Morphological Changes in Dual pH‐ and Temperature‐Responsive Ultra‐Low Cross‐Linked Poly(N‐isopropyl acrylamide)‐co‐acrylic Acid Microgels,” Colloid and Polymer Science 297, no. 5 (2019): 667–676. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 267. Nerapusri V., Keddie J. L., Vincent B., and Bushnak I. A., “Swelling and Deswelling of Adsorbed Microgel Monolayers Triggered by Changes in Temperature, pH, and Electrolyte Concentration,” Langmuir 22, no. 11 (2006): 5036–5041. [DOI] [PubMed] [Google Scholar]
- 268. Karg M., Pastoriza‐Santos I., Rodriguez‐González B., von Klitzing R., Wellert S., and Hellweg T., “Temperature, pH, and Ionic Strength Induced Changes of the Swelling Behavior of PNIPAM−Poly(allylacetic Acid) Copolymer Microgels,” Langmuir 24, no. 12 (2008): 6300–6306. [DOI] [PubMed] [Google Scholar]
- 269. Farooqi Z. H., Khan H. U., Shah S. M., and Siddiq M., “Stability of Poly(N‐isopropylacrylamide‐co‐acrylic Acid) Polymer Microgels Under Various Conditions of Temperature, pH and Salt Concentration,” Arabian Journal of Chemistry 10, no. 3 (2017): 329–335. [Google Scholar]
- 270. Ekanem E. E., Zhang Z., and Vladisavljević G. T., “Facile Microfluidic Production of Composite Polymer Core‐Shell Microcapsules and Crescent‐Shaped Microparticles,” Journal of Colloid and Interface Science 498 (2017): 387–394. [DOI] [PubMed] [Google Scholar]
- 271. Zhang B., De Alwis Watuthanthrige N., Wanasinghe S. V., Averick S., and Konkolewicz D., “Complementary Dynamic Chemistries for Multifunctional Polymeric Materials,” Advanced Functional Materials 32, no. 8 (2022): 2108431. [Google Scholar]
- 272. Mueller E., Poulin I., Bodnaryk W. J., and Hoare T., “Click Chemistry Hydrogels for Extrusion Bioprinting: Progress, Challenges, and Opportunities,” Biomacromolecules 23, no. 3 (2022): 619–640. [DOI] [PubMed] [Google Scholar]
- 273. Feng Q., Li D., Li Q., et al., “Assembling Microgels via Dynamic Cross‐Linking Reaction Improves Printability, Microporosity, Tissue‐Adhesion, and Self‐Healing of Microgel Bioink for Extrusion Bioprinting,” ACS Applied Materials & Interfaces 14, no. 13 (2022): 15653–15666. [DOI] [PubMed] [Google Scholar]
- 274. Feliciano A. J., Alaoui Selsouli Y., Habibovic P., Birgani Z. N. T., Moroni L., and Baker M. B., “Granular Polyrotaxane Microgels as Injectable Hydrogels for Corneal Tissue Regeneration,” Biomaterials Science 12 (2024): 4993–5009. [DOI] [PubMed] [Google Scholar]
- 275. Karvinen J., Joki T., Ylä‐Outinen L., Koivisto J. T., Narkilahti S., and Kellomäki M., “Soft Hydrazone Crosslinked Hyaluronan‐ and Alginate‐Based Hydrogels as 3D Supportive Matrices for Human Pluripotent Stem Cell‐Derived Neuronal Cells,” Reactive and Functional Polymers 124 (2018): 29–39. [Google Scholar]
- 276. Grover G. N., Lam J., Nguyen T. H., Segura T., and Maynard H. D., “Biocompatible Hydrogels by Oxime Click Chemistry,” Biomacromolecules 13, no. 10 (2012): 3013–3017. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 277. Moon N. G., Pekkanen A. M., Long T. E., Showalter T. N., and Libby B., “Thiol‐Michael ‘Click’ Hydrogels as an Imageable Packing Material for Cancer Therapy,” Polymer 125 (2017): 66–75. [Google Scholar]
- 278. Liu Z. Q., Wei Z., Zhu X. L., et al., “Dextran‐Based Hydrogel Formed by Thiol‐Michael Addition Reaction for 3D Cell Encapsulation,” Colloids and Surfaces B: Biointerfaces 128 (2015): 140–148. [DOI] [PubMed] [Google Scholar]
- 279. Sui X., van Ingen L., Hempenius M. A., and Vancso G. J., “Preparation of a Rapidly Forming Poly(ferrocenylsilane)‐Poly(ethylene Glycol)‐Based Hydrogel by a Thiol‐Michael Addition Click Reaction,” Macromolecular Rapid Communications 31, no. 23 (2010): 2059–2063. [DOI] [PubMed] [Google Scholar]
- 280. Wiseman H. and Halliwell B., “Damage to DNA by Reactive Oxygen and Nitrogen Species: Role in Inflammatory Disease and Progression to Cancer,” Biochemical Journal 313, no. Pt 1 (1996): 17–29. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 281. Patel R. G., Purwada A., Cerchietti L., et al., “Microscale Bioadhesive Hydrogel Arrays for Cell Engineering Applications,” Cellular and Molecular Bioengineering 7, no. 3 (2014): 394–408. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 282. Mueller E., Abrishamkar A., Galaev R., Lau K. K., Neely L., and Hoare T., “Coaxial Extrusion Bioprinting of Hydrazone Crosslinked POEGMA Hydrogels: Optimizing Needle Geometry to Achieve Improved Print Quality,” Bioprinting 35 (2023): 00307. [Google Scholar]
- 283. Scanga R., Chrastecka L., Mohammad R., Meadows A., Quan P.‐L., and Brouzes E., “Click Chemistry Approaches to Expand the Repertoire of PEG‐Based Fluorinated Surfactants for Droplet Microfluidics,” RSC Advances 8, no. 23 (2018): 12960–12974. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 284. Hua Z., Man J., Liu G., et al., “Complex Suspended Janus Droplets Constructed Through Solvent Evaporation‐Induced Phase Separation at the Air–Liquid Interface,” Langmuir 38, no. 36 (2022): 10994–11002. [DOI] [PubMed] [Google Scholar]
- 285. Kurashina Y., Tsuchiya M., Sakai A., et al., “Simultaneous Crosslinking Induces Macroscopically Phase‐Separated Microgel From a Homogeneous Mixture of Multiple Polymers,” Applied Materials Today 22 (2021): 100937. [Google Scholar]
- 286. Staff R. H., Schaeffel D., Turshatov A., et al., “Particle Formation in the Emulsion‐Solvent Evaporation Process,” Small 9, no. 20 (2013): 3514–3522. [DOI] [PubMed] [Google Scholar]
- 287. Wei H., Xie J., Jiang X., Ye T., Chang A., and Wu W., “Synthesis and Characterization of Dextran–Tyramine‐Based H2O2‐Sensitive Microgels,” Macromolecules 47, no. 17 (2014): 6067–6076. [Google Scholar]
- 288. Lee Y., Choi K.‐H., Park K. M., Lee J.‐M., Park B. J., and Park K. D., “In Situ Forming and H2O2‐Releasing Hydrogels for Treatment of Drug‐Resistant Bacterial Infections,” ACS Applied Materials & Interfaces 9, no. 20 (2017): 16890–16899. [DOI] [PubMed] [Google Scholar]
- 289. Sakai S., Ueda K., Gantumur E., Taya M., and Nakamura M., “Drop‐On‐Drop Multimaterial 3D Bioprinting Realized by Peroxidase‐Mediated Cross‐Linking,” Macromolecular Rapid Communications 39, no. 3 (2018): 1700534. [DOI] [PubMed] [Google Scholar]
- 290. Gantumur E., Sakai S., Nakahata M., and Taya M., “Horseradish Peroxidase‐Catalyzed Hydrogelation Consuming Enzyme‐Produced Hydrogen Peroxide in the Presence of Reducing Sugars,” Soft Matter 15, no. 10 (2019): 2163–2169. [DOI] [PubMed] [Google Scholar]
- 291. Liu Y., Sakai S., and Taya M., “Production of Endothelial Cell‐Enclosing Alginate‐Based Hydrogel Fibers With a Cell Adhesive Surface Through Simultaneous Cross‐Linking by Horseradish Peroxidase‐Catalyzed Reaction in a Hydrodynamic Spinning Process,” Journal of Bioscience and Bioengineering 114, no. 3 (2012): 353–359. [DOI] [PubMed] [Google Scholar]
- 292. Sonnenschein M. F., Werness J. B., Patankar K. A., Jin X., and Larive M. Z., “From Rigid and Flexible Foams to Elastomers via Michael Addition Chemistry,” Polymer 106 (2016): 128–139. [Google Scholar]
- 293. Zhang H., Betz A., Qadeer A., Attinger D., and Chen W., “Microfluidic Formation of Monodispersed Spherical Microgels Composed of Triple‐Network Crosslinking,” Journal of Applied Polymer Science 121, no. 5 (2011): 3093–3100. [Google Scholar]
- 294. Wang Q., Liu S., Wang H., Zhu J., and Yang Y., “Alginate Droplets Pre‐Crosslinked in Microchannels to Prepare Monodispersed Spherical Microgels,” Colloids and Surfaces A: Physicochemical and Engineering Aspects 482 (2015): 371–377. [Google Scholar]
- 295. Stock S., Jakob F., Röhl S., et al., “Exploring Water in Oil Emulsions Simultaneously Stabilized by Solid Hydrophobic Silica Nanospheres and Hydrophilic Soft PNIPAM Microgel,” Soft Matter 17, no. 36 (2021): 8258–8268. [DOI] [PubMed] [Google Scholar]
- 296. Stock S., Röhl S., Mirau L., Kraume M., and von Klitzing R., “Maximum Incorporation of Soft Microgel at Interfaces of Water in Oil Emulsion Droplets Stabilized by Solid Silica Spheres,” Nanomaterials 12 (2022): 2649. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 297. Ramli R. A., Hashim S., and Laftah W. A., “Synthesis, Characterization, and Morphology Study of Poly(acrylamide‐co‐acrylic acid)‐grafted‐poly(styrene‐co‐methyl methacrylate) “Raspberry”‐Shape Like Structure Microgels by Pre‐Emulsified Semi‐Batch Emulsion Polymerization,” Journal of Colloid and Interface Science 391 (2013): 86–94. [DOI] [PubMed] [Google Scholar]
- 298. Volpatti L. R., Shimanovich U., Ruggeri F. S., et al., “Micro‐ and Nanoscale Hierarchical Structure of Core–Shell Protein Microgels,” Journal of Materials Chemistry B 4, no. 48 (2016): 7989–7999. [DOI] [PubMed] [Google Scholar]
- 299. Chen M., Aluunmani R., Bolognesi G., and Vladisavljević G. T., “Facile Microfluidic Fabrication of Biocompatible Hydrogel Microspheres in a Novel Microfluidic Device,” Molecules 27, no. 13 (2022): 4013. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 300. Lapeyre V., Ancla C., Catargi B., and Ravaine V., “Glucose‐Responsive Microgels With a Core–Shell Structure,” Journal of Colloid and Interface Science 327, no. 2 (2008): 316–323. [DOI] [PubMed] [Google Scholar]
- 301. Duncanson W. J., Lin T., Abate A. R., Seiffert S., Shah R. K., and Weitz D. A., “Microfluidic Synthesis of Advanced Microparticles for Encapsulation and Controlled Release,” Lab on a Chip 12, no. 12 (2012): 2135–2145. [DOI] [PubMed] [Google Scholar]
- 302. Wei X., Yao X., Yue J., et al., “Recent Advances on the Generation, Stabilization, and Potential Applications of Double Emulsions Based on the Microfluidic Strategy,” Food Engineering Reviews 16, no. 1 (2024): 129–145. [Google Scholar]
- 303. Long F., Guo Y., Zhang Z., et al., “Recent Progress of Droplet Microfluidic Emulsification Based Synthesis of Functional Microparticles,” Global Challenges 7, no. 9 (2023): 2300063. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 304. Thiele J. and Seiffert S., “Double Emulsions With Controlled Morphology by Microgel Scaffolding,” Lab on a Chip 11, no. 18 (2011): 3188–3192. [DOI] [PubMed] [Google Scholar]
- 305. Haghgooie R., Toner M., and Doyle P. S., “Squishy Non‐Spherical Hydrogel Microparticles,” Macromolecular Rapid Communications 31, no. 2 (2010): 128–134. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 306. Liu Y., Chen Z., and Xu J., “Recent Advances in the Microfluidic Generation of Shape‐Controllable Hydrogel Microparticles and Their Applications,” Green Chemical Engineering 5, no. 1 (2024): 16–30. [Google Scholar]
- 307. Seiffert S., “Non‐Spherical Soft Supraparticles From Microgel Building Blocks,” Macromolecular Rapid Communications 33, no. 15 (2012): 1286–1293. [DOI] [PubMed] [Google Scholar]
- 308. Keller S., Dekkers R., Hu G. X., et al., “A Simple Microfluidic Tool to Design Anisotropic Microgels,” Reactive and Functional Polymers 167 (2021): 105012. [Google Scholar]
- 309. Wang J., Hu L., Song Y., and Serpe M. J., “Non‐Spherical Janus Microgels Driven by Thiolated DNA Interactions,” Polymer 55, no. 10 (2014): 2340–2346. [Google Scholar]
- 310. Hwang D. K., Oakey J., Toner M., et al., “Stop‐Flow Lithography for the Production of Shape‐Evolving Degradable Microgel Particles,” Journal of the American Chemical Society 131, no. 12 (2009): 4499–4504. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 311. Xu W., Wei M., and Serpe M. J., “Janus Microgels With Tunable Functionality, Polarity, and Optical Properties,” Advanced Optical Materials 5, no. 2 (2017): 1600614. [Google Scholar]
- 312. Yuan H., Ma Q., Song Y., Tang M. Y. H., Chan Y. K., and Shum H. C., “Phase‐Separation‐Induced Formation of Janus Droplets Based on Aqueous Two‐Phase Systems,” Macromolecular Chemistry and Physics 218, no. 2 (2017): 1600422. [Google Scholar]
- 313. Lu A. X., Jiang K., De Voe D. L., and Raghavan S. R., “Microfluidic Assembly of Janus‐Like Dimer Capsules,” Langmuir 29, no. 44 (2013): 13624–13629. [DOI] [PubMed] [Google Scholar]
- 314. Behra M., Schmidt S., Hartmann J., Volodkin D. V., and Hartmann L., “Synthesis of Porous PEG Microgels Using CaCO3 Microspheres as Hard Templates,” Macromolecular Rapid Communications 33, no. 12 (2012): 1049–1054. [DOI] [PubMed] [Google Scholar]
- 315. Hu Q., Liu X., Liu H., et al., “3D Printed Porous Microgel for Lung Cancer Cells Culture In Vitro,” Materials & Design 210 (2021): 110079. [Google Scholar]
- 316. Xia P., Zhang K., Gong Y., Li G., Yan S., and Yin J., “Injectable Stem Cell Laden Open Porous Microgels That Favor Adipogenesis: In Vitro and In Vivo Evaluation,” ACS Applied Materials & Interfaces 9, no. 40 (2017): 34751–34761. [DOI] [PubMed] [Google Scholar]
- 317. Mou C.‐L., Ju X.‐J., Zhang L., et al., “Monodisperse and Fast‐Responsive Poly(N‐isopropylacrylamide) Microgels With Open‐Celled Porous Structure,” Langmuir 30, no. 5 (2014): 1455–1464. [DOI] [PubMed] [Google Scholar]
- 318. Elsayed M., Kothandaraman A., Edirisinghe M., and Huang J., “Porous Polymeric Films From Microbubbles Generated Using a T‐Junction Microfluidic Device,” Langmuir 32, no. 50 (2016): 13377–13385. [DOI] [PubMed] [Google Scholar]
- 319. Gultekinoglu M., Jiang X., Bayram C., Ulubayram K., and Edirisinghe M., “Honeycomb‐Like PLGA‐b‐PEG Structure Creation With T‐Junction Microdroplets,” Langmuir 34, no. 27 (2018): 7989–7997. [DOI] [PubMed] [Google Scholar]
- 320. Zhang P., Li Y.‐H., Chen L., et al., “Hierarchical Porous Metal–Organic Frameworks/Polymer Microparticles for Enhanced Catalytic Degradation of Organic Contaminants,” Frontiers of Chemical Science and Engineering 16, no. 6 (2022): 939–949. [Google Scholar]
- 321. Huang X., Liu L., Wang J.‐L., et al., “Designing Self‐Floating Anisotropic Macroporous Hydrogel by Step Emulsification and Buoyancy‐Assisted Microfluidics,” Chemical Engineering Journal 446 (2022): 137348. [Google Scholar]
- 322. Costantini M., Jaroszewicz J., Kozoń Ł., et al., “3D‐Printing of Functionally Graded Porous Materials Using On‐Demand Reconfigurable Microfluidics,” Angewandte Chemie International Edition 58, no. 23 (2019): 7620–7625. [DOI] [PubMed] [Google Scholar]
- 323. Andrieux S., Drenckhan W., and Stubenrauch C., “Generation of Solid Foams With Controlled Polydispersity Using Microfluidics,” Langmuir 34, no. 4 (2018): 1581–1590. [DOI] [PubMed] [Google Scholar]
- 324. Griffin D. R., Weaver W. M., Scumpia P. O., Di Carlo D., and Segura T., “Accelerated Wound Healing by Injectable Microporous Gel Scaffolds Assembled From Annealed Building Blocks,” Nature Materials 14, no. 7 (2015): 737–744. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 325. Costantini M., Guzowski J., Żuk P. J., et al., “Electric Field Assisted Microfluidic Platform for Generation of Tailorable Porous Microbeads as Cell Carriers for Tissue Engineering,” Advanced Functional Materials 28, no. 20 (2018): 1800874. [Google Scholar]
- 326. Tu W., Hu W., Chen J., et al., “Controllable Fabrication of Core‐Shell Microcapsules Using Sodium Alginate/Gellan Gum as Shell Material by Microfluidics,” Food Hydrocolloids 168 (2025): 111514. [Google Scholar]
- 327. Zhu Y. and Fang Q., “Integrated Droplet Analysis System With Electrospray Ionization‐Mass Spectrometry Using a Hydrophilic Tongue‐Based Droplet Extraction Interface,” Analytical Chemistry 82, no. 19 (2010): 8361–8366. [DOI] [PubMed] [Google Scholar]
- 328. Roman G. T., Wang M., Shultz K. N., Jennings C., and Kennedy R. T., “Sampling and Electrophoretic Analysis of Segmented Flow Streams Using Virtual Walls in a Microfluidic Device,” Analytical Chemistry 80, no. 21 (2008): 8231–8238. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 329. Mohamed M. G. A., Kheiri S., Islam S., Kumar H., Yang A., and Kim K., “An Integrated Microfluidic Flow‐Focusing Platform for On‐Chip Fabrication and Filtration of Cell‐Laden Microgels,” Lab on a Chip 19, no. 9 (2019): 1621–1632. [DOI] [PubMed] [Google Scholar]
- 330. Hsu M. N., Wei S.‐C., Guo S., Phan D.‐T., Zhang Y., and Chen C.‐H., “Smart Hydrogel Microfluidics for Single‐Cell Multiplexed Secretomic Analysis With High Sensitivity,” Small 14, no. 49 (2018): 1802918. [DOI] [PubMed] [Google Scholar]
- 331. Sun J., Li J., Huan Z., et al., “Mesenchymal Stem Cell‐Laden Composite β Cell Porous Microgel for Diabetes Treatment,” Advanced Functional Materials 33, no. 21 (2023): 2211897. [Google Scholar]
- 332. Antunes J., Gaspar V. M., Ferreira L., et al., “In‐Air Production of 3D Co‐Culture Tumor Spheroid Hydrogels for Expedited Drug Screening,” Acta Biomaterialia 94 (2019): 392–409. [DOI] [PubMed] [Google Scholar]
- 333. Kolb L., Allazetta S., Karlsson M., Girgin M., Weber W., and Lutolf M. P., “High‐Throughput Stem Cell‐Based Phenotypic Screening Through Microniches,” Biomaterials Science 7, no. 8 (2019): 3471–3479. [DOI] [PubMed] [Google Scholar]
- 334. Chan B. P. and Leong K. W., “Scaffolding in Tissue Engineering: General Approaches and Tissue‐Specific Considerations,” European Spine Journal 17, no. 4 (2008): 467–479. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 335. Banikarimi S. P., Mellati A., Abasi M., et al., “Cardiac Tissue Regeneration by Microfluidic Generated Cardiac Cell‐Laden Calcium Alginate Microgels and Mesenchymal Stem Cell Extracted Exosomes on Myocardial Infarction Model,” International Journal of Biological Macromolecules 292 (2025): 139247. [DOI] [PubMed] [Google Scholar]
- 336. Hann S. Y., Kang Y., Cui H., and Zhang L. G., “Microgels: From Synthesis to Tissue Regeneration Applications,” Biofabrication 17, no. 3 (2025): 032008. [DOI] [PubMed] [Google Scholar]
- 337. Ding A., Jeon O., Cleveland D., et al., “Jammed Micro‐Flake Hydrogel for Four‐Dimensional Living Cell Bioprinting,” Advanced Materials 34, no. 15 (2022): 2109394. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 338. Moon D., Song K. H., and Doh J., “Jammed Microgels Fabricated via Various Methods for Biological Studies,” Korean Journal of Chemical Engineering 40, no. 2 (2023): 267–275. [Google Scholar]
- 339. Baker B. M. and Chen C. S., “Deconstructing the Third Dimension: How 3D Culture Microenvironments Alter Cellular Cues,” Journal of Cell Science 125, no. Pt 13 (2012): 3015–3024. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 340. Chung S. E., Park W., Shin S., Lee S. A., and Kwon S., “Guided and Fluidic Self‐Assembly of Microstructures Using Railed Microfluidic Channels,” Nature Materials 7, no. 7 (2008): 581–587. [DOI] [PubMed] [Google Scholar]
- 341. de Souza Simões L., Madalena D. A., Pinheiro A. C., Teixeira J. A., Vicente A. A., and Ramos Ó. L., “Micro‐ and Nano Bio‐Based Delivery Systems for Food Applications: In Vitro Behavior,” Advances in Colloid and Interface Science 243 (2017): 23–45. [DOI] [PubMed] [Google Scholar]
- 342. Ravanfar R., Comunian T. A., Dando R., and Abbaspourrad A., “Optimization of Microcapsules Shell Structure to Preserve Labile Compounds: A Comparison Between Microfluidics and Conventional Homogenization Method,” Food Chemistry 241 (2018): 460–467. [DOI] [PubMed] [Google Scholar]
- 343. Koryakina I. G., Afonicheva P. K., Arabuli K. V., Evstrapov A. A., Timin A. S., and Zyuzin M. V., “Microfluidic Synthesis of Optically Responsive Materials for Nano‐ and Biophotonics,” Advances in Colloid and Interface Science 298 (2021): 102548. [DOI] [PubMed] [Google Scholar]
- 344. Jiao Y., Liu Y., Luo D., Huck W. T. S., and Yang D., “Microfluidic‐Assisted Fabrication of Clay Microgels for Cell‐Free Protein Synthesis,” ACS Applied Materials & Interfaces 10, no. 35 (2018): 29308–29313. [DOI] [PubMed] [Google Scholar]
- 345. Shepherd R. F., Conrad J. C., Rhodes S. K., et al., “Microfluidic Assembly of Homogeneous and Janus Colloid‐Filled Hydrogel Granules,” Langmuir 22, no. 21 (2006): 8618–8622. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Data Availability Statement
Data sharing not applicable to this article as no datasets were generated or analyzed during the current study.
